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Deoxyribozymes or DNA catalysts are synthetic single stranded DNA molecules capable of catalysis 
for a wide range or reactions. Deoxyribozymes are discovered by in vitro selection and are mostly 
dependent on bivalent metal ions for their activity. Very little is known about the structure and 
function of deoxyribozymes. The role of metal ions in the catalytic mechanism of deoxyribozymes is 
not well understood. The research presented in this thesis describes functional characterization of 
RNA ligating deoxyribozymes. In particular, the class of deoxyribozymes which form 2’,5’ branched-
RNA has been studied in detail.  
To investigate necessary nucleotides and functional groups for DNA catalysis, combinatorial mutation 
interference analysis and nucleotide analogue interference mapping of DNA have been developed. 
Additional biochemical and biophysical techniques including DMS interference, kinetic studies in the 
presence of combinations of monovalent and bivalent metal ions and trivalent lanthanides, 
phosphorothioate rescue experiments, DMS and DNase footprinting assays and spectroscopic methods  
(i.e. CD and fluorescence spectroscopy) have been employed to achieve better understanding about the 
mechanism of DNA catalysis. 
Lanthanides and specifically Tb3+ have been shown to be effective accelerators of several 2’,5’- 
branched RNA forming deoxyribozymes (e.g. 9F7, 9F13, 7S11 and 10DM24), when present in the 
appropriate concentrations. For 9F7, 100 µM Tb3+ in combination with 7 mM Mg2+ accelerated the 
enzyme up to 10000-fold. The acceleratory effect of other lanthanides (La3+, Ce3+, Gd3+, Eu3+ and 
Yb3+) was also observed when provided in concentrations ca 100 µM in combination with 80 mM 
Mg2+.  The optimal Tb3+ concentration for Mn2+-dependent reactions of 9F7, 9F13 and 7S11 was 10 
µM. In contrast to the beneficial effect of lanthanides for DNA-catalyzed branching reactions, a 
deoxyribozyme that synthesizes lariat RNA (6BX22) was inhibited by Tb3+.  
The 9F7 deoxyribozyme was studied in most detail. We have shown that presence of optimal 
concentration of Tb3+ increases the affinity of the enzyme to the active bivalent metal ion. Additional 
investigations e.g. phosphorothioate rescue experiments, foot printing and Tb3+ binding assays pointed 
toward activation of the 2’-OH at the branch site. Simultaneous coordination of the active metal ions 
with the 2’-OH electrophile and oxygen atoms of the nucleophile is conceivable.   
The ratio of the metal ions (Tb3+ and M2+) to nucleic acid components of the reaction was crucial for 
fast ligation. For 9F7 deoxyribozyme 100-fold excess of Tb3+ to oligonucleotides was required for 
preparative reactions reaching high yield within a short time. For 10DM24 deoxyribozyme, Tb3+ to 




The results of the fundamental studies on deoxyribozyme mechanism and folding reported in this 
thesis, expanded practical applications of 2’,5’ branched-RNA forming deoxyribozymes. Three 
immediate in vitro applications of branch forming deoxyribozymes have been introduced.  
Tb3+ mediated acceleration of 10DM24 was employed for post synthetic RNA labeling. The site 
specific attachment of a single guanosine to the RNA molecule in presence of Tb3+ was efficient and 
fast. Compared to the original report on using GTP as substrate for10DM24, Tb3+ accommodated the 
reaction at more neutral conditions (pH 7.5). The deoxyribozyme apparent affinity for GTP was 
significantly increased. The optimum GTP concentration for labeling was decreased from 3 mM to 10 
µM in kinetic scale. In preparative scale only 4-fold excess of GTP to RNA substrate was sufficient to 
reach high yields in less than 1 hour.  
Tb3+ mediated acceleration of 10DM24 deoxyribozyme was also employed to ligate adaptor RNAs to 
an mRNA as scaffold RNA to form a branched mRNA for in vitro translation experiments, in which 
the ribosome response to the branched mRNA was studied. The results suggested that ribosome is not 
able to bypass the branch point. The ribosomal interference has potential applications in the field of 
cellular and molecular biology.  
Preparative scale syntheses of branched RNAs with sequence similarities to the yeast actin mRNA 
have been achieved using 6BX22 deoxyribozyme. Preliminary binding assays have been performed 
with 2’,5’ branched RNA products (resembling part of the lariat RNA) and spliceosomal proteins and 






Known natural biocatalysts are mostly proteins. However, since 1980s potential abilities of nucleic 
acids became a notable scientific interest. In 1981, Tomas Cech, reported conservatively on RNA-based 
catalysis in ciliated protozoan Tetrahymena1. In 1984, Sydney Altman and his coworker announced the 
catalytic activity  of RNase P in the absence of any protein component2. Since then several natural 
ribozymes have been discovered which most of them are involved in trans-phosphorylation reactions3. 
Examples include hammerhead ribozyme4, hairpin ribozyme5 and group II intron6. Since discovery of 
the ribozymes, the catalytic ability of DNA was doubted, however, in vitro selection has been used to 
discover artificial catalytic DNAs. The first successful discovery of deoxyribozymes was an answer to 
the fundamental question about the catalytic ability of the DNA in the absence of the 2’-OH functional 
group.  
1.1 In vitro selection 
Naturally, DNA is responsible for genetic information storage and is double stranded. DNA lacks the 
properties that proteins use for catalysis such as pKa near neutral condition (as in histidines), primary 
alkyl amines (as in lysines), carboxyl groups (as in aspartates) and sulfhydryl groups (as in cysteines). 
DNA also lacks the 2’-OH group which is present in ribozymes and is anticipated to be involved in the 
catalytic mechanism of ribozymes7. Despite doubts about possibility of existence of catalytic DNAs, in 
vitro selections have been performed to discover catalytically active DNA sequences.  
In vitro selection was first used to identify artificial RNA catalysts (ribozymes). In 1990, two 
independent groups reported on strategies to select functional nucleic acids. Systematic evolution of 
ligands by exponential enrichment (SELEX) was introduced by Tuerk and Gold8. They report on a 
selection procedure to identify specific RNA ligands to bacteriophage T4 DNA polymerase. During the 
same year, Robertson and Joyce, had reported an in vitro selection strategy to enrich an RNA sequence 
with DNA cleavage activity within a randomized pool of RNA sequences9.  
In vitro selection for DNA-catalysts is performed with single stranded DNA libraries. It is anticipated 
that in a random library of DNA molecules there are sequences which can adapt to a three-dimensional 
fold that fulfills catalysis. The first in vitro selected deoxyribozyme, was a Pb2+ dependent RNA 
cleaving DNA and was discovered in 1994 by Breaker and Joyce10. The cleavage reaction obeyed 
Michaelis-Menten kinetics with a multiple turnover kcat value of 1 min-1 at 23°C and pH 7.0. The 
deoxyribozyme discovered by Breaker and Joyce provided a rate enhancement of 105-fold over the un-
catalyzed reaction.  In vitro selection starts with a random DNA library which is prepared by solid-
phase synthesis. The DNA library contains a random region (usually 40-nucleotide long, N40) embedded 
between two fixed DNA strands that serve as PCR primer binding sites. Permutation of 4 nucleotides at 





the selection procedure starts is 0.2-1 nmol which covers small portion of the sequence space (~1 out of 
1010). In vitro selection consists of several iterated rounds. The procedure of in vitro selection for 
discovery of RNA ligating deoxyribozymes is described here (Fig 1.1.-1). The general procedure of in 
vitro selection for other types of deoxyribozymes is similar with variations at the separation step.  
In the first step, DNA library is covalently attached to one RNA substrate. In the next step, by supplying 
the second RNA substrate, DNA sequences are allowed to catalyze the reaction of interest i.e. ligation 
of the second RNA to the substrate which has been already covalently bound to the DNA library. Buffer 
pH, metal ions, temperature and incubation times are adjusted according to the desired stringency. The 
selection pressure is often increased in later rounds of selection. The next step is separation of active 
molecules. For RNA ligating deoxyribozymes, separation is trivial and is based on the fact that the 
molecular weight of the entire RNA-DNA conjugate is larger for the DNA species which actively 
ligated the two RNAs. Catalytically active DNA sequences can be separated by denaturing 
polyacrylamide gel electrophoresis (PAGE). The last step of each round is (error-prone) PCR to amplify 
the active DNAs. Templated polymerase activity (PCR) results in double stranded DNA molecules. To 
separate the two strands, a DNA overhang is conjugated to the reverse primer with a non-amplifiable 
linker e.g. polyethylene glycol (PEG) or C3-alkyl linker.  The tailed-primer facilitates separation of the 
active sequence of the PCR product from its complement using denaturing PAGE. The selection is 
iterated ~8-12 rounds, enriching the population of active DNAs with the desired criteria e.g. high rate or 
reduced metal ion dependence. Finally, individual deoxyribozyme sequences are cloned, sequenced and 
characterized11.  
Here standard procedure was explained for separation of the active molecules based on the size 
difference and gel retardation. This separation strategy is not always useful. One of the challenges for in 
vitro selection is to separate only the desired active DNAs but not those sequences which perform an 
undesired reaction that lead to the same molecular weight. For example historically, attempts to discover 
deoxyribozymes which catalyze 2’-5’ or 3’-5’ linear ligation led to discovery of 2’,5’ branch forming 
deoxyribozymes. Clever strategies have been designed to overcome such problems. A negative selection 
pressure was applied after the DNA catalyzed ligation step to eliminate those active DNAs which were 
catalyzing the undesired reactions. A previously known deoxyribozyme for RNA cleavage at 3’-5’ 
junctions12 was used to cleave the ligated RNAs containing the desired 3’-5’ linkage. Those RNA-DNA 
conjugates which were not cleaved by the RNA-cleaving deoxyribozyme were anticipated to have 2’,5’ 







Fig  1.1-1 General procedure for in vitro selection of RNA ligating deoxyribozymes. In vitro selection consists of several 
rounds of enrichment of the active molecules within a random library. The first round of selection starts with a library 
of single stranded DNA with random sequences. The length of the random region of each DNA is usually 40 nucleotides. 
The donor RNA substrate is ligated to the 5’ end of the DNA library using T4 RNA ligase. The acceptor RNA substrate 
and metal ions are provided in the next step to support the enzymatic reaction of interest (here RNA ligation). Active 
molecules are separated by PAGE and amplified by PCR. For PCR a reverse primer bearing a non-amplifiable region 
(usually a C3-alkyl linker with a DNA overhang) is used which allows separation of the sense strands (the active 
sequence) from their complementary strands by denaturing PAGE. Active strands are used for the next rounds of 
selection. 
Employing oligonucleotides as substrates, in vitro selection allowed discovery of deoxyribozymes for 
catalysis of formation, or cleavage of phosphodiester bonds14. However deoxyribozymes are not limited 
to nucleic acid substrates. Deoxyribozymes  catalyze a wide range of reactions15. Examples include the 
catalysis of Diels-Alder reactions, thymine dimer repair and formation of nucleopeptide linkage 
between amino acid’s side chains and RNA molecules.  The reactions of deoxyribozymes are not always 
accommodated with large changes in the molecular weight of the active DNAs. For example in vitro 
selection for deoxyribozyme capable of dephosphorylation of a substrate is not possible by using 
standard gel shift at the separation step. The hydrolysis of the phosphate group is not sufficient to cause 
gel retardation of the DNA-substrate conjugate. In a report by Silverman and coworker on the discovery 
of phosphatase deoxyribozyme for dephosphorylation of a tyrosine in a peptide chain16, a previously 
selected deoxyribozyme17 was used to capture the dephosphorylated peptides-DNA conjugates. The 
dephosphorylated tyrosines (within the catalytically active DNA-peptide conjugate) were covalently 
attached to a DNA strand which facilitated their separation by gel shift16.   
Beneficially deoxyribozymes require only metal ions (usually Mg2+, Mn2+ or Zn2+) as cofactors for their 
catalytic activity and can easily be isolated and reused for multiple reactions. DNA catalysts can be 





next few sections several classes of deoxyribozymes are described with a wide range of catalytic 
abilities on various substrates.  
1.2 RNA-cleaving deoxyribozymes 
10-23 and 8-17 are two well-known RNA cleaving deoxyribozymes12. 10-23 has the ability to cleave 
any purine-pyrimidine junction with robust activity for A-U and G-U sites, and significantly reduced 
activity for A-C and G-C sites19. 8-17 originally was selected for the cleavage at A-G junction. Both 10-
23 and 8-17 deoxyribozymes have been selected in presence of MgCl2 but addition of MnCl2 improves 
their reaction rates. There have been several reports to generalize application of RNA cleaving 
deoxyribozymes for any dinucleotide junctions20,21.  
A variant of 8-17 deoxyribozyme, 8–17 NG, was selected for DNA substrates with a ribo-junction at the 
cleavage site. 8-17 NG best catalyzes purine-purine junctions compared to pyrimidine-pyrimidine 
junctions.20 In 2004, Cruz et al.21 performed a new in vitro selection with a randomized pool biased to 
the 8-17 sequence and predicted secondary structure. They also used DNA substrates with only one 
ribonucleotide at the cleavage junction. The outcome DNA enzymes showed modular similarities to the 
8-17. Neither of the enzymes selected by Cruz et al. were able to cleave all the possible junctions. 
Nevertheless they report efficient cleavage for the enzymes E2112 and E5112 for NrA and NrC 
junctions, E1111 for NrG and NrC junctions, E1722 for NrA and NrG junctions, E2121 for NrG 
junctions when a combination of Mg2+ and Mn2+ ions were provided. In the presence of only Mg2+ the 
substrate generality of these enzymes was shown to be more limited. One should note that these 
enzymes were selected with a DNA/RNA chimeric substrate and their activity for RNA substrate was 
not proved.21 
Most of the RNA-cleaving deoxyribozymes catalyze 2′-hydroxyl transesterification and form 2′,3′-
cyclic phosphate and 5′-hydroxyl termini. A recent report by Silverman and coworkers introduced a 
series of new deoxyribozymes for RNA hydrolysis, resulting in 3’-OH and 5’-phosphate groups of the 
cleaved products22. Employing T4 DNA or T4 RNA ligase in the capture step of in vitro selection they 
positively selected for the desired active sequences. T4 DNA ligase and T4 RNA ligase require 3’-OH 
and 5’-phosphate termini for ligation reaction. The selection emerged three classes of RNA hydrolyzing 
enzymes i.e. 9SE, 9SH and 9SK deoxyribozyme families.  Figure 1.2-1 depicts the differences of the 
reaction mechanism and products of transesterification reaction (catalyzed by 10-23, 8-17) and RNA 






Fig  1.2-1 Transesterification (A) and hydrolysis (B) reactions of RNA cleaving deoxyribozymes. Examples of 
deoxyribozymes which catalyze transesterification reactions are 10-23 and 8-17. Members of 9SE and 9SH 
deoxyribozyme family, in the other hand, catalyze cleavage of an RNA substrate by hydrolysis. 
1.3 RNA-ligating deoxyribozymes  
Since 2001, Silverman and coworkers set up several in vitro selections to find RNA ligating 
deoxyribozymes using 2′,3′-cyclic phosphate RNA with 5′-hydroxyl RNA or 3′-hydroxyl RNA with 5′-
triphosphate RNA. Theoretically, formation of native 3’-5’, non-native linear 2’-5’ or branched 2’,5’  
phosphodiester bonds are possible with both substrate combinations. However, most of the efforts to 
discover RNA ligating deoxyribozymes resulted in discovery of 2’,5’ branch forming deoxyribozymes. 
Examples include 7S1123, 9F7 24,25,6BX2226, 6CE827 and 10DM2428. 7S11 family deoxyribozymes 
adapt a specific structure by forming a three-helix junction (3HJ) that brings the nucleophile i.e. 2’-OH 
of the branch site in the vicinity to the electrophile i.e. 𝛼-phosphate of the donor RNA (Fig 1.3-1). The 
three helix junction fold of 7S11 was taken as a structural model for rational design of new 
deoxyribozymes.  
Most of the discovered 2’,5’-branch forming deoxyribozymes prefer adenosine as the branch 
nucleotide28. However, there are exceptions to this general “rule”. For example 6CE8 accepts all 
nucleotides as branch site with preferences of U>C=A>G27. 6BX22 accepts A>U>C as branch site. G 
was accepted by 6BX22 but the rate and yield of the reaction were reduced26. Interestingly, members of 
9F7 family select different nucleotide as branch site while using the same RNA substrate as the acceptor 
RNA. The RNA substrate used for in vitro selection of these enzymes contained a UAUN overhang (N 
stands for any nucleotide). 9F13 and 9F18 chose the first U overhang as branch site while 9F7 and 9F21 
take the 2’-OH of the adjacent A as their nucleophile24. 
 
Fig  1.3-1 Three helix junction (3HJ) formed by 7S11 deoxyribozyme 
family. The sequences of acceptor RNA upstream and downstream of 
the branch site are involved in formation of P1 and P2 paired 
regions. The length of the P1 is 5 nucleotides long. Additionally first 
four nucleotide of the donor RNA are involved in formation of the P4 
paired region with four nucleotides of the loop B in the catalytic core. 
P4 is extended by base pairing of the donor RNA with the right 





On the way to discover 3’-5’ ligating deoxyribozymes with high yield and acceptable reaction rate 
which can be used as general ligase (i.e. capable for N↓N ligation) two strategies have been implicated 
to increase the selection pressure in favor of 3’-5’ bond formation. In one strategy, the enzyme region 
was designed offset from the ligation junction, such that the new RNA linkage is formed within a 
duplex region. The strategy was successful and a set of enzymes were selected using this strategy which 
all form exclusively native 3’-5’ bonds but their reaction rates and generality were suboptimal. 8AY13 
was the fastest enzyme with the kobs 0.008 min-1 at 37 °C and 40 mM Mg2+, pH 9.0 (41% yield at 3 h 
incubation)30. 
In a second strategy, which is also explained in the sub chapter 1.1, an additional stringent positive 
selection was introduced to the selection rounds. DNA species which were capable of ligation and were 
up-shifted in PAGE separation were cleaved with 8-17 which was a previously selected RNA cleaving 
deoxyribozyme. 8-17 is only capable of cleaving native 3’-5’ linear bonds. Therefore, the DNA species 
which formed the native 3’-5’ linear bond were cleaved and thereby their electrophoretic mobility was 
increased in the next round of PAGE separation. Only the RNA-DNA conjugates which passed both 
positive selections were enriched by PCR, afterwards13. Two deoxyribozymes have been selected by this 
strategy; 9DB1 and 7DE5 which are capable of ligation for D↓RA and A↓R junctions where D denotes 
for A, G or U and R stands for purines A or G31. The 9DB1 reaction rate in presence of 40 mM Mg2+, 
pH 9.0 at 37 °C was 0.036 min-1. The reaction rate for 7DE5 in presence of 1 mM Zn2+, pH 7.5 at 23°C 
was 0.019 min-1. The two deoxyribozymes were shown to effectively ligate naturally relevant RNA 
sequences to form Tetrahymena group I intron P4-P6 domain (160 nt) and G-riboswitch (72 nt).  
1.4 DNA-cleaving deoxyribozymes 
The first DNA cleaving deoxyribozyme was selected during an in vitro selection experiment which 
aimed to discover a deoxyribozyme for amide bond cleavage (10MD5 family). Out of all 44 active 
DNA species no one was able to cleave any amide bond but rather their cleavage sites were inside the 
double helical DNA binding arms32.  10MD5 was characterized further for its substrate requirements 
and dependence on metal ions and pH. 10MD5 is active in presence of Mn2+ and narrow range of Zn2+ 
concentration and pH 32.  Later on deoxyribozymes were reported with better tolerance regarding pH33 
and substrate sequence generality34.  
More recently two additional classes of Zn2+ dependent DNA hydrolyzing deoxyribozymes were 
selected by Breaker and coworkers35. I-R3 was chosen as the representative of their selection which was 
shown to be solely active with Zn2+. Other bivalent metal ions such as Mg2+, Mn2+, Cu2+, Co2+, Cd2+ and 
Ni2+ did not activate the I-R3 catalysts.  
Silverman and coworker attempted in vitro selection for lanthanide assisted DNA hydrolysis in presence 





of Zn2+ and micromolar concentrations of lanthanides e.g. Ce3+, Eu3+, and Yb3+. Examples include 7YK 
and 6YJ families of deoxyribozymes. Individual members of these families were active in the presence 
of combinations of Zn2+ and various lanthanide ions. Neither of the enzymes were active in the absence 
of lanthanide ions but Zn2+ could be omitted from the reactions of members of Yb3+ dependent enzymes 
i.e. 6YL4 and 6YL2436. The two enzymes 6YL4 and 6YL24 are the first examples of DNA hydrolyzing 
deoxyribozymes which are independent from Zn2+.  
1.5 DNA-ligating deoxyribozymes 
For DNA catalyzed DNA ligation, one of the DNA strands needs to be activated in advance. In 1995, a 
deoxyribozyme was selected which was able to form the natural 3’-5’ phosphodiester bond using an 
activated 3’-phosphorimidazolide substrate37. To ligate two DNAs with 3’- and 5’- hydroxyl groups, a 
three step strategy is proposed using deoxyribozymes for each step. There has been a report on catalytic 
DNAs being capable of self-phosphorylation. The source of activated phosphate for these enzymes was 
any of the standard triphosphorylated ribonucleotides or deoxyribonucleotides38. Additionally, several 
self-capping DNAs were selected and reported. Capping deoxyribozymes catalyze the transfer of the 
AMP moiety of ATP to their 5′-terminal phosphate group, thereby forming a 5′,5′-pyrophosphate 
linkage39. Furthermore, self-ligating deoxyribozymes, which facilitate formation of 3’,5’ phosphodiester 
bond by catalyzing nucleophilic attack of their 3’-OH to their 5’-adenylated end and release of AMP 
was reported in 200440. The combination of these three catalytic DNAs would allow ligation of two 
DNA strands in vitro (Fig 1.5-1)41.  
Formation of a branched DNA by a deoxyribozyme is also reported. As an example, 8LV 
deoxyribozyme family42 use a DNA containing a single ribonucleotide as the acceptor strand and an 




Fig  1.5-1 Three step DNA ligation, using 5’- and 3’-OH bearing DNA strands catalyzed by three different 
deoxyribozymes. In the first step the 5’ end of the DNA substrate is phosphorylated in presence of Ca2+ and using ATP.  
In the second step the monophosphorylated substrate is adenylated and thereby activated using ATP and in presence of 





1.6 Peptide-modifying deoxyribozymes 
Amino acid side chains of peptides are another set of deoxyribozyme substrates. In 2008, several 
deoxyribozymes have been reported which were able to catalyze formation of a nucleopeptide linkage 
by activating the OH group present in amino acid side chains (i.e. in Tyr, Ser) for nucleophilic attack to 
the 𝛼-phosphate of a triphosphorylated RNA. The amino acid with the 2’-OH nucleophile was flanked 
by DNA strands which were designed to hybridize to the DNA binding arms and participate in 
formation of a three helix junction (3HJ) structure to facilitate catalysis. Tyr1 was selected as the 
representative of these enzymes43.  In 2011, a new selection was performed to discover DNA enzymes 
which are able to perform the same type of reaction but for a nucleophile –OH of a Tyr which was 
embedded between amino acids instead of nucleotides. 15MZ36 is a representative of this set of 
selection (Fig 1.6-1 A)17. 
Furthermore, in 2012, two enzymes were reported with the ability to distinguish phosphorylated and 
non-phosphorylated Tyr (and/or Ser) within a peptide chain; 8VM1 and 8VP1. These enzymes catalyze 
formation of a linkage between phosphorylated Tyr (or Ser) with 𝛼-phosphate of a triphosphorylated 
RNA (Fig 1.6-1 B)44. More recent, a phosphatase deoxyribozyme has been reported; 14WM916. 14WM9 
catalyzes Zn2+ dependent phosphomonoester hydrolysis of tyrosine and serine side chains (Fig 1.6-1 C). 
For 14WM9 in vitro selection, the deoxyribozyme 15MZ3617, was applied to ligate a DNA strand to the 
dephosphorylated products and therefore tag the active molecules by an increase in their molecular 
weight. 
1.7 Deoxyribozymes with small molecules as substrates 
In vitro selections for deoxyribozymes which catalyze modifications of small molecules are challenging 
due to difficulties of the capture steps. In the other hand catalysis of organic chemical reactions is of 
interest for chemists. Strategies have been developed for in vitro selection of known reactions in organic 
chemistry such as Diels-Alder or Friedel–Crafts.  
Diels-Alder reaction forms a carbon- carbon bond between a conjugated diene and a substituted 
alkene45. The deoxyribozyme, DAB2246 has been selected by Silverman and coworkers to catalyze the 
reaction in presence of Ca2+, Mn2+ or Mg2+ at pH 7.5. Friedel–Crafts reaction attaches substituents to an 
aromatic ring. There are two main types of Friedel–Crafts reactions: alkylation reactions and acylation 
reactions. Friedel-Craft alkylation reaction using an indole and acyl imidazole was subjected for an in 








Fig  1.7-1 Schematic depiction of three types of reaction catalyzed by DNA on peptide substrates. A) Nucleopeptide bond 
formation catalyzed by Tyr1 and 15MZ36. The amino acid Tyr is embedded in DNA strand (Tyr1) or peptide chain 
(15MZ36). B)  phosphor-anhydride bond formation catalyzed by 8VM1 and 8VP1. For 8VP1 a phosphorylated serine is 
accepted as well. C) Phosphatase reaction catalyzed by 14WM9.  The red lines indicate triphosphorylated RNAs. The 
black lines indicate either DNA or peptide chains. The green lines represent peptide chains. 
In addition to Diels-Alder and Friedel-Craft deoxyribozymes, in vitro selection revealed DNA aptamers 
which bind porphyrins such as N-methylmesoporphyrin IX (NMM) and catalyze their metalation with  
Cu2+ or Zn2+48. It has been discovered that Fe (III)-porphyrin IX (hemin) competitively binds to the 
same DNA aptamers. Hemin, is a cofactor of variety of enzymes e.g. peroxidases and monooxygenases 
and has intrinsic oxidation activity49. The oxidative activity of hemin was enhanced upon binding to 
these DNA aptamers which encouraged scientists to apply the deoxyribozyme peroxidase50 in 
biosensors.  
1.8 Generality of deoxyribozymes 
Most of deoxyribozymes are involved in formation or breaking of a P-O bond. Examples include all 
RNA ligating or cleaving deoxyribozymes, phosphorylating38, adenylating39 and DNA ligating40 
deoxyribozymes and also all the deoxyribozymes reported for peptide modification. DNA enzymes are 
not limited to catalysis of formation and hydrolysis of P-O bonds. For example Diels-Alder 
deoxyribozyme (DAB22) catalyzes formation of a C-C bond46 . UV1A and UV1C deoxyribozymes 
which catalyze thymine dimer photo reversion, break a C-C bond51,52. Although in vitro selection is 
reported to be challenging when an N atom is the nucleophile or the leaving group53 there are reports for 
successful reductive amination (formation of  C-N bond) 54 or breaking an N-glycosidic bond of a 5’ 
terminal guanosine of a DNA substrate ( C-N bond, 10-28 55 and 10FN1056, catalyzing deglycosylation). 
One common question about catalytic nucleic acids is when a specific sequence of RNA (a ribozyme) 
can catalyze one type of reaction, is the same sequence of DNA (possibly with a couple of mutations) 
capable of catalyzing the same reaction. Another common question is what are the rate differences 
between a deoxyribozyme and a ribozyme that both catalyze the same reaction type. The reports on the 
nucleic acid enzymes performing Diels-Alder reaction addressed such questions.  The first report for 
Diels-Alder reaction by nucleic acid catalysis was on a ribozyme (39M49) 57,58. Based on the 39M49 
sequence Chandra and Silverman started new in vitro selections with a library of random sequence 





Alder reaction. The best outcome of the selection, DAB22 (introduced in section 1.7), was from the 
biased pool and showed similar activity to the ribozyme 39M49 but it had 13 mutations relative to it. 
The mfold-predicted secondary structures of the two enzymes were quite dissimilar. Therefore, it was 
concluded that although DAB22 has been selected from the biased pool, it is a new catalytic sequence46.  
1.9 Applications of deoxyribozymes 
Currently, most of the applications of deoxyribozymes e.g. DNA computing and molecular logic gate 
designs18 or in vivo applications59 in the direction of therapeutics60,61 are based on RNA cleaving 
deoxyribozymes. For applications of deoxyribozymes in biological context, the main challenge is 
delivery and stability of the deoxyribozymes. In situ production of single stranded DNAs has been 
reported using an expression vector containing Moloney mouse leukemia virus reverse transcriptase 
(MMLV-RT) and the deoxyribozyme sequence under a T7 promoter. The deoxyribozyme sequence was 
transcribed to RNA and subsequently reverted to the single stranded stage by MMLV-RT62. 
Alternatively, in situ synthesis of deoxyribozymes was achieved by insertion of the deoxyribozyme 
sequence inside M13 bacteriophage DNA which provided amplification of the deoxyribozyme sequence 
using rolling circle amplification (RCA)63.  
Aptamers are single stranded DNA or RNA molecules which form a unique conformation with specific 
recognition abilities to target molecules. Aptamers are in analogy to protein antibodies and are applied 
in research and therapeutics64 with the same logic but have advantageous aspects to protein antibodies. 
Aptamer and deoxyribozymes are easily synthesized compared to protein enzymes. They can adapt the 
active fold even after denaturation by heat or absence of the required metal ions, when the amenable 
temperature and metal ions are present again. Additionally, aptamers can respond to presence of small 
targets e.g. non-chelated metal ions such as Pb2+ or Mg2+, while in the other hand protein antibodies are 
limited when the target molecule is not immunogenic. In vitro synthesis is another advantage of nucleic 
acid aptamers and deoxyribozymes since production of protein antibodies gets limited when the target 
molecules are toxic.  
Aptamers and deoxyribozymes are employed as part of biosensors. Biosensors consist of recognition 
and signal transduction modules which are connected to a proper readout system. Aptamers only serve 
as the recognition motif while deoxyribozymes can perform both tasks (recognition and signal 
transduction). When a deoxyribozymes is used, the target molecules must either accelerate or inhibit the 
enzyme65. Until now a vast number of aptamers, ribozymes and deoxyribozymes have been selected in 
vitro for a wide range of target molecules with different target specificity and sensitivity. Ellington and 
co-workers have created a searchable online aptamer database. The database was started with 239 
published aptamers and unnatural ribozymes discovered until 200466. More recently a new database for 





There are three types of biosensors based on their readout systems i.e. fluorescent, colorimetric or 
electrochemical readout systems. Peroxidase deoxyribozyme68 is an example which is combined with a 
fluorescent detector. Several reports are available which use peroxidase deoxyribozyme e.g. for 
detection of Pb2+ in blood samples69. 
The peroxidase deoxyribozyme catalyzes oxidation of non fluorescent substrate to highly fluorescent 
substrates by H2O270,71. It is employed in the same way that protein peroxidase HRP (horseradish 
peroxidase) is applied in ELISA68. 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)72,73, 
3,3’,5,5’-tetramethylbenzidine sulfate (TMB)74 or Amplex UltraRed (AUR)69 are examples of the 
substrates used for peroxidase activity in biosensors. The enzyme performs multi-turnover reaction 
which allows signal amplification.  
First generations of colorimetric biosensors were based on Pb2+ dependent RNA cleaving 
deoxyribozymes and metallic nanoparticles. Metallic nanoparticles have high extinction coefficient and 
distance-dependent optical properties. Therefore their aggregation level can be monitored by UV-Vis 
spectroscopic methods. In an 8-17 based biosensor reported by Liu et al. in 2003, single stranded DNAs 
were immobilized on gold nanoparticles (AuNPT). RNA substrates of 8-17 deoxyribozymes had an 
overhang complementary to immobilized DNAs (Fig 1.9-1). Before RNA cleavage formation of 
aggregates of AuNPs was possible because the RNA-deoxyribozyme complexes bridged the AuNPs. 
Nanomolar concentrations of Pb2+ resulted in cleavage of the RNA substrates and dispersion of the 
AuNPT75.  
Using 8-17 for detection of Pb2+ requires that the enzymes is exclusively active in the presence of Pb2+ 
but no other metal ions. Although, it has been shown that the enzyme 8-17 is active in the presence of 
absence 4 M Li+ when no Pb2+ is present,  the reaction rate was ~200’000 fold slower for 4 M Li+. This 
is considered as an excellent selectivity of Pb2+ over the large excess of monovalent metal ions76. 
 
Fig  1.9-1 Colorimetric biosensor for Pb2+ detection. Single stranded DNAs (gray) were immobilized on the surface of 
gold nanoparticles (AuNPTs). In the absence of Pb2+ the 8-17 deoxyribozymes (green) forms bridges between AuNPTs 
and causes aggregation of AuNPTs. The DNA-RNA complex bridges are destabilized upon presence of Pb2+ and 
cleavage of the RNA substrates. Dispersion of the AuNPTs is detectable by colorimetric methods. Figure is adapter 





Electrochemical sensing has advantages over fluorescent or colorimetric methods. The instrumental 
setup for electrochemical sensors cost less and easy signal amplification results in higher sensitivity. In 
a case report, Pb2+ dependent 8-17 deoxyribozyme was immobilized onto a gold electrode via its 5’ end. 
A methylene blue (MB) group was attached to the 3’ end of the enzyme. While the RNA substrate was 
hybridized to the enzyme, the stiff RNA-DNA duplex of the substrate-enzyme binding arms kept the 
MB group away from the surface and therefore electron transfer between the surface and MB was 
reduced. Upon presence of nanomolar concentration of Pb2+ the RNA substrate was cleaved and 
released and the electron transfer rate between the MB and the surface was increased77. 
Most of the applications described above were based on RNA-cleaving deoxyribozymes or the 
peroxidase deoxyribozyme. However, RNA-ligating deoxyribozymes have the potential for future 
applications. Deoxyribozymes application can be expanded for RNA labeling and RNA 
functionalization based on RNA-ligating deoxyribozymes78 . Labeled RNAs are used to study functional 
and regulatory RNAs. Current RNA labeling methods directly incorporate modifications via solid-phase 
synthesis and therefore are limited in the length of the synthesized labeled RNA fragment. Usually, for 
RNA molecules larger than 50 nucleotides, several smaller labeled RNA fragments are prepared and 
ligated via T4 RNA or T4 DNA ligases. In a new approach by our group the 3’-5’ ligating 
deoxyribozyme 9DB1 was applied to ligate labeled fragments of SAM III riboswitch79. 
During the last decade, lots of regulatory RNAs have been discovered and extensively studied. siRNAs 
and miRNAs in eukaryotic cells function in transcriptional or post-transcriptional level, based on 
complete or partial complementarity to the target mRNA80,81. Studies have also shown small RNA 
dependent regulation in prokaryotes and archaea82. Small RNAs (sRNAs) interfere with transcription or 
translation of mRNAs. sRNAs are responsible for several aspects of bacterial life e.g. environmental 
adaptation, virulence and sensation of metabolites83.  Another class of RNA regulators that are involved 
in sensation of metabolites is riboswitches. Binding of the riboswitches to their ligands stabilizes 
conformations which trigger transcriptional or translational initiation or termination, causing on or off 
switches for the downstream genes84. Riboswitches are also involved in RNA stabilization e.g. 
glucosamine-6-phosphate activated riboswitch (glmS)85 and eukaryotic cellular processes such as 
alternative splicing e.g. thiamin pyrophosphate (TPP) riboswitch 86,87.  
An additional potential applications for deoxyribozymes which are able to form 2’,5’ branched RNA is 
synthesis of lariat RNAs. Lariat RNAs are intermediate products of splicing reactions by spliceosome88 
or Group II introns89. Structurally, a lariat RNA is a 2’,5’ branched RNA in which the strand extended 
from 2’ of the branch site loops around to be the same RNA strand which provides the branch site (Fig 
1.9-2). For in vitro synthesis of lariat RNAs two strategies are available: 1) two-step strategy which 
consists of formation of an inter-molecular 2’,5’ branched RNA and subsequent closure of the loop by 





latter, to form a lariat RNA, the provided RNA substrate need to serve as both donor and acceptor and 
binds to both binding arms of the deoxyribozyme.  
 
Fig  1.9-2 Deoxyribozymes mediated lariat formation. For lariat formation, the donor RNA which is normally 
hybridized to the right binding arm of the deoxyribozyme, loops around and hybridizes to the left binding arm of the 
deoxyribozyme to provide the nucleophile and fulfill the task of the acceptor RNA. 
Lariat RNA formation is intrinsically more difficult compared to simple 2’,5’ branched RNA. The loop 
closure may constrain the appropriate hybridization of regions of the RNA which must bind to 
deoxyribozyme. Secondly, the loop present in the lariat RNA may evolve secondary and tertiary 
structures interfering with the deoxyribozyme activity. Thirdly, partial complementarity between the 
loop sequence and the catalytic core could interrupt formation of the active fold. A large number of 2’, 
5’ branch forming deoxyribozymes are discovered, with the most effective one being 7S11, raising the 
hope for in vitro formation of lariat RNAs24 but only one enzyme, 6BX22, is reported being capable of 
formation of lariat RNAs using biologically related RNA substrates26. 
In summary, the considerably emerging field of nanobiotechnology can benefit from advances in the 
field of DNA-catalysts. Understanding the basics of a system (here DNA catalysis) promotes further 
development of the application of that system. Functional characterization of deoxyribozymes would 
open new routes to improve deoxyribozyme applications.  
1.10 Functional characterization of (deoxy) ribozymes 
Functional studies and understanding the mechanism and sequence requirements of deoxyribozymes 
promotes engineering and expanded application of deoxyribozymes in molecular biology and 
nanotechnology. Little is known about the mechanism of deoxyribozymes from chemical point of view 
and our understanding about three dimensional folding of deoxyribozymes are limited. There are 
programs e.g. “mfold” to predict possible secondary structures. “mfold” is based on  Michael Zuker 
algorithm which was proposed in 198191 to calculate minimum free energy (MFE) structure of a given 
DNA or RNA sequence. MFE algorithm is used by several other secondary structure prediction 
programs such as “RNAfold”92. Mathematical MFE algorithm in combination to constraints from 
biochemical data such as DNase /RNase cleavage patterns or selective 2′-hydroxyl acylation analyzed 
by primer extension (SHAPE) lead to more accurate prediction of secondary structures, implicated in 





are not directly applicable for functional DNAs. Software, methods and strategies should be developed 
for investigation of the structure and function of catalytic DNAs. 
Crystal structure of the RNA cleaving enzyme 10-23 in complex with its inactivated substrate (2’-OMe 
modification at the cleavage site) was reported in 1999 by Joyce and coworkers94.  The reported 
structure consisted of two 10-23 DNA and two RNA substrates forming four stems of DNA binding 
arms and RNA substrates. The catalytic cores of the two 10-23 DNAs were hybridized together with 
two four way junction on both sides of the hybridized region forming the fifth stem (Fig 1.10-1). 10-23 
deoxyribozyme contains the sequence GCTAGCT in its catalytic core. This sequence is partly 
palindromic. In the reported structure the two four-way junctions provided an additional extra A in the 
5’ of the sequence and resulted in formation of an 8-nucleotides long stem in the catalytic core of the 
2:2 DNA-RNA complex. Such structure was not in agreement with the biochemical data. The rate 
constant for the enzyme 10-23 was reported to be independent from the enzyme concentration. 
Therefore, the crystalized specimen which required two DNA could not resemble the active structure.  
Fig  1.10-1 Crystal structure of 10-23 deoxyribozyme A) 
The RNA cleaving deoxyribozyme 10-23 and the inactive 
substrate used for crystallization. The adenosine at the 
cleavage site was inactivated with replacement of its 2’-
OH by 2’-OMe.  B) The schematic depiction of crystal 
structure of 10-23. Two 10-23 DNA and two RNA 
substrates participated in formation of extended stems. 
Each substrate was hybridized to both DNA binding 
arms upstream and downstream of the cleavage site. In 
this scheme, substrates are shown in red. DNAs are 
shown in green or black.  
1.10.1 Role of metal ions  
Ribozymes and deoxyribozymes are highly dependent on metal ions for folding95,96 and catalysis97,98. 
Most of the natural ribozymes are dependent on both K+ and Mg2+ as the two abundant metal ions in 
contact to nucleic acids in cellular environment. Cytosolic concentrations of  free Mg2+ and K+ are  0.2-
1 mM and 140 mM respectively99,100. In vitro selected (deoxy) ribozymes in the other hand are normally 
selected in presence of sodium chloride and a combination of bivalent or trivalent metal ions and are 
mostly dependent on bivalent metal ions such as Mg2+, Mn2+ and Zn2+. Specific types of 
deoxyribozymes are also reported to strictly being active in presence of trivalent lanthanide ions36. 
To neutralize the negatively charged backbone of nucleic acids a “metal ion atmosphere” must surround 
(deoxy) ribozymes. Individual metal ions have different commitment. Some metal ions are only 
transiently present and are exchanged with the metal ions in the bulk solution. Diffusely bound101 metal 
ions are normally not detectable in X-ray crystallographic data. The charge-screening metal ions 
decrease the electrostatic repulsion between the phosphate groups and allow compact folding of the 





In the first hydration shell of charged molecules (metal ions or phosphate groups of DNA), the water 
molecules are strongly arranged with pronounced orientations towards or away from the ion102. For 
example Mg2+ predominately binds to six water molecules in an octahedral geometry. For diffusely 
bound metal ions water shell maintains intact and the anionic and cationic charges interact via Columbic 
interactions through solvent103. There are two types of site bound metal ions. Outer sphere coordination 
is defined when the water shells of a metal ion and a phosphate group or any other electronegative 
functional group of nucleic acids share one or more water molecule. Inner sphere binding is defined 
when the two charges are in direct contact without an intervening water molecule (Fig 1.10-2). 
Dehydration of the two charges causes an enthalpic burden on the system which is compensated by 
consequent direct interaction of the two charges104.  
 
Fig  1.10-2 Modes of metal ion binding to nucleic acids A) diffuse binding in which the solvation shell of the ion and its 
phosphate ligand remain intact B) outer sphere complex in which the ion and its ligand share their solvation shells C) 
inner sphere complex in which the ion and its ligand make direct contact without any water bridge. Mg2+ ions are 
green; water molecules are blue, phosphorous atoms are yellow and oxygen atoms are red. Water shells are defined by 
dotted lines. The figure is adapter from104. 
Strong dependence of (deoxy) ribozymes to metal ions raised ideas that suggest (deoxy) ribozymes are 
metaloenzymes. However, it is possible that the metal ions are only important for the formation of the 
active fold and are not present in the catalytic center and the reaction is facilitated by general acid base 
catalysis, destabilization of the substrates or stabilization of the charge or shape of the transition state105. 
Several investigations on the dependence of (deoxy) ribozyme on metal ions proved that catalytic DNAs 
or RNAs are not necessarily metaloenzymes. 
Despite general dependence of (deoxy) ribozymes on bivalent metal ions, there are examples of (deoxy) 
ribozymes which their activity is solely dependent on monovalent metal ions. Deoxyribozymes which 
have a G-quadruplex in their active structure are only dependent on monovalent metal ions. Thymine 
dimer repair deoxyribozymes UV1A and UV1C are two examples which their exclusive dependence on 
K+ and Na+ but not on Li+ and bivalent metal ions allowed prediction of presence of a G-quadruplex in 
their structure106. Additional supporting data such as DMS probing of the folded UV1A51 proved this 
prediction. Involvement of a G-quadruplex in UV1C was further confirmed by 6-methylisoxanthopterin 
(6MI)107 substitution for single guanine residues within UV1C. Additionally, 6MI substitution improved 
the UV light sensitivity of the modified UV1C to violet region (345 nm)52. 
Additionally, Geyer and Sen performed in vitro selection of RNA cleaving ribozymes which were active 





performed in the presence of 1 M Na+ at pH 7.0 but the best activity was observed with 0.5 M Na+.  
They have shown addition of Zn2+, Pb2+, Mg2+ and Ca2+ does not significantly improve the reaction105.  
Hammerhead and hairpin ribozymes are shown to be active in presence of high concentrations of 
monovalent metal ions (4 M Li+) or even non-metallic cations (4 M NH4+  or [Co(NH3)6] +3) 108 ,109. 
Hairpin ribozyme was 10-fold slower in presence of 4 M Li+ when compared to its activity in presence 
of 10 mM Mg2+. Grasby and coworkers109 have proved enzymatic activity of hairpin ribozyme in 
presence of Cobalt (III) hexamine and proposed that metal ions play a passive role in the hairpin 
ribozyme catalysis and are probably required only for structural purposes. 
The in vitro selected RNA cleaving deoxyribozyme  8-17 was also shown to be active in presence of 4 
M Li+ or NH4+  but not with any other monovalent metal ion or cobalt hexamine76. However its activity 
was 1000-fold slower in presence of 4 M Li+ compared to its activity in presence of 10 mM Mg2+. The 
8-17 enzymatic activity in presence of 4 M Li+ was ~200’000-fold slower than its activity in presence of 
100 µM Pb2+, making the 8-17 deoxyribozyme a great choice as a lead sensor.  
In the absence of three dimensional structures, spectroscopic techniques are helpful to investigate metal 
ion binding sites and their role in catalysis. Many of the metal ions involved in deoxyribozyme folding 
and catalysis such as Na+, K+, Zn2+, Pb2+and Mg2+ do not have rich spectroscopic properties. Although 
Mn2+ is paramagnetic and can be applied as a probe in EPR studies110, it is required in mM ranges for 
deoxyribozyme activities, and high levels of free Mn2+  in solution can bury the signal of bound Mn2+. 
Lanthanides are spectroscopically rich elements and can be used for such studies.  
1.10.2 Lanthanides and nucleic acids  
The fifteen lanthanide elements, [Xe] 4fn 5s2 5p6, are known as rare-earth elements. Lanthanides are 
commonly denoted as Ln and possess atomic numbers from 57 to 71. Lanthanides consist of Lanthanum 
(La), Cerium (Ce), Praseodymium (Pr), Neodymium (Nd), Promethium (Pm), Samarium(Sm), 
Europium (Eu), Gadolinium (Gd), Terbium (Tb), Dysprosium (Dy), Holmium (Ho), Erbium (Er), 
Thulium (Tm), Ytterbium (Yb), Lutetium (Lu).  
The filling of the 4f orbitals from La to Lu is accompanied by a smooth decrease in ionic radii and pKa 
of the bound water to the metal ions of the series111. The decrease in lanthanides’ ionic radii is known as 
“lanthanide contraction”.  Considering the effective ionic radii reported by Shannon and Prewitt in 
1976112, in the beginning of the lanthanide series eight-coordinate ionic radii of La3+ and Ce3+ are 1.160 
and 1.143 Å . The ionic radii of the last two members of the lanthanide series, Yb3+ and Lu3+, are 0.985 
and 0.977 Å respectively. The Shannon ionic radius of biologically abundant Mg2+ ion with 
coordination number of eight is 0.89 Å. Because of similarities of the size of lanthanides and 
magnesium ions, lanthanides are considered as useful probes of metal binding sites for biomolecules 





For lanthanides, the geometry of the first coordination shell is not determined by the type of the 
lanthanide ions but mainly by the electrostatic attraction of charged ions of solvent molecules or by 
electrostatic and steric repulsion between the solvent molecules36. The coordination number of the 
aquatic trivalent lanthanides changes from nine for the lighter ions (La3+ to Nd3+) to eight for the heavier 
ions (Gd3+ to Lu3+)114.  
As a consequence of 4f orbitals shielding by filled 5s and 6p orbitals, direct photoexcitation of 
lanthanides give rise to extremely weak luminescence upon electric dipole transitions between states 
with configuration of 4fn. In aqueous solution, the weak signal is further suppressed upon non-radiative 
relaxation through OH oscillators of water115. Therefore, when free in water, due to the low molar 
absorptions of lanthanides they can only be effectively excited by lasers. Lanthanide luminescence can 
be significantly enhanced by chelating ligands in a process called “sensitization”. 
In sensitized luminescence of lanthanides a ligand acts as antenna or sensitizer. The ligand is excited 
and passes its energy efficiently and non-radiatively to the lanthanide ion. The hard Lewis acidity of the 
lanthanide ions results a specific preference for ligands with atoms that can act as hard Lewis bases. 
Therefore,  combinations of amines and carboxylic groups116 are commonly used in lanthanide 
ligands117 such as  1,4,7,10- tetrakiscarboxymethyl-1,4,7,10-tetraazacyclododecane (DOTA)118. 
Sensitized lanthanide luminescence was employed in wide range of applications. As an example, a short 
hairpin RNA was studied using sensitized luminescence of Tb3+ in complex with DOTA119. Ligand 
mediated Tb3+ luminescence was also used for double stranded DNA detection120. Terbium-complex 
with difloxacin (DFX) was shown to specifically enhance luminescence intensities with double stranded 
DNA while single stranded DNA increased the luminescence less strongly.  
Additionally, lanthanides can be sensitized directly by nucleic acids. To this end, lanthanides must be 
bound to nucleic acids by some degrees of inner sphere coordination. For diffuse lanthanides or the ones 
with outer sphere coordination, luminescence is non-radiatively quenched by the first layer of water 
shell121. In a study by Feig et al. it was proposed that in a DNA sequence the keto tautomer of guanines 
can coordinate Eu3+ via N7 and O6 sites. The enol tautomer of guanines were proposed to be able to 
coordinate to both Tb3+ and Eu3+ via N1 and O6 sites.113 
Sensitized luminescence of Tb3+ and Eu3+  have been used for detection of G-quadruplex forming 
DNAs122,123. Sensitized luminescence of Tb3+ upon binding to G-quadruplex forming DNAs suggested 
that Tb3+ occupies the central cavity of G-tetrads of a quadruplex.  The hypothesis was further proved 
by CD spectroscopy and FRET analysis of two covalently bound fluorophors upon Tb3+ titration124. 
Binding of lanthanide ions to biologically relevant RNAs e.g. tRNA125 and hairpin ribozyme126 had 
great impact on understanding the properties of metal ion binding sites of these natural sequences. In 
addition to the direct sensitized luminescence studies, luminescence resonance energy transfer 





natural systems such as U2-U6 snRNA complex.   Based on LRET and in combination with 
biochemical and mutational studies three metal ion binding sites were proposed for U2-U6 snRNA 
complex, in consensus sequence ACAGAGA, AGC triad and internal stem loop (ISL) of U6 snRNA121. 
More recently the activity of G-quadruplex hemin deoxyribozyme was promoted upon presence of Tb3+ 
as a stabilizer of the G-quadruplex74.  
The application of lanthanides in molecular biology is not limited to luminescence studies. Tb3+ 
footprinting assays have been used to study natural folding of RNA molecules such as tRNA128 or 
Hepatitis Delta Virus (HDV) ribozyme129. Micromolar concentration of Tb3+ can probe metal ion 
binding sites via site-specific cleavage while millimolar concentrations of lanthanides are normally used 
for Tb3+ footprinting assays based on the accessibility of the RNA backbone to the solution126. The 
ability of lanthanide ions for phosphodiester bond cleavage was shown to be enhanced when 
coordinated with synthetic complexes consistent of pyridyl, hydroxyl-benzyl and nitro functional 
groups130. Enhanced RNA strand scission of lanthanides complexes were further developed toward 
designing artificial sequence- specific ribonucleases131.  
Lanthanides also have been used in biochemical assays for functional studies of ribozymes. For 
hammerhead ribozyme or the leadzyme a bell-shaped titration curve was observed upon titration of 
lanthanide  in the presence of standard bivalent metal ions i.e. La3+ titration for Mg2+ dependent reaction 
of hammerhead132 and  Nd3+ titration for Pb2+ dependent reaction of leadzyme133. These observations led 
to the hypothesis of a two-metal ion mechanism for catalysis of RNA cleavage134. Two-metal ion 
mechanism was proposed as a general mechanism for RNA cleaving activities of other catalytic RNAs 
e.g. RNase P hydrolysis of tRNA precursor or group I and group II intron self-splicing97.  For two-metal 
ion mechanism, one of the metal ions activates the attacking water or sugar hydroxyl at the cleavage 
site, while the other metal ion coordinates and stabilizes the oxyanion leaving group. Both ions act as 
Lewis acids and stabilize the expected pentavalent transition state.  
The RNA cleaving deoxyribozyme 8-17 was inhibited upon presence of micromolar concentrations of 
Tb3+. 135 In contrast, lead dependent deoxyribozyme accepted Lu3+, Tm3+ and Tb3+ as cofactor for RNA 
cleavage catalysis111. The lead dependent deoxyribozyme was active in presence of 60 µM of lanthanide 
and 10 mM Mg2+ when Zn2+ was absent. Recently, new deoxyribozymes were selected in vitro which 
strictly require lanthanides in addition with Zn2+.36 
Altogether, lanthanides have been proven to be useful as a probing agent for biophysical and 
biochemical studies of metal ion binding sites of (deoxy)ribozymes. The Mg2+ binding sites of several 







1.11 Solid phase synthesis of nucleic acids 
In parts of this thesis, combinatorial libraries of DNA/RNA chimera have been synthesized using the 
standard protocol for solid phase synthesis of RNA which is described in this section. Solid phase 
synthesis of RNA is usually performed on controlled-pore glass (CPG) or polystyrene solid supports. 
Phosphoramidite oligonucleotide synthesis proceeds in the 3′- to 5′-direction (opposite to the 5′- to 3′-
direction of DNA and RNA biosynthesis). RNA synthesis consists of iterated rounds of a cycle with 
four steps; 1) coupling of the new phosphoramidite to the immobilized growing RNA strand, 2) 
Capping 3) oxidation of the phosphorus atom in the backbone, and 3) detritylation and formation of a 
free 5’-OH of the growing RNA strands (Fig 1.11-1).  
The building blocks of RNA synthesis (phosphoramidites) bear several orthogonal protection groups. 
The 5’-OH is protected by 4,4′-dimethoxytrityl (DMT).  The 2’ position bears a 
[(triisopropylsilyl)oxy]methyl (TOM) protection group. The phosphoramidite moiety bears a ß-
cyanoethyl protection group and contains a diisopropylamino group. Before each round, mild acidic 
conditions are used for removal of the 5’-DMT group of the growing strand. DMT cation has absorbtion 
at 498 nm136 which is usually monitored as the efficiency of the last coupling step. After removal of the 
DMT group and washing steps, the new phosphoramidite is incubated in presence of an activator and 
water-free acetonitrile. The activator is usually tetrazole or its derivative e.g. 5-Benzylthio-1H-tetrazole 
(BTT). 5′-hydroxyl group of the growing RNA strand attacks the phosphorus atom of the 
phosphoramidite moiety. Diisopropylamino group is released and a phosphite triester bond is formed 






Fig  1.11-1 Solid phase synthesis of RNA. Synthesis starts with detritylation of the first phosphoramidite which is 
immobilized on solid support by an ester linkage. In each round, one phosphoramidite is coupled. The synthesis is 
continued by two capping steps before and after oxidation step. Final step of each round is deprotection of the 5’-DMT 
group. After final round, the synthesized RNA strands are cleaved off the support and get deprotected. 
The unreacted strands are capped with an acetyl group in capping step using acetic anhydride. The 
phosphite triester formed in the coupling step is unstable to acid and must be converted to a stable 
pentavalent phosphate tri-ester prior to the next acidic detritylation step. Oxidation is performed in 
presence of iodine, water and pyridine. The phosphate group remains protected by the cyanoethyl group. 
The cyanoethyl group prevents undesirable reactions at phosphorus during subsequent synthesis cycles. 
Before the next coupling step, an additional capping step is necessary to remove any remained water 
molecule from oxidation step. The synthesis is continued by detritylation of the incorporated 
phosphoramidite.  
After synthesis and final detritylation, one hour room temperature incubation with concentrated 
ammonium hydroxide efficiently hydrolyses the ester linkage of the synthesized strands and the solid 
support. The incubation is prolonged to 16 h at 55°C to deprotect the nucleobases from the acetyl and 
benzyl protection groups. The silyl moiety of the 2’ protection group (TOM) is fluoride-labile137. The 






DNA synthesis is similar to RNA synthesis with slight differences. The 2’ deoxy position does not 
require any protection group therefore DNA phosphoramidites are synthesized in fewer steps compared 
to RNA phosphoramidites138. The coupling efficiencies of DNA phosphoramidites are higher than RNA 
phosphoramidites due to less steric hindrance.  The coupling times for DNA phosphoramidites are 
therefore shorter than RNA phosphoramidites. Finally, the last deprotection step of RNA (removal of 
TOM group) is not required for DNA oligos.  
 
Fig  1.11-2 Activation, coupling and oxidation steps during RNA solid phase synthesis. In the first step, tetrazole or a 
tetrazole derivative protonates the nitrogen atom of the phosphoramidite moiety. After coupling and formation of a 






1.12 Thesis outline 
Fundamental mechanistic study of deoxyribozymes is the main focus of this scientific report. Functional 
characterization of deoxyribozymes is necessary to expand their applications in molecular biology. The 
2’,5’-branched RNA forming deoxyribozymes which are a specific type of ligating deoxyribozymes 
were chosen for analysis and investigations. In this thesis, the research is presented in two main 
chapters.   
Chapter 2 describes functional characterization of 2’,5’-branched RNA forming deoxyribozymes. An 
efficient method for combinatorial mutation interference analysis (CoMA) is introduced to investigate 
nucleobase requirements of deoxyribozymes. Identifications of the essential nucleotides of 2’,5’- 
branched RNA forming deoxyribozymes is described in this chapter. The results of the CoMA were 
further validated using biochemical and biophysical approaches. The effects of lanthanide ions on the 
ligation rates of deoxyribozymes have been extensively studied. The kinetic studies in presence of 
lanthanide revealed exciting acceleration effect upon presence of lanthanides which was beneficially 
utilized for the application of deoxyribozymes.  
The focus of chapter 3 is on application of RNA ligating deoxyribozymes. Preparative synthesis of 
2’,5’-branched RNAs was the first immediate application of this type of deoxyribozymes.  Tb3+ 
mediated acceleration reduced the reaction times also in preparative scale. Experiments have been setup 
to build up platforms of using branched RNAs to answer questions of molecular biology. Preliminary 
data on RNA-RNA and RNA-protein interactions of components of yeast spliceosome in vitro with 
2’,5’-branched RNAs and in vitro translation using branched RNAs as the template are described 
shortly in chapter 3. The binding assays have been in collaboration with the group of Dr. Vladimir Pena, 
Research Group Macromolecular Crystallography at Max Planck Institute for Biophysical Chemistry 
(MPI-BPC), Göttingen, Germany and the group of Professor Reinhard Lührmann, department of 
Cellular Biochemistry at MPI-BPC.  The in vitro translation studies were in collaboration with the 
group of Professor Marina Rodnina, the department of Physical Biochemistry at MPI-BPC.  
The main application described in chapter 3 is based on the benefits of Tb3+ for post-synthetic 
attachment of (labeled-) GTPs to RNA molecules by deoxyribozymes. Conditions for preparative GTP 
attachment to model RNA and biologically relevant RNAs in presence of Tb3+ have been optimized and 
reported. Additionally, strategies have been proposed for purification of (labeled-)GTP-attached long 
RNA molecules. The removal of non-GTP-attached RNAs is especially crucial when double labeling of 
a long RNA is aimed. The chapter 4 of the thesis is a general discussion on the characterization and 
application of deoxyribozymes. Material and methods are described in chapter 5. Chapter 6 includes 




2 Functional characterization of deoxyribozymes 
At the time of start of this project, traditional approaches e.g. deletion or point mutations were available 
for characterization of functional DNAs e.g. deoxyribozymes. Analysis of single point mutants is 
laborious and does not provide comprehensive insights. We developed a new approach for 
combinatorial and reliable simultaneous investigation of individual nucleotides of functional DNA i.e. 
combinatorial mutation interference analysis (CoMA)139. CoMA revealed functionally important 
nucleotides in two deoxyribozymes, 9DB131 and 7S1123 and led to engineer the enzyme 9DB1 to a 
minimized version. Knowing necessary nucleotides for catalysis, the next step was investigation of the 
functional groups of those necessary nucleotides. To this end, nucleotide analogue interference mapping 
of DNA (dNAIM) was developed in our lab140. In this study CoMA and dNAIM have been used to 
investigate 2’,5’-branched RNA forming deoxyribozymes. The two methods are described in the next 
section. 
2.1 Combinatorial mutation interference analysis (CoMA) 
CoMA consists of four steps, 1) combinatorial solid phase synthesis of mutant libraries, 2) separation of 
active mutants, 3) Site-specific cleavage at the mutation sites and 4) analysis of interference pattern by 
denaturing PAGE. The first step is preparation of mutant DNA libraries. In each library, the mutation 
sites are encoded by a 2’-hydroxyl group as a chemical tag. Solid phase synthesis of such DNA-RNA 
chimeras demands precautions and procedures of RNA synthesis. 
Solid phase synthesis is an orthogonal chemical procedure which employs protected (deoxy) 
ribonucleoside phosphoramidites as building blocks. Single stranded nucleic acids are synthesized in 3’ 
to 5’ direction. CoMA employs standard procedure of RNA solid phase synthesis (described in section 
1.10). The pohsphoramidite solutions used for CoMA are mixtures of 2’-O-TOM-protected 
ribonucleotide phosphoramidites (rN) and deoxyribonucleotide phosphoramidites (dN) rather than only 
rN phosphoramidites. For preparation of the mixtures, the rN and dN phosphoramidites are mixed in a 
ratio that statistically would result in one ribonucleotide mutation per DNA molecule for most of the 
synthesized strands. Four mutant libraries need to be synthesized i.e. one library for each rN mutation. 
Synthesis of each mutant library requires four mixtures i.e. four parent dN phosphoramidites 
individually mixed with one of the rN phosphoramidites. Therefore, in total 16 different mixtures need 
to be prepared. 
To prepare a mutant library with maximum population of single mutants in a 40 nucleotide long 
catalytic core, the probability of rN incorporation at each independent event of phosphoramidite 
coupling must be 5%. This value is dependent on the length of the DNA of interest and is easily 
calculated based on the binomial distribution.  
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In the formula above, i is the number of mutations per molecule (here preferred to be 1), rNe is the 
effective ribonucleotide incorporation rate, n is the number of coupling events for which rN/dN 
mixtures are used (which is for deoxyribozymes catalytic core normally 40), and �𝑛𝑖 � is the 
combinatorial function. The relative coupling efficiencies of ribonucleotides are normally less than 
deoxyribonucleotides. In practice, the rN:dN ratio of mixtures must be 10:90  to efficiently incorporate 
5% ribonucleotide at each coupling step. This ratio was determined by experimental calibration curves 
for mixtures of each ribonucleotides in deoxyribonucleotides (supplementary information of 
reference139). 
 
Fig  2.1-1 Combinatorial mutation interference analysis (CoMA). CoMA consists of four steps. The first step is statistic 
incorporation of 2’-OH tag encoded mutations within the functional DNA sequence. Afterwards, the active mutants are 
separated and the mutation sites are visualized upon site specific hydrolysis at mutation sites (step 3) and subsequent 
PAGE analysis using denaturing conditions (step 4). 
The second step of CoMA is separation of active mutants. To this end, DNA mutant libraries are ligated 
to one of the RNA substrates by T4 RNA ligase. Providing the second substrate and the metal ions 
required for catalysis, the mutants in which the mutation is tolerated will catalyze the branching reaction 
of the two RNA strands. As one of the RNA strands is already ligated to the DNA library, the molecular 




weight of the active mutants is increased which allows separation of active mutants of the library from 
inactive ones. 
The third step benefits from the 2’-OH tag which was introduced to the mutation sites by solid phase 
synthesis in the first step. The active and inactive fractions as well as unseparated libraries are 
radiolabeled at 3’ end. Then, alkaline hydrolysis cleaves the DNA-RNA chimera backbone at the sites 
of RNA mutations and results in a ladder indicating the present mutations in each fraction. In the fourth 
step, the samples are loaded on a denaturing gel and band intensities are analyzed after quantification. 
After subtracting the background counts, interference values are defined for each position of the 
catalytic core and for each mutation by the ratio of the unselected band to the corresponding band in the 
active fraction.  
Interference value pos. n = intensity pos. n unseparated library/ intensity pos. n active fraction 
Interference value of 1 means that the mutation had no effect on the reaction. We emphasize on 
interference values higher than 2 which means that the band intensity of the mutation at the active 
fraction was less than 50% of the band intensity at unselected library. Interference values higher than 10 
are assigned as 10 since the error range increases by increase in the interference values.  
CoMA is a powerful method to achieve comprehensive data about all three possible mutations of all 40 
nucleotides of the deoxyribozymes catalytic core. Achieving the same data with traditional strategies i.e. 
synthesizing single point mutants and kinetic studies of individual mutants would be a lot more labor 
intensive and time consuming.  However, CoMA is unable to reveal information in cases that the 2’-OH 
chemical tag itself is detrimental. Those positions are distinguishable in the PAGE analysis. In cases 
that a ribonucleotide with the parent nucleobases is not accepted (i.e. the hydrolyzed band is absent in 
the active fraction of parent library as well as all three mutant libraries), the 2’-OH is detrimental.  
Nucleotide analogue interference mapping of DNA (dNAIM)140 has conceptual similarities to CoMA. 
dNAIM has four steps. In the first step libraries of modified nucleosides are synthesized. Modified 
nucleosides are distributed in the catalytic core and are tagged with a 2’-OH. Separation of the active 
modified DNAs, alkaline hydrolysis and PAGE separation is similarly performed as in CoMA. dNAIM 
supports complementary data on CoMA and pinpoints essential functional groups of essential 
nucleotides. 
In this study, CoMA was applied to investigate nucleotide requirements of several 2’,5’ branch forming 
deoxyribozymes including 6BX22, 9F13 and 9F7.  dNAIM was employed for further analysis of 




2.2 9F7 deoxyribozyme family 
For chemical investigations of the catalytic mechanism of deoxyribozymes, we decided to study 
members of 9F7 deoxyribozyme family. 9F7 deoxyribozyme family was reported in 2003 by Silverman 
and coworker. They designed an in vitro selection experiment with the aim of achieving 
deoxyribozymes that catalyze the attack of a terminal 2′(3′)-hydroxyl of an RNA onto a 5′-triphosphate 
of another RNA. They expected to select deoxyribozymes with linear 2’-5’ or 3’-5’ RNA products. The 
selection was performed with 40 nucleotide randomized region embedded in two binding arms for the 
RNA substrates. The acceptor RNA substrate contained 4 nucleotide long overhang UAUC. The final 
nucleotide was either A, C, dA or dC. dA and dC were used to promote 3’-5’ linear ligation. Despite the 
original goal of that selection, all the active sequences catalyzed formation of branched RNAs using 2’-
OH of an internal nucleotide. The enzymes 9F13 and 9F18 used the 2’-OH of the first U in the acceptor 
overhang to attack the alpha phosphate of the donor RNA whereas 9F21 and 9F7 employed the 2´-OH 
of the adjacent A in the acceptor overhang.24  
9F7 and 9F21 have been studied further for their substrate requirements. The result for 9F7 is 
summarized in Fig 2.2-1. For 9F7, the RNA overhang after the branch site adenosine could be removed 
completely. RNA ligation with no RNA overhang after the adenosine results in formation of a linear 
RNA with a 2’-5’ junction. Formation of linear 2’-5’ RNA by 9F7 was shown to be successful but the 
reaction rate was 100-fold slower compared to branched RNA formation. For fast ligation the overhang 
after the branch point needed to be at least one nucleotide long. 
Although, selection rounds were performed in the presence of Mg2+, these enzymes showed faster 
reaction kinetics in the presence of Mn2+ e.g. for 9F7 the kobs was reported to be ∼ 0.3 min-1 with 20 mM 
Mn2+ and 0.006 min-1 with 100 mM Mg2+.25 The two enzymes did not support any catalysis in the 
presence of Zn2+, Ni2+ or Cd2+ (10 µM-10 mM). 10 mM Co2+ resulted in a very low yield ligation with 
the kobs of 105 fold slower than the reaction in the presence of 20 mM Mn2+ (0.000’004 vs 0.3 min-1). 
The two enzymes showed no significant dependence on monovalent metal ions. 
Originally, the enzyme 9F7 contained a deleted nucleotide in the left binding arm, resulting in a bulge 
loop in the acceptor RNA (five nucleotides upstream of the A branch site). A complete base paired left 
binding arm of the enzyme showed to reduce the activity of the enzyme by 2-fold for Mn2+ dependent 
reaction and by 10-fold for Mg2+ dependent reaction. Functional investigations by Silverman and 
coworker had used the complete base paired left hand binding arm. We used the “G-deletion” version of 
9F7 as it was originally discovered and was shown to be faster. 
The interaction of metal ions or deoxyribozyme’s nucleobases with the functional groups of the 
substrate for the in-line attack of the 2’-OH to the alpha phosphate and release of the pyrophosphate is 
not well understood for these deoxyribozymes. Several methods are available to study metal ion 




interactions and to delineate critical nucleobase contacts in nucleic acid enzymes. Lanthanide ions have 
proven to be useful for probing metal ion binding in (deoxy) ribozymes. We focused on Tb3+ due to its 
particular properties for spectroscopic investigations. We performed combinatorial mutation 
interference analyses (CoMA) under various conditions to identify functional nucleotides of the 9F7 
deoxyribozyme. The folding and interactions of 9F7 with metal ions were further investigated by 
luminescence and footprinting experiments. 
 
Fig  2.2-1 Original 9F7 and its substrate requirements. The branch site adenosine of the substrate is marked bold and 
underlined. 9F7 has 40 nucleotide in its single stranded catalytic core. Original report on the 9F7 had a point deletion in 
the left-binding arm of the enzyme. The enzyme was well studied according to its tolerance to substrate mutation. The 
substrate requirements of the 9F7 are marked in the figure. The figure is adapted from 25.  
2.2.1 Lanthanide assisted acceleration of 9F7 
To study metal ion interactions of the 9F7 deoxyribozyme, we benefited from spectroscopic properties 
of rare earth elements i.e. lanthanides and in particular Tb3+. Firstly, we proved that the 9F7 
deoxyribozyme interact competently with lanthanide ions. Impressive rate enhancement of 9F7 
deoxyribozyme was observed upon addition of micromolar concentrations of Tb3+ when the reaction 
was performed in presence of millimolar concentrations of M2+.  Slow Mg2+ dependent reaction of the 
enzyme (kobs 0.003 min-1 in the presence of 80 mM Mg2+) was accelerated ca 120-fold upon addition of 
Tb3+ (kobs 0.35 min-1 in the presence of 80 mM Mg2+ and 100 µM Tb3+). In a chase experiment, addition 
of Tb3+ one hour after start of the reaction had the same effect, indicating that the acceleration is 
particularly due to the presence of Tb3+ (Fig 2.2-2 A).  
The Tb3+ mediated acceleration was dependent on Tb3+ concentration. Fig 2.2-2 B shows Mg2+ 
dependent catalysis of 9F7 in the presence of three representative concentrations of Tb3+. Addition of 
Tb3+ below a critical concentration had no significant effect. The reactions proceeded to completion in > 
8h with the kobs <0.01 min-1.  At optimum Tb3+ concentration, the reaction was accelerated and reached 
>80% yield in 5-10 min. Higher concentrations than the optimum resulted in fast reaction but low final 
yield.   
Similar effects were observed by other lanthanides i.e. La3+, Ce3+, Eu3+, Gd3+ and Yb3+. Lanthanides 
were titrated to 9F7 reactions in the presence of 80 mM Mg2+ ([Ln3+]: 0-200 µM). Plotting the yield of 
ligated RNA product as a function of lanthanide concentration revealed the optimum concentrations of 
lanthanides are in the same range. 





Fig  2.2-2 9F7 and the effect of Tb3+ on Mg2+ dependent reactions. A) Acceleration of 9F7 reaction. The kobs of 9F7 
reaction in the presence of 80 mM Mg2+ is 0.003 min-1 (green). Presence of additional 100 µM Tb3+ increased the 
reaction rate to 0.35 min-1 (red). Addition of Tb3+ at 60 min after start of the reaction had the same effect (black). B) 
Tb3+ effect on 9F7 reaction is dependent on the concentration of Tb3+.  50 µM Tb3+ had no effect on the kinetic behavior 
of the enzyme and the reaction proceeded to reach > 80 % yield after 8 h. 100 µM Tb3+ increased the reaction rate. The 
reaction yield reached > 80% within 10 min. 200 µM Tb3+ increased the reaction rate but decreased the maximum yield. 
C) Gd3+ effect on 9F7 reactions. The effect of Gd3+ was similar to Tb3+.  
Addition of Ln3+ had no effect up to a "critical" concentration of ca. 50-70 µM. The activity of the 
deoxyribozyme strongly increased up to the optimal concentration of 100-125 µM Ln3+, at which ~ 80% 
yield was achieved within 5 min. Further increase in [Ln3+] up to 200 µM caused reduced ligation 
yields. The maximum yield dropped significantly below those achievable in the absence of Ln3+ (Fig  
2.2-3 for Eu3+, Tb3+ and Gd3+ titration and Fig 2.2-4 for La3+ and Ce3+ titration). 
 
Fig  2.2-3 Titration kinetics of 9F7 in presence of Mg2+ for Eu3+, Gd3+ and Tb3+.  Ligation yield of 9F7 in the presence of 
80 mM Mg2+ and increasing concentrations of the three lanthanides are plotted against time. The time points were 
taken at 5 min, 5 h and 9 h. The curves were fitted to the equation: fraction ligated = (Y0+Ya*([Ln3+]n/([Ln3+]1/2,an 
+[Ln3+]n)))*(1-[Ln3+]m/([Ln3+]1/2,b m + [Tb3+]m)). Fit values are summarized in table 2.2-1.  
 





Fig  2.2-4 Titration kinetics of 9F7 in presence of Mg2+ for Ce3+ and La3+. Ligation yield of 9F7 in the presence of 80 mM 
Mg2+ and increasing concentrations of lanthanides. The time points were taken at 5 min, 2 h and 5 h. The connecting 
lines are B-spline interpolation of data (no fit values are available).  
In the presence of 20 mM Mn2+, the optimal [Tb3+] was ca. 10-fold lower than with Mg2+, which was 
best visible at early time points (below 2 min). The optimum Tb3+ concentration was maintained below 
50 µM in the presence of 5 mM Mn2+. The optimum range was broader at lower Mn2+ concentration (Fig 
2.2-5). 
 
Fig  2.2-5 Tb3+ titration kinetics of 9F7 in presence of Mn2+. Ligation yield of 9F7 reaction in the presence of 20 or 5 mM 
Mn2+ and increasing concentrations of Tb3+. Gel images are only shown for 20 mM Mn2+. 
 




Table  2.2-1 Fit values of the 9F7 activity and lanthanide titrations in the presence of Mg2+ or Mn2+. The ligation yields 











Tb3+ with 80 mM Mg2+ 
5 min 0.02 0.91 71 18 139 5 
5 h 0.66 0.31 67 60 162 5 
Tb3+ with 20 mM Mn2+ 
1 min - 0.9 4.6 1.3 50 1.8 
60 min - 0.95 - - 97 2.2 
Gd3+ with 80 mM Mg2+ 
5 min 0.01 0.76 77 32 164 8 
5 h 0.60 0.33 70 118 178 11 
Eu3+ with 80 mM Mg2+ 
5 min 0.008 0.76 81 7 171 5 
5 h 0.61 0.33 69 14 192 7 
 
As the optimal concentration of Tb3+ was shown to be only dependent of the type of bivalent metal ion, 
the kinetic activity of the enzyme was further investigated in the presence of increasing concentrations 
of Mg2+ and Mn2+ and in the presence or absence of optimum concentrations of Tb3+ i.e. 100 µM Tb3+ 
for Mg2+ dependent reactions and 10 µM Tb3+ for Mn2+ dependent reactions. Result showed that the 
presence of optimal concentrations of Tb3+ increases the affinity for the divalent metal ions (Fig 2.2-6). 
The Kd,app for Mg2+ decreased from >200 mM to 57 mM, and Kd,app for Mn2+ decreased ca. 3-fold from 
7.6 mM to 2.6 mM.  
 
Fig  2.2-6  Mg2+ and Mn2+ titration kinetics of 9F7. Reaction rates of 9F7 in presence or absence of optimal 
concentrations of Tb3+ are plotted against [Mg2+] or [Mn2+].  Optimum concentrations of Tb3+ in Mn2+ and Mg2+ 
dependent reactions were 10 and 100 µM respectively. Titration curves were fitted to the equation kobs = 
kmax*[M2+]/(Kd,app+[M2+]).  
The impressive effect of Tb3+ was especially notable at low divalent metal ion concentrations. At 2 mM 
Mn2+, addition of 10 µM Tb3+ caused ~ 400-fold acceleration (kobs 0.002±0.003 and 0.94± 0.18 min-1 in 
the absence and presence of Tb3+, respectively). For Mg2+ dependent reactions, the lowest Mg2+ 




concentration which led to detectable ligation product was 7 mM Mg2+. Addition of 100 µM Tb3+ 
caused 104-fold faster ligation (kobs 7x10-6 and 0.08 min-1 in the absence and presence of Tb3+, 
respectively). For the reaction in the presence of 7 mM Mg2+, in the absence of Tb3+, the ligation yield 
was only 1% after 24 h. in the presence of Tb3+, the reaction yielded  >95% product in one hour, thereby  
t1/2 was reduced from 1600 h to 10 min. 
Table  2.2-2 Acceleration of Mg2+ dependent reactions of 9F7 upon presence of Tb3+. kobs and t1/2 were calculated 
according to the fit equation: 𝒀 = 𝒀𝒎𝒂𝒙�𝟏 − 𝒆−𝒌𝒐𝒃𝒔∙𝒕�,  𝒕𝟏 𝟐� = 𝒍𝒏 𝟐 𝒌𝒐𝒃𝒔









t1/2 acceleration by Tb3+ 
7 - 1% in 24 h 7x10-6 ~ 1600 h  
7 100 >95% in 1 h 0.08 ~ 10 min ~10000-fold 
10 - 1% in 5.5 h 3x10-5 ~ 400 h  
10 100 >95% in 0.5 h 0.14 ~ 5 min ~5000-fold 
80 - >95% in 16 h 0.003 ~ 4 h  
80 100 >95% in 0.15 h 0.35 ~ 2 min ~120-fold 
 
When Tb3+ was tested as the only cofactor for 9F7 (10-100 µM Tb3+), i.e., in the absence of Mn2+ or 
Mg2+, no ligation was observed up to 24 hours even when 3M NaCl or 2M KCl were present.  In the 
presence of 80 mM Mg2+, Fe3+ and Al3+ (1-100 µM) as trivalent non-lanthanide metal ions neither 
accelerated nor inhibited the 9F7 reaction. Higher concentrations of Fe3+ and Al3+ caused degradation of 
the RNA substrates.  
2.2.2 HPLC analysis of the effect of Tb3+ on the reaction components 
The reduced ligation amplitude at high concentrations of lanthanides could potentially be rationalized 
by accelerated hydrolysis of the triphosphate at higher Tb3+ concentrations. This hypothesis was tested 
by HPLC analysis of the fate of donor RNA upon incubation under different metal ion combinations. 
Donor RNA (Tr12) was hybridized to a complementary DNA oligonucleotide (D064) resembling the 
deoxyribozyme binding arm. The retention times of the complementary DNA and tri- and mono-
phosphorylated donor RNA are shown in Fig 2.2-7 A. The RNA-DNA complex was incubated under 
various conditions. More than 80% of triphosphate was still intact after 1 h in presence of 100 µM Tb3+ 
and 80 mM Mg2+. The triphosphate content decreased only slightly with 200 µM Tb3+ (Fig 2.2-7 B).  
In 9F7 kinetic experiments the acceptor: DNA: donor ratio was 1:3:6. Scaled up reactions (50-fold) in 
had similar results compared to kinetic experiments when the reaction volume was increased 10-fold 
(100 µl reaction). The ligation yield with 100 µM Tb3+ was 81% in 15 min while the ligation yield for 
200 µM Tb3+ was only 30% after 1 h. Ligation yield in presence of 80 mM Mg2+ (in the absence of 
Tb3+) was 68% in 8 h (Fig 2.2-8). 
 





Fig  2.2-7 HPLC analysis of the triphosphorylated donor substrate. A) Validation of individual peaks of the HPLC 
chromatogram of the donor RNA. B) HPLC analyses of the fate of triphosphate donor RNA in presence of Tb3+. Donor 
RNA (Tr12) was hybridized to its complementary DNA (D064) to resemble the deoxyribozyme binding arm. 
 
Fig  2.2-8 HPLC analyses of 9F7 reaction. The acceptor: DNA: donor RNA ratios were 50:150:300 pmol. The reactions 
have been performed in 100 µl volume at 37°C. Yields were calculated according to the 
equation:  𝒀𝒊𝒆𝒍𝒅 = �𝒃𝒓𝑷 𝒃𝒓𝑷𝜺� � / ��
𝒃𝒓𝑷
𝒃𝒓𝑷𝜺� �+ �
𝒂𝒄. 𝒂𝒄.𝜺� ��, when brP and ac. are the intensities under the UV
260nm 
trace for the branched product and acceptor RNA substrates and 𝜺 is their extinction coefficient.  
When the donor, acceptor, and deoxyribozyme were used in equimolar ratios for preparative purposes, 
the DNA-catalyzed RNA ligation reaction was also accelerated by Tb3+. To maintain good yield after 
short incubation times, the substrate-DNA concentration was 1 µM, resulting in 100 equivalents of Tb3+ 
in respect to pre-ligation complex. At higher substrate-DNA concentrations (lower Tb3+ to nucleic acid 




ratio), the ligation reaction was slower, likely due to increased unspecific binding of  Tb3+ to the nucleic 
acids, causing reduced availability of “active” Tb3+ ions (Fig 2.2-9). 
 
Fig  2.2-9 HPLC analyses of preparative 9F7 reactions. Acceptor: DNA: donor ratios are 1:1:1. The reactions were 
performed with 100 pmol of each component in either 100 or 10 µl. The concentrations of the metal ions were constantly 
80 mM Mg2+ plus 100 µM Tb3+, therefore the [Tb3+]/[oligonucleotide complex] were 100 and 10 fold respectively for 100 
and 10 µl reaction volumes.  
In summary the HPLC analysis of the nucleic acid components of the 9F7 reaction revealed that 
although decomposition of the triphosphorylated donor RNA to mono and dephosphorylated state is 
increased upon long incubation with 200 µM Tb3+ (> 1 h) but the extent of decomposition is much less 
than the inhibitory effects  at high Tb3+ concentrations. Additionally, HPLC analysis showed that for 
preparative applications of Tb3+ acceleration, the ratio of Tb3+ metal ion to the RNA-DNA complexes 
should be maintained higher than 10 for fast ligation. 
Another possible hypothesis for reduced ligation yield at high Tb3+ concentrations could be that Tb3+ 
promotes the reverse reaction. To test this hypothesis branched RNA product of the 9F7 was 5’ 
radiolabeled and annealed with 9F7. Samples were incubated in the presence of increasing 
concentrations of Tb3+ and in the presence of bivalent metal ions and absence or presence of 5-50 µM 
inorganic pyrophosphate (PPi). The hypothesis was rejected as no specific hydrolysis of the branched 
product was observed up to 48 h. These data also proved stability of the branched product at various 
Tb3+ concentrations.  Fig 2.2-10 shows the results in the presence of 5 µM PPi (equimolar to branched 
product). 
 





Fig  2.2-10 Stability of branched RNA product of 9F7. Incubation of branched RNA product of 9F7 with bivalent metal 
ions and high concentrations of Tb3+ in the presence of inorganic pyrophosphate (PPi). 
In summary, functional characterizations of 9F7 confirmed necessity of the bivalent metal ions i.e. Mn2+ 
or Mg2+ for the catalysis. Tb3+ and other rare earth elements accelerated the reaction rate of the enzyme 
when provided at an optimal concentration. At higher concentrations the ligation reactions of 9F7 were 
fast but the maximum yields were reduced. HPLC analysis of the fate of the RNA substrates excluded 
possibility of the degradation of the RNA substrates or decompositions of the triphosphate of the donor. 
In addition, we did not observe promotion of the reverse reaction at high Tb3+ concentrations. We 
continued further studies on 9F7 by performing CoMA in presence of different metal ions.  
2.2.3 Combinatorial mutation interference analysis of 9F7 
Combinatorial mutation interference analysis (CoMA) provides comprehensive data about the 
nucleobase requirement of deoxyribozymes for catalysis in different conditions e.g. metal ions, pH, time 
and temperature. In the case of 9F7, different nucleotides might be involved in formation of the catalytic 
core for Mg2+ and Mn2+ dependent reactions of 9F7. It is also conceivable that optimal concentrations of 
Tb3+ alter the nucleobase requirements of the enzyme. To compare necessary nucleotides of 9F7 at low 
and high bivalent metal ion concentrations, we decided to perform the separation step of CoMA at 2 
mM and 20 mM Mn2+. To compare the effect of different metal ions we additionally performed the 
separation step of CoMA in the presence of 80 mM Mg2+. To examine the influence of Tb3+, we 
included the CoMA in the presence of optimal concentrations of Tb3+ (10 µM Tb3+ with 2 mM Mn2+ and 
100 µM Tb3+ with 80 mM Mg2+).  





Fig  2.2-11 Autoradiogram of denaturing gels reflecting hydrolysis pattern of 9F7 combinatorial mutation interference 
analysis. CoMA was performed in 5 different conditions. Four mutant libraries were subjected for separation of active 
mutants in presence of low Mn2+ (2 mM), low Mn2+ (2 mM) plus optimum Tb3+ (10 µM), high Mn2+ (20 mM), Mg2+ (80 
mM) and Mg2+ (80 mM) plus optimum Tb3+ (100 µM). A) The gel for high Mn2+ CoMA is shown as a representative gel. 
The separation of active mutant was performed in the presence of 150 mM NaCl, 2 mM KCl and 20 mM MnCl2 at pH 
7.5. Active, inactive fractions and unselected libraries were hydrolyzed in presence of 10 mM NaOH for 10 min at 95°C. 
For each lane a control water lane is loaded when the samples were incubated for 10 min at 95°C in the absence of 
NaOH. B) Active fractions of 9F7 deoxyribozyme in 5 different conditions: low Mn2+, low Mn2++ Tb3+, high Mn2+, Mg2+ 
and Mg2++ Tb3+. Unselected libraries are loaded on the side as control. The upper parts of the gels are zoomed in in Fig 
2.2-12.  
 
Fig  2.2-12 Autoradiogram of denaturing PAGE reflecting hydrolysis pattern of 9F7 active mutants at the 5’ end of the 
catalytic core under 5 different conditions i.e. in presence of low Mn2+ (2 mM), low Mn2+ (2 mM) plus optimum Tb3+ (10 
µM), high Mn2+ (20 mM), Mg2+ (80 mM) and Mg2+ (80 mM) plus optimum Tb3+ (100 µM). The hydrolysis was 
performed in presence of 10 mM NaOH. This figure is a zoomed view of the top of the gels that are shown in Fig 2..2-11 
B.  





Fig  2.2-13 Interference values for 9F7 mutant libraries at 5 different conditions shown as bargraphs. Interference 
values were calculated based on the quantifications of the intensities of the bands of gel images in 2.2-11. Interference 
value for each position is defined as: Interference value pos. n = intensity pos. n unseparated library / intensity pos. n active fraction. 
The interference values below 2.0 were considered as negligible. The interference values higher than 10.0 were assigned 
as 10.0. The interference values are grouped based on the mutations types. The x-axes of all plots are the sequence of the 
catalytic core of the enzyme in the direction of 5’ to 3’. The conditions at which the 9F7 ligation reactions were 
performed are marked on top of each set of plots.  
The ligation reaction time at separation step of CoMA affects presence of non-efficient mutants in the 
active fraction. For each of the 5 conditions, the 9F7 reaction times were selected according to the 
kinetic of the enzyme in the presence of individual conditions. The time in which the three-molecular 
format kinetics of the enzyme reached more than 90% of the maximum yield was chosen to stop the 9F7 




reactions for that specific metal ion condition. The reaction times were 10 h with 2 mM Mn2+, 8 h with 
80 mM Mg2+, 2 h with 100 µM Tb3+ + 80 mM Mg2+, 1 h with 10 µM Tb3+ + 2 mM Mn2+, and 20 min 
with 20 mM Mn2+. For all five reactions, these incubation times reproducibly resulted in formation of ca 
30% ligation product in all four mutant libraries. After separation and alkaline hydrolysis the samples 
were loaded on denaturing PAGE. Fig 2.2-11 A shows a representative gel for full set of CoMA. Fig 
2.2-11 B shows the active fractions of the 5 tested conditions. Fig 2.2-12 is a zoomed in view of the 
active fractions in the 5’ end of the catalytic core. 
 
Fig  2.2-14 Contour graph of interference values of 9F7 combinatorial libraries for the 5 tested conditions i.e. low Mn2+ 
(2 mM), low Mn2+ (2 mM) plus optimum Tb3+ (10 µM), high Mn2+ (20 mM), Mg2+ (80 mM) and Mg2+ (80 mM) plus 
optimum Tb3+ (100 µM).  The high interference values which reflect detrimental effects of a mutation are assigned with 
red colors. Low interference values which are refection of tolerance to the mutations are assigned with green colors.  
The interference  The sequence of the catalytic core is shown in the 5’ to 3’ direction. The contour graph represents the 
same data as in Fig 2.2-13.  
Fig 2-2-13 and 2.2-14 show the interference values of all four libraries of 9F7 under all 5 conditions in 
bar graphs or a contour plot. The region in between A18 and T35 showed tolerance to all mutations in 
all the tested conditions. It was conceivable that the two regions (A1-G17 and C36-G40) are required to 
be connected via a linker. All 18 nucleotides were dispensable. Complete removal of the mutable region 
resulted in 2-fold decrease in the reaction kobs. When one, two or three nucleotides of the mutable region 
were retained the reaction rates improved and reached 80% of the reaction rate of the original 9F7. The 
reaction rates of the trimmed 9F7 in the presence of 2 mM Mn2+ and 80 mM Mg2+ were 70% and 86% 




of the original enzyme. Importantly, Tb3+ accelerated the trimmed variant as effectively as the original 
9F7 deoxyribozyme (Fig 2.2-15). 
For 9F7 CoMA, the 2'-OH chemical tag had an inhibitory effect at several positions, when the ligation 
reaction was performed with 2 mM Mn2+ or 80 mM Mg2+.  At low Mn2+, ribonucleotides were not well 
tolerated at A1, A2, G4, C8, G12, A14, C38 and G39. Addition of 10 µM Tb3+ to 2 mM Mn2+ relieved 
the 2'-OH interference at all positions. A similar result was obtained when Tb3+ was used in the presence 
of Mg2+ with two differences. Firstly, 2’-OH was tolerated at G39 even in the absence of Tb3+ and 
secondly, the detrimental effect of 2'-OH persisted at A1, A2 and A14. At 20 mM Mn2+, the 2'-OH 
group was tolerated at all positions.  
 
 
Fig  2.2-15 Kinetics of trimmed versions of 9F7 A) kinetics in the presence of 20 mM Mn2+. All the tested trimmed 
versions of 9F7 were active. The sequence of each trimmed version is marked in Fig 2.2-14. B) The sequence of original 
and trimmed 9F7. The linker region (the region with toleration to all mutations) is marked with red color in the original 
sequence. Three nucleotides of the linker region (ACT) were remained in the chosen trimmed version of the enzyme for 
high activity. C) The kinetic activity of the original and trimmed 9F7 in the presence of 2 mM Mn2+, 80 mM Mg2+ in 
presence or absence of optimum Tb3+.  
 





Fig  2.2-16 Interference values of the 2‘-OH at individual positions of the catalytic core of 9F7 in the presence of 2 mM 
Mn2+ ± 10 µM Tb3+, 80 mM Mg2+ ± 100 µM Tb3+ and 20 mM Mn2+. Presence of high Mn2+ or optimum concentrations of 
Tb3+ relieved the detrimental effects of 2’-OH and reduced the interference values below 2.0.  
Several mutations were detrimental or reduced the activity of the enzyme when Mn2+ concentration was 
low (2 mM). Addition of 10 µM Tb3+ to the 2 mM Mn2+ or increase in the Mn2+ concentration (up to 20 
mM) relieved some of the mutation effects. Examples include: T9C, A5G, G15C, G16C, C38U, C13G, 
C13U, C36G, C37G, C38G and A14U. Presence of optimum Tb3+ concentration to the Mg2+ dependent 
reaction also relieved mutation effects at A2G, A5G, T9G, T10G, C36G, C37G, C38G T9C, A14C, 
G15C, G16C, G17C, A2U and C13U. In summary, high concentration of bivalent metal ion or presence 
of optimum Tb3+ increased the reaction rates and allowed slow mutants being present in the active 
fraction.  
Several positions tolerated mutations only in Mg2+ or Mn2+ dependent reactions. Fig 2.2-17 is rearranged 
plot of Fig 2.2-14 to emphasize the similarities and differences of 9F7 nucleobase requirements for 
Mg2+ and Mn2+ dependent reactions. Individual mutations of any nucleotides in the region C13-G39 to 
U were better tolerated in the presence of Mn2+. Also, Mn2+ resulted in better tolerance of the region 
G15-C38 for C point mutations. C36-C38 mutations to G were better accommodated in the presence of 
Mn2+ as well. The only case that the interference value of the mutation for the Mg2+ dependent reaction 
was lower than Mn2+ dependent reaction was G4C. In general nucleobases requirement of the enzyme 
for the Mg2+ dependent reaction (80 mM) was higher than Mn2+ dependent reaction (when performed 
with 20 mM).  





Fig  2.2-17 Interference values for of the necessary nucleobases of 9F7 for Mg2+ (80 mM) and Mn2+ (20 mM) dependent 
catalysis. The site of the deleted linker is marked by two dashes. The plot is an excerpt of the plot shown in 2.2-14 which 
is rearranged for better comparison between Mg2+ and Mn2+ dependent reactions.  
In summary, CoMA revealed nucleotide positions which are necessary for catalysis in all conditions. 
Position G4 was an example of those nucleotides. In addition, CoMA provided insights about 
nucleobases  at which the mutations are only tolerated under certain conditions e.g. in presence of Tb3+ 
or high concentration of Mn2+. To further explore the interactions of 9F7 catalytic core with metal ions 
we used the spectroscopic properties of Tb3+. Inner-sphere coordination of Tb3+ to the trimmed version 
of the 9F7 catalytic core was quantitatively analyzed using sensitized luminescence of Tb3+.  
2.2.4 Sensitized luminescence of Tb3+ 
We explored sensitized luminescence of Tb3+ to probe Tb3+ interactions with trimmed 9F7 in complex 
with its RNA substrates. We chose a pre-ligation complex formed with standard active donor substrate 
and inactivated acceptor substrate, containing 2’-deoxyadenosine at the branch-site (R013). Addition of 
Tb3+ to annealed complexes under various divalent metal ion conditions resulted in an increase in Tb3+ 
luminescence upon excitation at 284 nm. Quantitative information on Tb3+-binding was obtained by 
titration experiments up to 200 µM Tb3+, in the presence of 1-100 mM Mg2+ or 1-10 mM Mn2+. The 
intensity changes of Tb3+ luminescence signal at 543 nm was measured over time. 
It is noteworthy that different binding kinetics of Tb3+ was observed depending on the type of the 
divalent metal ions and concentration of Tb3+. In the presence of Mn2+, a fast increase in emission was 
followed by a fast and further slow decrease of characteristic signature within 10 min (Fig 2.2-18 B). 
The emission intensities after an equilibration time of 10 min for each data point are plotted against Tb3+ 
concentration in Fig 2.2-18 C.  





Fig  2.2-18 Sensitized Tb3+ luminescence in competition with Mn2+. A) A typical emission spectrum of sensitized Tb3+ in 
the presence of 2µM DNA. The excitation wavelength was set at 284 nm. B) Kinetics of luminescence intensity at 545 nm 
upon excitation at 284. Upon addition of each Tb3+ aliquots the initial increase in the luminescence was rapidly 
decreased within the first 2 min. The decrease in the luminescence was further continued with slower rate.  C) Tb3+ 
titration in the presence of Mn2+. For consistency the luminescence intensities are reported after 10 min equilibration 
time for each Tb3+ addition events. 
In the presence of Mg2+, three different binding modes were observed. At low concentrations of Tb3+ 
(<20 µM), an initial increase was followed by an exponential decay to almost the initial value within 1-3 
min.  At slightly elevated Tb3+ concentrations (between 20 and 60 µM), the signal intensity increased 
rapidly and stayed at the elevated level for at least 10 min. Higher Tb3+ concentrations (>60 µM), 
resulted in a slower response of the emission intensity.  
As anticipated for both Mg2+ and Mn2+,  competitive M2+ and Tb3+ binding, the maximal emission 
intensities and the apparent affinity for Tb3+ i.e. [Tb3+]1/2, decreased with rising divalent metal ion 
concentrations. Table 2.2-3 summarizes the fit values for Tb3+ titration in the presence of increasing 
concentrations of bivalent metal ions.  
Table  2.2-3 Fit values of the titration curves from Fig 2.2-18 and 2.2-19. The curves were fit to the equation I = Imax • 
[Tb3+]n / ([Tb3+]1/2n + [Tb3+]n). 
divalent metal ion Imax [Tb3+]1/2 (µM) n 
Mn2+ 1 mM  245 69 2.4 
2 mM  167 67 2.6 
5 mM  145 86 2.8 
10 mM 82 101 2.7 
Mg2+ 1 mM 508 93 2.9 
10 mM 493 100 2.8 
20 mM  436 114 2.6 
100 mM 373 139 2.6 
 





Fig  2.2-19 Sensitized luminescence of Tb3+ in competition with Mg2+. A) Typical kinetic of Tb3+ luminescence at various 
[Tb3+] when the enzyme is folded in the presence of Mg2+. The final concentration of Tb3+ after each addition is indicated 
in µM. B) Tb3+ titration in the presence of 1-10 mM Mg2+. C) Tb3+ titration in the presence of 20 mM Mg2+ to the active 
trimmed 9F7 and an inactive mutant G4T. The detector voltage was set at 600 V. D) Tb3+ titration to the active trimmed 
9F7 and inactive G4 mutants in the presence of 20 mM Mg2+. The detector voltage was set at 800 V.   
 
Table  2.2-4 Kinetics of trimmed 9F7 in comparison to G4 mutants. 
 Position 4 of the 9F7 core  
Conditions G A C U  
Mn2+high 0.88 0.12 0 0 % in 1h 
 0.95 0.66 0 0 %in 24h 
Mn2+low + Tb3+ 0.91 0.23 0 0  
 0.95 0.75 0 0  
Mg2+ 0.23 0 0 0  
 0.78 0 0 0  
Mg2+ + Tb3+ 0.88 0 0 0  
 0.91 0 0 0  
 
Based on CoMA, G4 was potential candidate nucleotide for coordination of metal ions; the sensitivity to 
the 2’-OH ribose modification was relieved with Tb3+, no mutations were allowed with Mg2+, and a 
purine nucleotide must be retained for activity with Mn2+. Kinetic experiments on point mutants of G4 




proved CoMA data (Table 2.2-4). We further analyzed G4 mutants according to their Tb3+-binding 
properties. Luminescence response upon Tb3+ titration (up to 200 µM ) for inactive G4T mutant had a 
slight left-shift titration curve in comparison to the trimmed 9F7 (G4) in the presence of 20 mM Mg2+. 
Significant differences were observed at low Tb3+ concentrations. Active trimmed 9F7 (G4) showed 
persistence luminescence increase only above 25 µM Tb3+ but all three G4 inactive mutants showed this 
transition at Tb3+ concentration below 20 µM (Fig 2.2-19). 
To summarize, sensitized luminescence of Tb3+ confirmed presence of specific binding sites for Tb3+ in 
the catalytic core of the enzyme. Additionally, it was shown that bivalent metal ions and Tb3+ compete 
for the peripheral metal ion binding sites. Finally, the CoMA data for involvement of position G4 in 
formation of the catalytically important bivalent metal ion binding site was supported with the 
luminescence data.  
2.2.5 9F7 folding studies by DMS and DNase probing assays 
To further investigate the deoxyribozyme folding and interactions with metal ions we performed 
footprinting assays in presence or absence of metal ions. DNase I probing is based on the accessibility 
of DNA backbone for cleavage by the protein enzyme DNase I. DMS probing is one of the four 
reactions of Maxam- Gilbert sequencing141. Dimethylsulfate (DMS) alkylates the N7 of guanines, N1 of 
adenines and N3 of cytosines. Additionally, DMS is reactive with N3 and N1 of the enol-tautomers of 
uracils and guanines142. The alkylated positions are identified by primer extension142 or site specific 
cleavage by aniline or piperidine treatment. The latter is specific for the methylations at N7 of guanines 
and is used in this study. Methylation at N7 of guanosines enhances formation of apurinic sites by 
weakening the glycosidic bond. Upon piperidine treatment, β-elimination of the ribose is catalysed and 
the open ring of the apurinic ribose is released143. The cleavage products are 3’ phosphorylated DNA 
strand 5′ of the displaced guanosine and 5’ phosphorylated DNA strand 3′ of the guanosine (Fig 2.2-
20)144.  
 
Fig  2.2-20 DMS-mediated methylation of N7 of guanines in a DNA strand and piperidine cleavage at the site of 
methylation. 




Three different sample compositions were used to compare different folding states of the DNA. First, 
the DNA enzyme was analyzed as the only nucleic acid component in the sample (9F7min alone, Dt), 
second in complex with inactivated substrates (standard acceptor RNA and 5'-monophsphorylated donor 
RNA, iS), and third in complex with the 2',5'-branched RNA product (brP). The accessibility of 
nucleotides in the catalytic region of trimmed 9F7 was probed in buffer without divalent metal ions and 
in the presence of 20 mM Mn2+ (Fig 2.2-21).  
DMS mediated methylation at N7 of guanosines of 9F7 was reduced G4, G6, G7, G11, G12 and G15 in 
the folded brP sample in the presence of Mn2+. The protection was less pronounced in iS complex. G16 
and G17 remained accessible in all samples, suggesting that these nucleotides are not actively 
participating in formation of the active structure.  
T20t in the trimmed catalytic core of 9F7 corresponds to T35 in the original length 9F7. Superscript “t” 
stands for trimmed when the number of the nucleotide position is changed after trimming.  DNase I 
resulted in a strong cleavage band at T20t. High accessibility of this position was consistent with the 
CoMA data that suggested that this nucleotide is not involved in essential interactions or catalysis. 
Digestion at G7 was blocked in both post-hybridization states i.e. iS and brP, even in the absence of 
Mn2+, while cleavage at position T9 was unaffected. The DNase-mediated strand break at G17 was 
enhanced in the brP complex, while reduced intensity was observed at C21. Strikingly, cleavage at most 
of the positions was strongly diminished in the presence of Mn2+, especially for brP complex  although 
Mn2+ is known to increase the activity of DNase I145.  
Altogether, DMS and DNase probing assays provided further supports to the CoMA data. Structural 
changes upon presence of buffer and metal ions were reflected on the DNase I digestion or piperidine 
cleavage patterns. Investigations of the deoxyribozyme 9F7 was further continued by phosphorothioate 
rescue experiments.   





Fig  2.2-21 DMS and DNase I probing assays of trimmed 9F7 in presence and absence of buffer and metal ions. Three 
samples have been subjected for probing assays. 1) Dt is the trimmed 9F7 DNA as the only nucleic acid component of 
the sample. 2) iS is the complex of Dt with inactivated substrates. 3) brP is the complex of the Dt with branched product 
of 9F7. Numberings are based on trimmed 9F7. The numbers which are different before and after trimming are 
marked with superscript letter “t”.  
2.2.6 Phosphorothioate rescue experiments 
To further explore the specific synergistic effects of bivalent metal ions and trivalent rare earth elements 
on activation of the RNA substrates, we investigated the catalytic activity of the 9F7 using 
phosphorothioate-modified donor substrates. One oxygen atom at either the α or γ phosphate was 
replaced by sulfur in the donor RNA.  Phosphorothioate (PS) interference and metal ion rescue 
experiments have the potential to reveal crucial information about metal ion interactions in the active 
site.146 Installation of γ-PS can be easily achieved by in vitro transcription using γ-S-GTP. In contrast, 
transcription with α-S-GTP results in incorporation of PS at the 5'-terminal α-phosphate and at all other 
guanosines in the strand. To avoid cumulative effects of more than one PS in the substrate, we designed 
an alternative donor substrate (Tr14) that contained only one guanosine at the 5'-end, and otherwise 
consisted of only A, C and U.  
Replacement of the γ-phosphate by PS in donor RNA (Tr12) caused a considerably reduced ligation 
rate compared to standard tirphosphorylated Tr12 (kobs 3x10-5 vs 0.003 min-1 in presence of 80 mM 
Mg2+; kobs 0.02 vs 0.30 min-1 in presence of 20 mM Mn2+). Addition of Tb3+ did not change the outcome 
of the reaction. Addition of 1 mM Cd2+ to the reaction with 80 mM Mg2+ did not significantly improve 
the ligation rate. In the presence of Cd2+ and Mg2+ the reaction rates were 2x10-4 min-1 for donor 




substrate bearing γ-phosphate (PS) and 0.005 min-1 for triphosphorylated substrate (PO). Addition of 2 
mM Mn2+ to the reaction with 80 mM Mg2+ accelerated ligations of both PO and PS RNAs by a factor of 
ca 10-20, which indicated no specific rescue effect for the γ PS (kobs 0.028 for PO and 4x10-4 for PS in 
the presence of 80 mM Mg2+ and 2mM Mn2+). In the presence of higher Mn2+ concentration (20 mM 
Mn2+ with 80 mM Mg2+), the ligation of the PS substrate was accelerated 250-fold, while the reaction of 
the PO substrate was only ca 70-fold faster than with Mg2+ alone (Fig 2.2-22).  
The alternative donor substrate with one guanine in the sequence, “1G”, was ligated less efficiently than 
standard donor substrate under the standard reaction conditions (kobs 0.03 vs 0.3 min-1 in the presence of 
20 mM Mn2+). Replacement of the α phosphate with PS resulted in comparable ligation rates using 
Mn2+ as cofactor (kobs 0.05min-1), while PS at the γ position again severely inhibited the reaction (kobs 
0.0004 min-1). Upon addition of 1 mM Cd2+, the kobs for the α-PS analog of “1G” substrate increased ca 
3-fold (kobs 0.13 min-1), while the ligation rate of the unmodified substrate remained unaffected (kobs 0.03 
min-1). Presence of 10 µM Tb3+ had a comparable 3-fold effect for the α-PS substrate, while ligation of 
the unmodified Tr14 was ca 10-fold faster than in the absence of Tb3+. Collectively, these results point 
toward important interactions at the α- and γ- phosphates of the donor RNA, although the PS and rescue 
effects were less pronounced than for other metalloribozymes147. 
 





Fig  2.2-22  Phosphorothioate effects and metal ion rescue attempts for 9F7-catalyzed ligation of standard acceptor RNA 
with standard or alternative “1G” donor RNA containing γ- and 𝛼-phosphorothioate.  
2.2.7 Tb3+ mediated acceleration of other enzymes 
In addition to 9F7, 9F13 (from the same deoxyribozyme family), 6CE8 27 (the deoxyribozyme capable 
of branch formation with any nucleotide at branch site) and three-helix Junction (3HJ) forming 
deoxyribozymes, 7S1123 and 10DM2428, have been investigated for their response to Tb3+. In presence 
of Mg2+ 7S11 and 10DM24 were accelerated upon presence of 100 µM Tb3+ (Fig 2.2-23 A shows the 
data for 7S11). Additionally, Mn2+ dependent reaction of 7S11 and 9F13 were best accelerated in the 
presence of 5-20 µM Tb3+ (Fig 2.2-23 B and 2.2-24). Addition of 150 µM Tb3+ to Mn2+ dependent 
reaction of 6CE8 inhibited the reaction.  Further investigation of the enzyme 6CE8 is required to 
confirm if Tb3+ only inhibits the enzyme. High concentrations of Tb3+ (~ 150 µM) were inhibitory for 
Mn2+ dependent reaction of the other three enzymes i.e. 9F7, 9F13, and 7S11. It can be predicted that in 




the case of 6CE8 not only the enzyme is not inhibited at low concentrations of Tb3+ (ca. 10 µM) but also 
is accelerated. Tb3+ acceleration of 10DM24 enzymatic reaction was further studied and employed for 
single GTP attachment to RNA molecules (Section 3.1).  
 
Fig  2.2-23 Tb3+ mediated acceleration of Mg2+ and Mn2+ dependent reactions of 7S11. Mg2+ dependent reaction was 
accelerated upon presence of 100 µM Tb3+. Mn2+ dependent reaction was accelerated upon presence of 1-10 µM Tb3+.  
Further investigations have been performed on 9F13 deoxyribozyme employing combinatorial mutation 
interference analysis in the presence of 20 mM Mn2+ (Fig 2.2-25). 9F13 CoMA revealed complete 
mutation tolerance for G11-T15 and G20-T33. A couple of deletion mutants (appendix I) have been 
tested for trimming 9F13. When the region G20-T33 was completely removed the enzymatic activity of 
the enzyme reduced significantly (~10% product in 8h). In contrast, complete removal of T13 and T15 
had slight acceleration effect (kobs 0.41 vs 0.24 min -1 trimmed and original 9F13 at 25°C). Removal of 
T13-T15 and replacement of the region G20-T33 with two thymidines (9F13 trim) improved the 
reaction rate by 4-fold (kobs 0.99 vs 0.24 min-1  for trimmed and original 9F13 at 25°C and in the 
presence of 20 mM Mn2+). The trimmed 9F13 had only 23 nucleotides and contained 12 guanines in the 
catalytic core (Fig 2.2-26).  
 
Fig  2.2-24 Kinetics of original 9F13 deoxyribozyme in the presence of 20 mM Mn2+ and micromolar concentrations of 
Tb3+. Kinetic curves were fit to the equation yield=Ymax• [a1• (1–e –k1• t) + (1–a1) • (1-e–k2•t)]. In the table a2=1-a1.  





Fig  2.2-25 Combinatorial mutation interference analysis of 9F13 in the presence of 20 mM Mn2+. Left is the 
autoradiogram of the hydrolysis pattern of active, inactive and unselected mutant libraries of 9F13. Right is the 
interference values of each mutant library for individual positions of 9F13 catalytic core.  
 
Fig  2.2-26  9F13 trimming kinetics. The original sequence and trimmed sequence of 9F13 are shown in the left. The 
uridine branch site is marked bold and underlined. Kinetic experiments have been performed in the presence of 20 mM 
Mn2+ at 25°C.  The kinetic data shows 4-fold rate acceleration upon removal of the mutable region.  
In summary, our investigations demonstrated that the Tb3+ dependent acceleration of 2’,5’- branched 
RNA formation is not a specific case for 9F7 but also is valid for another member of 9F7 family (9F13) 
and also for three-helix junction forming deoxyribozymes i.e. 7S11 and 10DM24.  
2.2.8 Discussion 
Tb3+ was shown to be an effective accelerator for catalysis of 2’,5’ phosphodiester bond formation with 
9F7 and 9F13, 7S11 and 10DM24. Tb3+ mediated acceleration was investigated in details for 9F7. The 
kinetics of the enzyme was enhanced up to 10000-fold at low concentrations of bivalent metal ions. The 




affinity of the enzyme to the bivalent metal ions was increased upon presence of optimum 
concentrations of Tb3+. Bivalent metal ions were shown to be necessary for 9F7 catalysis suggesting 
their involvement in the catalytic center of the enzyme (Fig 2.2-27).  
 
Fig  2.2-27 The effect of Tb3+ on 9F7 affinity to the active M2+.Optimum Tb3+ increases the affinity of the enzyme to its 
active metal ion. Mg2+ and Tb3+ ions are shown in orange and pink. The Mg2+ ion involved in the formation of the 
catalytic center is marked with red border. Presence of optimum Tb3+ facilitates formation of the catalytic center at 
lower concentrations of Mg2+. At the same time, the increased affinity of the catalytically important metal ion binding 
site to the bivalent metal ion accelerates the reaction.  
The significance of the Tb3+-mediated acceleration of RNA ligation reaction is clearer when compared 
to previous reports of the Tb3+ and other lanthanides effect on ribozymes and deoxyribozymes. The 
RNA cleaving deoxyribozyme 8-17 which was reported to be active in the presence of Mg2+, Zn2+, Pb2+ 
or Co2+ was inhibited upon addition of micromolar Tb3+ concentrations135. Magnesium dependent 
reaction of hammerhead ribozyme was reversibly inhibited upon presence of Tb3+ in micromolar 
concentrations148. For the nucleolytic ribozymes, under special conditions small acceleration effects 
were reported. For example, when tested in the presence of high concentrations of Na+ or spermidine (> 
1 M), low amounts of Tb3+ (<25 µM) accelerated the hairpin ribozyme-catalyzed RNA cleavage up to 
2.5-fold, while higher Tb3+ (> 30 µM) inhibited the ribozyme126. Upto 30-fold increase in the leadzyme 
activity was reported by Ohmichi et al133 with an optimal combination of Nd3+ :Pb2+ (1:3). 
The 9F7 and 9F13 lanthanide mediated acceleration was observed in a narrow range of lanthanide 
concentrations. Interestingly, the optimum range was dependent on the identity of the active bivalent 
metal ion, disrespect to M2+ concentration. Although the ratio of [Tb3+]: [M2+] was shown not to be 
important, the ratio of [Metal ions]: [nucleic acid components] was crucial for fast ligation. As a rule of 
thumb, our data suggests [Tb3+]: [DNA] must be ca. 10:1 for fast ligation reaction. It is likely that not-
enough Tb3+ ion is available for binding to specific binding sites of the DNA-RNA complex when the 
[Tb3+]: [DNA] ratio is below 10.  
Different hypotheses could be reasoned for reduced ligation yield at inhibitory Tb3+ concentrations. We 
showed hydrolysis and inactivation of the triphosphate of the donor RNA is not the cause of the 
inhibition. Although decomposition of the triphosphorylated RNA to mono- and diphosphorylated RNA 
was slightly enhanced in the presence of 200 µM Tb3+, more than 70 percent of donor RNA remained 
intact and triphosphorylated but not ligated. Hydrolysis, site specific degradation of the branched 




product or any evidence for increased reverse reaction was not observed in the presence of Tb3+ and in 
the presence or absence of inorganic pyrophosphate. Two other yet possible hypotheses for inhibition at 
high lanthanide concentrations are: 1) Misfolding of DNA to an inactivated form in the presence of high 
concentrations of Ln3+. 2) Displacement of the active bivalent metal ion from (a) catalytically important 
position(s) by Ln3+.   
Combinatorial mutation interference analyses led to minimization of 9F7 and 9F13 catalytic cores to 
70% and 57% of original lengths. The trimmed 9F7 contained 27 nucleotide in the catalytic core from 
which 11 nucleotides were guanines. Trimmed 9F13 was 23 nucleotide long with 12 guanines in the 
catalytic core. Trimmed 9F7 was slightly slower compared to the original length 9F7 when performing 
the reaction in the presence of 2 mM Mn2+ or 80 mM Mg2+. But importantly the trimmed and original 
9F7 were equally fast in the presence of optimum Tb3+. Trimmed version of 9F13 was 4 fold faster than 
original length enzyme. It can be deduced that the full length 9F13 had inactive folds for which the 
mutable region was participating. The removal of this region eliminates possibility of formation of 
inactive folds of the enzyme.  
For CoMA of 9F7, several 2’-OH sensitive positions were observed. Presence of high concentration of 
bivalent metal ion or optimum concentrations of terbium had relieved detrimental effects of 2’-OH. The 
relief of the 2’-OH effect was a significant observation especially when considering the reaction times 
of the CoMA separation steps. The 9F7 reaction at low Mn2+ and Mg2+ alone were stopped after 8-10 h, 
while at high Mn2+ and low Mn2++ Tb3+ and Mg2++ Tb3+ the reaction times were 20 min, 1h and 2h.  
Performing CoMA at various conditions allowed comparison of the nucleobases requirement of Mg2+ 
and Mn2+ dependent reactions of 9F7. In general nucleobase requirement of 9F7 was higher for Mg2+ 
dependent reaction. Mutations were better tolerated at elevated concentrations of metal ions or in the 
presence of optimum terbium. Additionally, nucleotides G41 and T42 were included in the mutation 
analysis as positive controls, for which the nucleotide requirements were known from previous 
studies.149 These two nucleotides interact with the acceptor substrate upstream of the branch-site 
nucleotide. Disruption of the DNA-RNA Watson-Crick base-pairs inhibited the reaction.149 The CoMA 
results confirmed these interactions, since only the parent (ribo) nucleotides were tolerated, but all 
mutations showed large interference effects under all assayed conditions.  
Tb3+ luminescence of folded 9F7 in pre-catalytic state in presence of Mg2+ or Mn2+ was studied. As it 
was expected in the presence of elevated concentrations of bivalent metal ions the [Tb3+]1/2 was 
increased. Comparison of luminescence binding curves of an inactive mutant of the enzyme (G4T) and 
the original enzyme showed a left-shift, indicating facilitated binding of Tb3+ when the active site is not 
intact. This observation was more pronounced at low concentrations i.e. for transition from state-1 to 
state-2, in Tb3+ titration to the folded enzyme in presence of Mg2+. These results underline the finding 
that coordination of a divalent metal ion in the active site is essential for activity, and further support the 




interpretation that Tb3+ first binds to peripheral sites before displacing catalytic metal ions, and causing 
inactive conformations. However, since the luminescence data were all recorded with inactivated 
substrates and reported on the sum of specific and unspecific binding of Tb3+ to the nucleic acid 
complex, the luminescence binding curves cannot be directly correlated to the kinetic results. 
Although the luminescence data are not sufficient to fully describe the details of Tb3+ binding, the 
results support our kinetic data which suggested that the 9F7 deoxyribozyme provides specific binding 
sites for Tb3+ ions. We hypothesize that acceleration of the ligation activity results from Tb3+ binding to 
structurally important sites which causes an increased affinity for divalent metal ions at catalytically 
critical M2+ binding sites.  
DMS Footprinting assay of 9F7 were in agreement with DNase I probing of the enzyme. Accessibility 
of the N7 of guanosines for methylation with DMS and the DNA backbone for cleavage with DNase I 
were generally reduced in post-hybridization states compared to pre-hybridization state as well as in 
post catalytic state compared to the pre-catalytic state. Presence of Mn2+ in post catalytic state of the 
enzyme reduced the DNase I and DMS based cleavage. The effect was more significant in DNase I 
probing assay.  
Replacement of the γ-phosphate by PS in standard donor RNA caused a considerably reduced ligation 
rate. Tb3+ did not improve the reaction rate in this case. These results indicated that the larger and softer 
sulfur atom was less well accommodated than oxygen at the γ position, and lent support to the 
hypothesis of preferred interaction of the terminal phosphate with hard lanthanides. Softer and more 
thiophilic metal ions such as Cd2+ and Mn2+ did not significantly rescue the PS effect.  
The alternative donor substrate, “1G” donor, was less efficiently ligated when triphosphorylated. 
Ligation was inhibited with γ- phosphorothioate, as in standard donor. In contrast, with α-
phosphorothioate, the reaction rate was improved. Addition of 1 mM Cd2+ improved the reaction rate 
further when the reaction was performed in the presence of 20 mM Mn2+ while Cd2+ had no effect on 
tirphosphorylated “1G” substrate. Addition of 10 µM Tb3+ accelerated the PO substrate more than α-PS 
substrate. Collectively, these results point towards important interactions at the α and γ-phosphates of 
the donor RNA, although the PS and rescue effects were less pronounced than for other 
metalloribozymes.150 
The acceleration effect was observed for other deoxyribozymes which form 2’,5’ branched-RNA. This 
observation points toward favorable activation of the 2’-OH nucleophiles. It is conceivable that 
activating metal ions interact simultaneously with nucleophile and electrophile. Impressive rate 
enhancement and Increased affinity of the enzyme to bivalent metal ions allowed branch formation at 
Mg2+ concentrations nearer to the Mg2+ concentrations in biological systems 99. In summary, these 




finding shifted the reaction rates and metal ion requirement of the enzyme into a region that makes it 





2.3 6BX22, a lariat forming deoxyribozyme 
In addition to 9F7 deoxyribozyme family and three-helix junction forming deoxyribozymes, we were 
interested to investigate the catalytic mechanism and nucleotide requirements of another type of 2’,5’-
branched RNA forming deoxyribozymes which is capable of formation of biological lariat RNAs. 
6BX22 catalyzes the nucleophilic attack of the 2’-OH of a specified branch site at the acceptor RNA to 
the alpha phosphate of a triphosphorylated donor RNA. Pyrophosphate is released and the 2’,5’  
phosphodiester bond is formed. 6BX2213 was selected in vitro, to ligate RNA sequences with natural 
sequence of spliceosome substrates. The in vitro selection started with a DNA library containing a 40 
nucleotide random region embedded with two constant binding arms to bind to the donor RNA (5’ of 
the random region) and acceptor RNA (3’ of the random region).  
The outcome of the selection, 6BX22 had 39 nucleotide in the catalytic core13 and was predicted to form 
a stem loop at the 3’ end of the catalytic core26. The in vitro selection was performed in presence of 20 
mM Mn2+. It was shown that the enzyme is not active with any of the followed metal ions: Mg2+, Ca2+, 
Zn2+, Fe2+, Co2+, Ni2+, Cd2+, [Co(NH3)6]3+  when provided as chloride salts in concentrations ranging 
between 10 µM-10 mM 26. 6BX22 was selected with A as branch site nucleotide but it was shown that 
the branch site can be mutated to C or U with almost similar activity. Branch site G was accepted with 
dramatically reduced yield. Capability of lariat formation was maintained upon mutation to C and U. 
Formation of lariat RNAs with two yeast RNAs, YBL059W (69 nucleotides) and ACT1 (309 
nucleotides) and one human related RNA fragment, ß-globin IVS1 (130 nucleotides) with 6BX22 
enzymes was proved to be efficient. In all three cases, the triphosphorylated RNAs were prepared by in 
vitro transcription with T7 RNA polymerase. The loop size of the lariat products of YBL059W, ACT1 
and ß-globin were 51, 266 and 94 nucleotides respectively. Preparative (nanomole) scale synthesis of 
ACT1 lariat RNA was shown to be successful, however disruptor DNAs were required to prevent RNA 
degradation26.  
2.3.1 6BX22 substrate requirements 
Our initial step for functional analysis of 6BX22 was combinatorial mutation interference analysis 
(CoMA). One of the requirements of CoMA is ligation of one of the substrates to the mutant DNA 
libraries which topologically cannot be accommodated by a lariat RNA. Therefore, in this study, 
intermolecular 2’,5’ branch formation, employing distinct acceptor and donor RNA substrates were 
studied rather than lariat RNA formation. Firstly, we optimized the length of the donor RNA for the 
bimolecular format reaction which is required for the second step of CoMA (Fig 2.2-1 B).  





Fig  2.3-1 6BX22 predicted secondary structure and kinetics. A) mfold predicted secondary structure of 6BX22 and the 
catalyzed reaction by 6BX22.  B) Optimization of 6BX22 binding arms length for trimolecular and bimolecular format 
branch formation. Reactions were performed in presence of 20 mM Mn2+. Time points were 0, 30, 90, 180 and 300 min. 
To perform bimolecular format reaction we chose the deoxyribozyme D003 with a binding arm with 8 
nucleotides for base pairing with Tr02. This length of base pairing is not sufficient to perform the 
reaction in trimolecular format. For trimolecular format kinetic experiments performed for 6BX22 Tr03 
was employed as donor RNA, forming 11 nucleotide long base paired region with the enzyme right 
binding arm, unless otherwise mentioned.   
Additionally, we explored 6BX22 substrate requirement, regarding the acceptor RNA and the length of 
the RNA overhang after the branch site. 6BX22 was shown to accept up to 40 nucleotide overhang 
(ACT1 lariat formation)26. Here the minimal length of the overhang required for the catalysis was 
investigated. The standard acceptor RNA which is used in this study is R01 with 9 nucleotide overhang 
after the branch site. Three minimized RNAs which form either none or 1 or 3 nucleotide overhangs 
have been tested. 6BX22 was not capable of ligation when the adenosine branch site is the 3’ end of the 
acceptor RNA i.e. at least one nucleotide overhang was shown to be required. Presence of 3 nucleotide 
overhang increased the reaction rate even higher than the original substrate which has 9 nucleotides 
overhang. (Fig 2.3-2)  The results suggested that the first nucleotide downstream of adenosine branch 
site (in this study, a cytosine) is required for catalysis. 
 
Fig  2.3-2 Kinetic assays for minimization of 
6BX22 acceptor RNA. The four acceptor 
RNAs used here have identical sequences 5’ of 
the branch site, therefore one deoxyribozyme 
(D002) was appropriate for all four acceptor 
RNAs. R02 did not have any nucleotide 
overhang after the branch site adenosine. R03 
and R04 beared one or three nucleotides after 
the branch site. R01 was the original acceptor 
substrate for 6BX22. The sequences 3’ of the 
branch site are shown on the right. The 
adenosine branch site is underlined.  




2.3.2 Combinatorial mutation interference analysis of 6BX22 
To identify the catalytically important nucleotides of the 6BX22 enzymatic core, combinatorial 
mutation interference analysis (CoMA, section 2.1) was performed. For the synthesis of the mutant 
libraries, the rN/dN mixtures were prepared by mixing of 100 mM rN and dN phosphoramidite solutions 
with the ratio of 10:90. Before synthesis of the mutant libraries the quality of the mixtures and the 
efficiency of the rN incorporation were analyzed by synthesis of analytical pentamers with the sequence 
of dTdT(rN/dN)dTdT. After synthesis and basic deprotection, the analytical samples were injected on 
anion exchange HPLC. Pentamers which contained the mutant rN had the 2’-O-TOM group and 
therefore their retention times were increased compared to the pentamers which contained the parent 
dN. The integrated area under both UV260 peaks for dTdTdNdTdT and dTdTrNdTdT were extracted and 
the efficiency of rN incorporation was calculated. The result is summarized in table 2.3-1.   
Table  2.3-1 Efficiency of rN incorporation in a mixture of rN:dN phosphoramidites 10:90.  Data were obtained 











A 7.7 4.3 7.7 5.5 
C 8.8 5.9 7.1 9.1 
G 8.1 6.5 8.4 6.7 
T 8.5 6.3 6.6 6.9 
 
After synthesis, deprotection and PAGE purification of the four mutant DNA libraries, donor RNA 
(Tr02) was ligated to the mutant libraries using T4 RNA ligase. The donor RNA-DNA libraries were 
radiolabeled at 3’ end. The radiolabeled donor RNA-DNA libraries were subjected for the 6BX22 
mediated branch formation with slight excess of acceptor RNA (R01). Active fractions were separated 
by denaturing PAGE. Alkaline hydrolysis was performed and PAGE analysis revealed the present 
mutants in each fraction of each library.  
Separation of active mutants and the conditions in which this separation takes place is a crucial step in 
CoMA. Short incubation times exclude the slow mutants being present in the active fraction, whereas 
too long incubation times allow presence of very slow mutants. For one of the 6BX22 libraries, rA 
mutant library, separation of active mutants was performed after different ligation times in presence of 
20 mM Mn2+ (Fig 2.3-3) The hydrolysis patterns for 0.5, 2, 3 and 5h were quite similar except for the 
band A31 which only appeared after 2h. Presence of the 2’-OH chemical tag in position A31 caused an 
interference value above 2.0 when 6BX22 reaction was stopped at 30 min which was reduced at longer 
time points. Therefore, we concluded that presence of 2’OH tag at position A31 reduces the rate of 
6BX22 reaction but is not detrimental. For the rest of the libraries, we chose to perform separation step 
of CoMA by 3 h of incubation. 





Fig  2.3-3 Kinetics of CoMA. rA mutant library of 6BX22 was 
subjected for CoMA with different ligation times. The reaction time 
for 6BX22 catalysis in step 2 of CoMA was limited to 0.5, 2, 3 and 5 hs. 
The hydrolysis patterns were almost similar for most bands except for 
A31. Data suggests that presence of the 2’-OH at A31 reduces the 






Fig 2.3-4 shows the CoMA of 6BX22 for all four libraries. The interference values are depicted for each 
library and each position. In CoMA, interference values for positions in which the 2’-OH chemical tag 
itself is detrimental are not informative. It is conceivable that those positions are sensitive to the sugar 
and DNA backbone conformation. In 6BX22 catalytic core, there are six examples of such positions; 
G3, G5, G6, C26, G28, G32 (numbers are based on original 6BX22 catalytic core).  
The nucleotides in between G11-A24 accepted all the three possible mutations under the experimental 
condition, suggesting that this region is not involved in formation of the catalytic core. We hypothesized 
that the catalytic core of 6BX22 consists of two subdomains, upstream and downstream of the mutable 
region and the mutable region is responsible only as a linker.  
This hypothesis was proven by kinetic experiments on minimized versions of 6BX22 enzyme. 
Minimization kinetics showed that although the identity of the linker sequence was not important, the 
length of the linker played a crucial role and must be longer than one nucleotide. The optimum length 
for the linker was observed to be 2 nucleotides.  The trimmed version in which the linker region was 
totally exchanged by two thymidines was chosen as the trimmed 6BX22 for further experiments of this 
sub chapter. Formation of branched product with the trimmed 6BX22 in standard condition has the kobs 
of 0.01-0.03 min-1 and reaches ca 80% in 3h. The capability of the enzyme for lariat formation was 
maintained to the same extent after minimization. (Fig 2.3-5). For further experiments the nucleotide 
numbers refer to the number of that specific nucleotide in the trimmed version (except if mentioned 
otherwise). The nucleobases having different numbers before and after trimming are marked with 
superscript “t” as an abbreviation for the word “trimmed”.  





Fig  2.3-4 Combinatorial mutation interference analysis (CoMA) for 6BX22. The separation step of CoMA (the second 
step) was performed after 6BX22  ligation in presence of 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl, 20 mM 
MnCl2 at 37°C. A) Autoradiogram of the hydrolysis gel of active, inactive and unselected libraries of 6BX22. B) 
Interference values of 6BX22 mutant libraries. Interference values were calculated by the ratio of intensity of a band in 
the unseparated library over the intensity of the corresponding band in the active fraction. Nucleotide numbers are 
based on original 6BX22 core. 
For some of the positions in which the 2’-OH tag was detrimental, we performed kinetic experiments 
with point mutants of trimmed 6BX22, to get insights about mutation interference (Fig 2.3-6). Mutation 
of G3, G6, G16t and G20t to A (the last two positions, G16t and G20t, are numbered as G28 and G32 in 
original catalytic core of the enzyme), resulted in either inactivation or reduced activity of the mutant. 
Mutations of G16t and G20t to C and T totally aborted the enzymatic activity of the enzyme. Altogether, 
these results suggest that at positions in which the DNA backbone conformation was a determining 
factor, the identity of the nucleobases is also crucial for catalysis. The only active point mutant was G20t 
mutated to A with reduced activity i.e. 20% yield after 3h.  





Fig  2.3-5 6BX22 trimming kinetics. A) 6BX22 original and trimmed enzymatic cores. The region which accepts all 
mutations and apparently does not participate in formation of catalytic core is marked green and underlined. The 
replacement TT in trimmed version of 6BX22 (marked red) was not originally present in the sequence. B) Branch 
formation catalyzed by trimmed 6BX22 with standard substrates. Time points were:0,1, 5, 10, 20, 40, 90, 180 min.  C) 
Kinetic curves related to B.  D) Lariat formation with original and minimized 6BX22. YLB059W mRNA (Tr04) was 
used as substrate. Time points were the same as B with an additional time pint at 120  min. E) kinetic curves related to 
D.  
 
Fig  2.3-6 Point mutant kinetics of trimmed 6BX22. Point mutants were directing positions at which the 2’-OH was 
detrimental. Kinetic experiments were performed with point mutation on trimmed 6BX22, except for G6A which is 
performed with a mutation on original 6BX22. Time points were 0, 5, 10, 20, 40, 60, 90, 120, 180. All the mutants were 
inactive except G20A with 20% yield at 3h. The numbers are based on the position of the specific nucleotides in the 
trimmed 6BX22 catalytic core. The positions which have different numbers after trimming are marked with superscript 
“t”.  
The essential sequence of 6BX22 was shown to be 27 nucleotide long and contain 14 guanosines.  High 
G-content of the catalytic core of the 6BX22 enzyme suggested presence of a G-quadruplex. The 
minimal requirement for formation of a G-quadruplex is four times 2 guanosines in a row, which is 
present in the minimized 6BX22 catalytic core. In this study, this hypothesis was investigated by studies 
on metal ion dependence of the enzyme, foot printing assays, spectroscopic methods and DNA 
nucleotide analog interference mapping (dNAIM140) which are described in the next sections.  




2.3.3 6BX22 dNAIM and DMS-interference  
The high G-content of 6BX22 core suggested presence of a G-quadruplex in its structure. Minimally 
two stacking G-quartets are required for formation of a G-quadruplex. The guanines participating in 
formation of a G-quartet employ functional groups at both Watson-Crick and Hoogsteen sides to form 
hydrogen bonds. Here we aim to study the functional group requirements of the guanines of the trimmed 
6BX22 catalytic core by DNA nucleotide analog interference mapping (dNAIM)140 and DMS-
interference (DMSi)39.  
dNAIM was developed in our research group and has conceptual similarities to CoMA. dNAIM consists 
of four steps; 1) synthesis of DNA libraries with the desired nucleobase modifications, 2) separation of 
active modified enzymes, 3) alkaline hydrolysis and 4) PAGE analysis. As in CoMA, the nucleobase 
modifications are statistically dispersed in the catalytic sequence and are encoded by a 2’-OH chemical 
tag.  
For dNAIM of 6BX22, trimmed DNAs with G modifications were synthesized by solid phase synthesis 
using mixtures of modified ribo-G phosphoramidites with non-modified deoxyribo- G phosphoramidite 
(rGmod/dG). Mixture of rG/dG was used to synthesize rG library as a control for the effect of 2’-OH 
chemical tag. The mixture r-c7G/dG was used to synthesis c7G (7deaza) library, revealing the 
importance of N7 of guanines. The two mixtures r-2-aminopurine (2AP)/dG and r-m1G/dG were used to 
synthesize libraries with modifications at Watson-Crick side of the guanines. The four modified libraries 
underwent the next steps of dNAIM including separation of active fractions, alkaline hydrolysis, PAGE 
and quantification. 
For DMSi, non-modified trimmed 6BX22 DNA was subjected for methylation by DMS. DMS 
methylates N7 of guanosines.  In addition to steric effects, methylated guanosines are charged positively 
at N7. The post synthetic DMS methylated library (m7G) was used in parallel to dNAIM libraries for 
separation of active species. Positions with detrimental effect of methylation were identifiable by 
piperidine cleavage and PAGE analysis. As DMSi was not dependent on alkaline hydrolysis and did not 
require the 2’-OH chemical tag, it provided data about guanines in which the 2’-OH tag was 
detrimental.  
For dNAIM, 2’-OH tag resulted in interference values higher than threshold 2.0, at four positions G3, 
G6, G16t and G20t, consistent with CoMA data. For these positions only the data from DMSi revealed 
information about the N7 of guanines. Interference of 2’-OH at G5 was at the border of being significant 
(interference values of 2.8 and 1.7 respectively for CoMA and dNAIM).  
c7G dNAIM and DMSi reflect the necessity of the N7 position for formation of hydrogen bonds. The 
two libraries reveal complementary information. When a band is absent in both libraries one can deduce 
that the N7 is involved in direct metal ion coordination or formation of a hydrogen bond. DMS based N7 




methylation resulted in interference values higher than 2 at G4, G5, G17t, G20t, G21t, G23t, G24t and at 
all the 2’-OH sensitive positions i.e. G3, G6, G16t and G20t. For positions G4, G20t, G23t and G24t the 
N7 methylation was not detrimental but reduced the band intensity of the active fraction and caused 
interference values between 2 and 5. Excluding the 2’-OH sensitive positions, c7G library revealed 
involvement of G4, G5 and G21t for the catalysis. G9 showed interference values slightly above 
threshold. For most of the positions c7G data and DMSi data were similar except at four positions.  G4 
and G20t had high interference value at c7G library but had less interference at DMSi analysis. 
Methylated G17t and G23t were detrimental while the absence of N7 in the c7G library was accepted.  
Both m1G and 2AP libraries give insights about the Watson-Crick side of guanines. In the m1G library 
formation of Watson-Crick base pair is disturbed by steric effects. The library with 2aminopurin lacks 
the keto functional group at the position 6 of the guanine and therefore is able to form maximum two 
hydrogen bonds instead of three. Both libraries resulted high interference by modifications at all 
guanines except for G5 in m1G library, G7 in 2AP library and G13t and G15t in both libraries (Fig 2.3-
7). In summary, dNAIM and DMSi, revealed which functional groups of the necessary guanosines are 
modifiable and are not involved in formation of any hydrogen bond or coordination to metal ions. 
 
Fig  2.3-7 Nucleotide analog interference mapping of DNA (dNAIM) and DMS-interference (DMSi) of guanines of the 
trimmed 6BX22. Modifications of dNAIM libraries were incorporated to the 6BX22 sequence during solid phase 
synthesis. Modification of the DMSi library was post synthetic using DMS. 6BX22 reactions for separation of active 
modified DNAs were in presence of 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and 20 mM Mn2+ at 37°C for 3 h. 
Interference values were defined as in CoMA by the ratio of a band in the unselected library to the corresponding band 
in the active fraction.  




2.3.4 6BX22 and metal ions 
To further explore possibility of presence of G-quadruplex in the catalytic core of 6BX22 we were 
interested to study the dependence of the 6BX22 deoxyribozyme on metal ions. G-rich sequences are 
dependent on monovalent metal ions such as Na+ or K+ to form G-quadruplexes106. The quadruplex 
formation rate increases with increase in the concentration of these monovalent salts.151 Standard 
reaction buffer for 6BX22 contains 150 mM NaCl, 2 mM KCl and 20 mM MnCl2. If the catalytic 
activity of the enzyme is dependent on formation of a G-quadruplex, it is expected that it is reduced at 
lower monovalent salt concentrations. We performed kinetic experiments in the absence of K+ ion or 
reduced amount or absence of Na+ ion (in all cases in presence of 20 mM Mn2+ at pH 7.5). Although, the 
kinetics of the enzyme was reduced at lower monovalent concentrations but still the enzyme was active 
in the absence of both monovalent metal ions and reached almost 50% of the yield that it could achieve 
in the presence of standard concentration of monovalent metal ions (Fig 2.3-8). Taken together, these 
kinetic data did not support presence of G-quadruplex in the catalytic core of the enzyme. 
 
Fig  2.3-8 Kinetics of 6BX22 enzyme in presence of 20 mM Mn2+ and reduced concentrations of monovalent salts  
Additionally, kinetic experiments have been performed to study the dependence of the enzyme on 
bivalent metal ions. In one experiment, the concentration of Mn2+ was reduced from 20 mM to 0 mM. 
The total ionic strength was kept constant by addition of appropriate concentrations of Mg2+ to 
compensate reduced concentration of Mn2+. The gel in Fig 2.3-9 A shows the ligation efficiency after 3h 
for combinations of Mg2+ and Mn2+ concentrations. The results are plotted in the same figure B. 
Additionally, product formation in the course of reaction was monitored in the presence of 5 mM Mn2+ 
and 15 mM Mg2+. The reaction rate was reduced 6-fold and reached 40% yield after 10h incubation at 
37°C. 





Fig  2.3-9 Kinetics of trimmed 6BX22 with reduced Mn2+. A and B) ligated fraction after 3 h incubation at different 
combinations of Mg2+ and Mn2+. C and D) individual kinetic data in presence of 20 mM Mn2+ and 15 mM Mg2+ plus 5 
mM Mn2+. Time points were 0, 5, 10, 20, 40, 80 min, 2, 4, 6 and 10 h.  
The trivalent cation, Tb3+, was shown to interact with G-quadruplex forming oligonucleotides derived 
from Tetrahymena122 or human telomeric sequences152. Here we investigated the activity of the enzyme 
6BX22 in the presence of Tb3+. In general, addition of Tb3+ to the Mn2+ dependent reactions of 6BX22 
reduced the rate and maximum yield of the reactions. Fig 2.3-10 shows the titration of Tb3+ in presence 
of different concentrations of Mn2+. Tb3+ concentration below 50 µM had slight effects on kinetics of the 
enzyme while concentrations above 100 µM reduced the yield dramatically. Incubation of the samples 
in presence of Tb3+ concentrations higher than 300 µM caused degradation of RNA substrate. The rate 
constant determined by exponential fit to the kinetic curves are marked beside each panel. One should 
note that comparison of kobs is only meaningful when the extrapolated maximum yields are in the same 
range. In the case of Tb3+ titration, the maximum yields are reduced and therefore, kobs values are not 
directly comparable.  
To further investigate, the Tb3+ mediated inhibition of 6BX22, single and double chase experiments 
have been performed (Fig 2.3-11). Single chase experiment started with 10 mM Mn2+.  After 20 min of 
starting the reaction, Tb3+ (100 µM) was added to the reaction mixture.  As it was expected the rate of 
product formation and the final yield were reduced upon addition of Tb3+ (50% vs 75% yield at 5h, 
compared to 10 mM Mn2+). For the double chase experiment, extra Mn2+ was added to the reaction 
mixture to reach final concentrations of 20 mM Mn2+ and 100 µM Tb3+.  The reaction which was 
decelerated by addition of Tb3+ in the first chase was retrieved and reaction reached to 75% yield within 
3h after addition of extra Mn2+.These data shows that inhibition of 6BX22 by Tb3+ is a reversible 
inhibition and suggests that both Mn2+ and Tb3+ compete for the same position in the enzyme which is 
crucial for catalysis. 





Fig  2.3-10 Tb3+ mediated inhibition of Mn2+ dependent 6BX22 reaction. The kobs values are not directly comparable as 
the extrapolated maximum yields are reduced upon presence of Tb3+.  
 
 
Fig  2.3-11 6BX22 single and double chase experiments with Tb3+ and Mn2+. For both chase experiments, addition of 
TbCl3 to the chase samples was 20 min after initiation of the reaction. For the double chase reaction, MnCl2 added to 
the sample at 80 min after reaction initiation up to 20 mM Mn2+. 10 and 20 mM Mn2+ reaction were performed in 
parallel as control experiments. 
In summary, independence of the catalytic activity of 6BX22 from monovalent ions was in 
disagreement with presence of a G-quadruplex in its active structure. And reversible inhibition of the 




deoxyribozyme with Tb3+, showed there is (are) specific binding site(s) for Tb3+. Presence of such 
binding sites allowed luminescence studies of 6BX22.  
2.3.5 Tb3+ luminescence 
Energy transfer from nucleic acids to inner-sphere coordinated Tb3+ ions is the basis of Tb3+ sensitized 
luminescence. This property makes Tb3+ an applicable probe for studying metal ion binding sites in 
DNA. Tb3+ luminescence was employed to study Mg2+ binding sites in ribozymes113 for which Tb3+ was 
an inhibitory metal ion148. In the case of 6BX22, the kinetic data suggested that Tb3+ binds to the same 
position of Mn2+ and causes reversible inhibition. Therefore, studying Tb3+ binding sites in 6BX22 
would shed light on the hypothetical binding sites for Mn2+ as well.  
Fig 2.3-12 A depicts excitation and emission spectra of Tb3+. For the excitation spectra the emission 
wavelength was set at 545 nm and excitation spectra of 150 µM Tb3+ alone or in the presence of 2 µM 
6BX22 DNA (D010) was recorded. For the emission spectrum, 150 µM Tb3+ in the presence of 2 µM 
DNA (D010) was excited at 284 nm. The four peaks, signature of Tb3+ sensitized luminescence, were 
detectable at 488, 543, 584 and 620 nm. For Tb3+ titrations, the intensity of the peak at 543 was plotted 
against [Tb3+].  
Tb3+ titrations were performed with pre-annealed RNA-DNA complexes in the presence of 150 mM 
NaCl, 2 mM KCl and 0 or 20 mM MnCl2. We were interested in the Tb3+ binding sites at the catalytic 
core of the enzyme. Hybridization of the enzyme binding arms to the RNA substrates or product leads to 
formation of stiff binding arms that can affect the three dimensional structure of the catalytic core of the 
enzyme. Therefore the DNAs used for Tb3+ titration were pre annealed with (inactivated) RNA 
substrates, “6BX22 hyb”. The acceptor substrate was the active substrate (R03) but the donor substrate 
was the inactive analog of Tr03 (R05) containing 5’-OH rather than 5’-triphosphate. 
Fig 2.3-12 B shows the complexes that have been used in Tb3+ luminescence study of 6BX22. In 
addition to Tb3+ titration to 6BX22 hyb, Tb3+ was titrated to left and right binding arms of the enzyme 
separately. This setup was aimed to specify how much each of the binding arms and the catalytic core 
contribute into the total intensity observed in Tb3+ titration to the 6BX22 hyb.  
[Tb3+]1/2 was observed to be 36 µM with maximum intensity of ca 30 a.u. for the left binding arm, in the 
absence of Mn2+. [Tb3+]1/2 was 139 µM with maximum intensity of ca 50 a.u. for the right binding arm at 
the same conditions (also the same detector voltage). [Tb3+]1/2 for 6BX22 hyb was 110 µM and reached 
maximum intensity of ca 100 a.u. Notably, the observed intensity for the left binding arm at 
concentrations below 100 µM Tb3+ was higher in comparison to 6BX22 hyb which consists of both 
binding arms and the catalytic core. This experimental setup showed that the Tb3+ luminescence data are 
not simply additive data and suggested that Tb3+ binding sites of the binding arms are affected when 
present in the context of the 6BX22 deoxyribozyme.  




In the presence of 20 mM Mn2+, as expected, the maximum luminescence intensity was decreased and 
[Tb3+]1/2 was increased for the same construct; [Tb3+]1/2 of 333 µM and max intensity 25 a.u. for the 
active trimmed 6BX22 hyb (at the same detector voltage as the previous experiment). Using an inactive 
form of trimmed 6BX22, containing a G6C mutation (D021), led to [Tb3+]1/2 of 301 µM and max 
intensity 19 a.u. Although the inactive mutant had shown lower [Tb3+]1/2 , one should consider that the 
maximum intensity of the same sample is reduced as well. In summary, Tb3+ luminescence data 




Fig  2.3-12 Tb3+ luminescence with trimmed 6BX22. A) Typical Tb3+ luminescence excitation and emission spectra. 
Excitation spectra are shown in the absence and presence of DNA. Emission spectrum is shown only in presence of DNA 
(2 µM D010). B) shows the three DNA-RNA complexes that have been used in C.  Investigation of Tb3+ binding to the 
catalytic core of 6BX22 hyb was aimed here. Double stranded left and right binding arms are control samples for Tb3+ 
binding to DNA out of the catalytic core. C) Tb3+ titration to 6BX22 hyb with active enzyme (D010) and the two binding 
arms, in presence of 50 mM HEPES pH 7.5, 150 mM NaCl and 2 mM KCl. D) Tb3+ titration to 6BX22 hyb complexes 
with active trimmed 6BX22 (D010)  or G6C inactive trimmed 6BX22 (D021) in the presence of 20 mM MnCl2.   In C 
and D data were fit to the equation: I=Imax •[Tb3+]n/([Tb3+]n +[Tb3+]1/2 n) 
2.3.6 Circular dichroism (CD)  




Circular dichroism (CD) spectroscopy is an ideal method for tracing conformational transitions of large 
macromolecules. For DNA molecules, the phosphate-sugar backbone and global helical arrangement 
define their CD spectra. Different types of DNA helices i.e. A, B or Z, parallel or antiparallel G-
quadruplex DNAs and I-motifs have specific known signatures in their CD spectra153 . B-form of DNA 
has the signature with four peaks at 211 nm (negative), 221 nm (positive), 245 nm (negative) and 
275 nm (positive)154. The characteristic signatures of B DNA are broadened in RNA-DNA hybrid155.  A 
parallel intermolecular G-quadruplex exhibits a positive ellipticity band at ~260 nm and a smaller 
negative band at ~240 nm156,157, whereas an antiparallel G-quadruplex has a typical signature with a  
positive band at 295 nm  and a negative band at 260 nm152.   
CD spectra of trimmed 6BX22 showed a positive band at 270 nm and a smaller negative band at 240 
nm. While the negative band remained unchanged, the positive band was enhanced and shifted to 265 
nm upon hybridization of the 6BX22 binding arms to the (inactivated) substrates. Standard active 
acceptor RNA (R01) and 5’-OH inactive donor RNA (R05) were used for binding arm hybridization. 
No additional changes were observed when the branched product was hybridized to the binding arms. 
Addition of Tb3+ (up to 150 µM), slightly decreased the positive band but left the negative band almost 
unaffected (Fig 2.3-13). In summary, CD data did not support any proof for presence of an anti-parallel 
G-quadruplex but was in agreement with presence of the RNA-DNA hybrid (binding arms) and/or 
parallel G-quadruplex in the 6BX22 enzyme. 
 
Fig  2.3-13 CD spectra of trimmed 6BX22 (3 
µM) in complex with inactivated substrates or 
branched product, in the presence of 50 mM 
HEPES, 150 mM NaCl, 2 mM KCl, 20 mM 
MnCl2 and increasing concentrations of TbCl3. 
6BX22 shows a negative band at 240 nm, 
which stays the same in presence of RNA 
substrates or branched RNA product. 6BX22 
DNA also shows a positive band at 270 nm 
which shifts to 265 nm and is increased by 
hybridization of its arms to substrates or 
product (br2). Presence of increasing 
concentrations of Tb3+ ion reduced the 





2.3.6.1 Stabilization by TMPyP4 porphyrine  




Further investigation on presence of a G-quadruplex in 6BX22 was performed with biochemical and 
biophysical analyses of a G-quadruplex binding porphyrine. It had been shown that modified porphyrins 
with cationic side arms e.g. tetra-(N-methyl-4-pyridyl) porphyrin (TMPyP4) can stabilize G-
quadruplexes158. TMPyP4 has been shown to stabilize telomeric G-quadruplexes and be an effective 
inhibitor of human telomerase.159 If a G-quadruplex is present in the 6BX22 catalytic core, it is 
conceivable that TMPyP4 mediated stabilization can decrease the dependence of the enzyme on metal 
ions. We have tested the activity of the enzyme in the presence or absence of Mn2+ and TMPyP4.  (Fig 
2.3-14) The dependence of the catalytic activity of the enzyme on Mn2+ was still remained and no 
acceleration of the enzyme was observed upon presence of 1- or 10-fold excess of TMPyP4. 
Additionally, TMPyP4 is a fluorescent dye. Fluorescence spectra reflect information about the changes 
of the local environment of the fluorophors. It was reported that the shape and intensity of TMPyP4 
emission spectra are altered upon interaction with G-quadruplexes. Excitation of intercalated TMPyP4 
into DNA (at 433 nm) results in an emission spectrum with two peaks at 660 and 720 nm.160  
 
Fig  2.3-14 TMPyP4 structure and its effect on 6BX22 catalytic activity A) TMPyP4 structure. B) 6BX22 kinetics in 
presence or absence of TMPyP4 and Mn2+.  Time points are 0, 2 and 8 h. 
 
Fig  2.3-15 TMPyP4 fluorescence in presence of 6BX22 DNA and metal ions. A) Emission spectra of 2 µM TMPyP4 by 
stepwise addition of buffer (50 mM HEPES pH 7.5) plus DNA, minimized catalytic core (4 µM), NaCl (150 mM), KCl (2 
mM) and MnCl2 (20 mM). B) Emission spectra of 2 µM TMpyP4 in presence of 150 mM NaCl, 2 mM KCl, 20 mM 
MnCl2 and 50 mM HEPES pH 7.5 and 4 µM of 6BX22 related and unrelated DNAs.   
Addition of metal ions (especially monovalents) to a DNA which forms a G-quadruplex increases the 
population of formed G-quadruplexes. To observe such effect, in the first experiments the emission 
spectra of 2 µM TMPyP4 was monitored by stepwise addition of DNA, NaCl, KCl and MnCl2. In this 
experiment, the trimmed 6BX22 catalytic core (without binding arms, D040) was used. Addition of 4 




µM DNA when 50 mM HEPES pH 7.5 was present resulted in formation of the expected two peaks at 
660 and 720 nm160 with ratio of 2:1 for the two peaks. Addition of metal ions did not lead to further 
significant changes in the emission spectra (Fig 2.3-15).  
6BX22 minimized core with and without binding arms (D040 and D009) and also two DNAs unrelated 
to 6BX22 catalytic core i.e. DNA templates for transcription of Tr02 and Tr03 were added to TMPyP4. 
Formation of a G-quadruplex was not predictable according to the sequences of the two unrelated 
DNAs. Notably, the emission spectra of the 6BX22 related and unrelated DNAs were almost similar and 
even slightly higher intensities were observed for unrelated DNAs suggesting that the observed effect is 
nothing specific to the 6BX22 catalytic core and its hypothetical G-quadruplex (Fig 2.3-15 B). 
Increasing concentrations of DNAs up to 16 µM (in presence of 2 µM TMPyP4) did not cause 
additional significant increase in the fluorescence intensity for 6BX22 enzyme or unrelated DNAs (Fig 
2.3-16 A). In a new experiment, TMPyP4 was titrated in presence of 20 µM 6BX22 DNA or unrelated 
DNA. The observed intensity increased upon addition of the ligand. The fluorescence increase was more 
significant for the 6BX22 unrelated DNA (Fig 2.3-16 C).  
 
Fig  2.3-16 DNA and TMPyP4 titrations.  A) emission spectra of 2 µM TMPyP4 with increasing concentrations of 6BX22 
enzyme (D009), or unrelated DNAs i.e. Tr02 template (D029) and Tr03 template (D030) in the presence of 50 mM 
HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and 20 mM MnCl2.  B) TMPyP4 spectra before and after 1 min incubation at 
95°C.  C) TMPyP4 titration in presence of 20 µM DNA (D009 and D030). Increase in TMPyP4 concentration resulted in 
higher intensities. The effect is stronger for Tr02 DNA template. Additionally, emission spectrum of 20 µM TMPyP4 in 
the absence of DNA is plotted on the graphs in C. 
 
TMPyP4 was reported to stabilize G-quadruplexes. Stability of DNA structures are usually investigated 
by UV260 nm or CD thermal melting analysis. Determination of melting temperature (Tm) for 6BX22 in 




presence of TMPyP4 was not possible because the TMPyP4 was not stable at high temperature. Fig 2.3-
16 B shows the emission spectra of TMPyP4 before and after 1 min incubation at 95°C. In summary, 
biochemical and luminescence studies with TMPyP4 did not provide any proof in favor of presence of a 
G-quadruplex in 6BX22 catalytic core.  
2.3.7 6BX22 foot printing assays 
Chemical DMS probing and enzymatic DNase I digestion have been used here to study 6BX22 folding. 
Footprinting assays such as dimethyl sulfate (DMS) probing or DNase probing reveal information on 
the accessibility of the N7 position of DNA guanines for methylation by DMS or phosphate-sugar 
backbone digestion by DNase. Conceivably, deoxyribozymes undergo structural changes upon 
hybridization to substrates, in presence of metal ions and in the course of reaction.  
Here, three sample compositions have been used for foot printing assays; Dt, iS and brP. Dt contained 
trimmed version of 6BX22 as sole nucleic acid component and resembled the pre-hybridization state. 
Complex iS had three components i.e. trimmed 6BX22, inactive acceptor substrate (R02) and inactive 
donor substrate (R05). Complex iS was representative of the pre-catalytic state. Complex brP contained 
trimmed 6BX22 hybridized to 6BX22 branched product and represented post-catalytic state of the 
enzyme. 
For most of the positions in the catalytic core of the enzyme, DNase I accessibility of the backbone was 
diminished upon hybridization to the substrate (Dt vs iS). The protection was even further increased 
upon presence of branched product (brP).  Examples for the described stepwise protection include T11t, 
T12t, G13t, G16t, G24t, C26t, and C27t. There are individual cases in which the protection increased in 
iS but reduced in brP complex. Examples for such positions include C14t, A22t and G23t (Fig 2.3-17 B). 
Addition of buffer to the samples further decreased accessibility of DNA backbone for DNase I 
digestion. The protection level increased to the extent that almost no cleavage was observed for any of 
the complexes in presence of 150 mM NaCl, 2 mM KCl and 20 mM MnCl2. This is noteworthy since 
MnCl2 is an activator of DNase I145. For the DNase I digestion shown in Fig 2.3-17 B, MnCl2 was 
excluded from the buffer. In presence of buffer (Mn2+ excluded) and in post catalytic state only C14t and 
G23t were accessible for DNase I digestion. Comparing individual complexes of Dt, iS and brP in 
presence and absence of buffer shows that the buffer dependent protection occurs for each composition 
and is not dependent on the hybridization state and catalytic state of the DNA. For example C27t was 
strongly cleaved in the absence of buffer but was protected in presence of buffer in all three sample 
compositions.  
Global folding of the inactive DNA mutant G6A showed almost the same pattern as the active DNA 
with specific local differences (Fig 2.3-17 B, lanes 7-12). In the absence of buffer, the protection levels 
of T11t, T12t and G16t in brP complex with G6A were weaker compared to the active fold. The same 




positions and in the presence of buffer showed less protection in iS complex with inactive mutant G6A 
in comparison to the iS of the active enzyme. Additionally, The observed effect at C14t in active DNA 
(protection at iS but cleavage at brP) was not evident in the mutant.  
 
Fig  2.3-17 DMS and DNase I probing of minimized 6BX22 (D010) and its inactive point mutant; G6A (D015). DNAs 
were radiolabeled at 3’ end. A) The three complexes used for probing assays. Dt: DNA as sole component, iS: DNA in 
complex with inactive acceptor RNA (R002) and inactive donor RNA (R005), brP: DNA with branched product. The 
G6 position was mutated to A for samples marked with inactive DNA. B) DNase I probing. The buffer contains 50 mM 
HEPES pH 7.5, 150 mM NaCl, 2 mM KCl. MnCl2 is not present for DNase I probing. C) DMS probing, sample 
composition, buffer and metal ions are as in B except that 20 mM MnCl2 is additionally present in buffer lanes. (The 
stem loop is predicted by m-fold). 
While the DNase I digestion reflects accessibility of the DNA backbone, DMS probing assay 
determines accessibility of the N7 positions of the guanines. For 6BX22 catalytic core and in the 
absence of buffer and Mn2+, there was no difference in methylation pattern of the enzyme comparing 
pre-hybridization and post-hybridization states. Presence of buffer and Mn2+ resulted in strong 




protection at positions G3-G6 in all three complexes, Dt, iS and brP. The protection level was increased 
from pre-hybridization state to pre- and post-catalytic states for these positions. G16t, G17t were only 
protected in post hybridization states (iS and brP). G21t and G23t were only protected in post catalytic 
state (brP). G13t remained unprotected in all cases (Fig 2.3-17 C, lanes 1-6).  
Interestingly, accessibility of G20t was increased in post catalytic state when metal ions were present, 
despite the overall trend of increasing protection upon presence of metal ions or hybridization to the 
binding arms. Increased cleavage at G20t was not observed in the G6A inactive mutant (Fig 2.3-17 C, 
lane 6 and 12). We hypothesized that the product formation causes structural changes in the 6BX22 in 
which the position G20t protrudes from the core and becomes accessible for methylation by DMS.  
To confirm this hypothesis, 6BX22 was annealed with its active substrates, R001 and Tr03 and 
incubated in the presence of 20 mM Mn2+. After indicated incubation times, samples were subjected to 
10 min DMS methylation and further piperidine cleavage. The result showed that G3-G6 and G15t-G17t 
became protected upon presence of Mn2+. The protection maintained in the course of the reaction. 
Position G20t became more accessible for methylation over time as it was expected (Fig 2.3-18 A).  
Kinetic data suggested that Mn2+ and Tb3+ compete for the same binding site in the 6BX22 catalytic 
core. Here, we investigated the effect of Tb3+ on the 6BX22 conformations which are formed in the 
presence or absence of Mn2+. In the presence of 20 mM Mn2+, increasing concentrations of Tb3+ up to 
150 µM did not perturb DMS pattern for pre-catalytic state. For post-catalytic state, the increased 
cleavage at G20t was unaffected but protection at G3-G6 was reduced by increasing concentrations of 
Tb3+(Fig 2.3-18 B). DMS foot printing in presence of 150 µM Tb3+ and increasing concentrations of 
Mn2+ revealed the same methylation pattern in pre catalytic states but different pattern in post catalytic 
states (Fig 2.3-18 C). These data shows that, to form the specific signature of active enzyme with brP 
(G3-G6 protection and G20 protrusion) Mn2+ was required.  
The inactivated complex used in DMS and DNase I (iS) consisted of inactive acceptor as well as 
inactive donor. Fig 2.3-18 D shows the DMS pattern of inactivated complex when the active donor is 
used (5’-ppp donor, Tr03). The only significant difference is at position G17t that is less protected in the 
presence of active donor. Altogether, foot printing assays revealed snapshots of structural changes of 









Fig  2.3-18 DMS probing of active 6BX22 and Tb3+ and Mn2+ titrations. A) DMS mediated cleavage pattern of active 
6BX22 complex over time. All lanes contain 50 mM HEPES pH 7.5, 150 NaCl and 2 mM KCl. 6BX22 reactions  have 
been performed in presence of 20 mM MnCl2. Time points are 0, 5, 20 and 90 min. samples were further incubated at 
room temperature for 10 min for DMS methylation. B) DMS pattern of the three samples Dt, iS and brP in presence of 
20 mM Mn2+ and increasing concentration of Tb3+. C) DMS pattern of the three samples Dt, iS and brP in presence of 
150 µM Tb3+and increasing concentration of Mn2+. D) DMS probing with two different inactivated complex. The 
complex in both lanes are like the iS complex, except that for 5’ppp lane the active donor RNA (Tr03) is used.  
To summarize, footprinting assays on the trimmed 6BX22 revealed structural changes upon addition of 
buffer and metal ions. The cleavage pattern was also dependent on the hybridization status and the 
catalytic states. Cleavage at position G20t was strongly increased in the course of reaction.  
2.3.8 Discussion and outlook  
Our investigations about substrate requirements of 6BX22 revealed that regarding the acceptor RNA 
substrate, the first nucleotide adjacent to the 3’ of the branch site adenosine is important for catalysis. In 
all substrates studied in this project, this position was occupied by a cytosine. One can hypothesize that 
this cytosine is employed for proper positioning of the branch site via Watson-Crick or Hoogsteen base 
pairing. In this case the identity of this cytosine must be important. Kinetic studies with point mutants of 
this cytosine would be useful to test this hypothesis.   
Regarding the nucleotide requirement of the 6BX22 catalytic core, CoMA revealed that the region G11- 
A24 and also the two nucleotides C38 and C39 accept all mutations. For all the other positions of 
6BX22 either 2’-OH chemical tag or transition and/or transversion of the nucleobases were shown to be 
detrimental. We hypothesized that the mutable region G11-A24 serves only as a linker between the two 
sub domains of the catalytic core. The hypothesis was confirmed by kinetic studies on trimmed versions 
of 6BX22. In fact, the two parts of the original enzyme i.e.  C1-C10 and G25-C39 required to be 
connected by a linker of at least 2 nucleotides long. The identity of the linker sequence was shown to be 
non-crucial. The linker was replaced by two thymidines in the trimmed 6BX22. Trimmed 6BX22 was a 




slightly better catalyst compared to the original 6BX22 and maintained the ability of forming lariat 
RNAs. From this point of discussion, for consistency, the numbering of the nucleobases are based on 
the trimmed 6BX22 and are marked with superscript letter “t”, except otherwise mentioned.  
The trimmed 6BX22 was 27 nucleotides long and contained 14 guanosines. High G-content and the fact 
that the guanosines’ arrangement in the catalytic core accommodated four times two guanosines in a 
row raised the idea of presence of a G-quadruplex in the catalytic core of 6BX22. G-quadruplexes adopt 
different topologies and can be formed with parallel or antiparallel DNA strands. The participating 
strands can be from different molecules (inter-molecular G-quadruplexes) or within the same DNA 
molecule, forming several loop structures to bring the four strands in position (intra-molecular G-
quadruplexes)161. G-quadruplexes are stabilized normally by a monovalent metal ion in the core of the 
G-tetrad. Bivalent metal ions e.g. Sr2+ and Pb2+ also have been shown to effectively stabilize such 
structures in vitro162.  
Porphyrine dyes with fluorescent properties have been suggested to selectively bind to G-quadruplexes 
and discriminate between G-quadruplexes and DNA double helices.163 Porphyrine dyes are also reported 
to stabilize such structures by axial stacking or intercalation to the G-quartet 158. G-quadruplexes are 
also known for specific CD spectra for parallel and anti-parallel forms of them156,164. Presence of a G-
quadruplex in 6BX22 catalytic core was investigated by several methods, including CD spectroscopy, 
kinetic and fluorescent studies using G-quadruplex stabilizing agent TMPyP4, dNAIM, DMSi, DMS 
and DNase I probing and studies on metal ion dependence of the enzyme. 
Sugar conformation of guanines of G-quadruplexes has been studied using spectroscopic methods such 
as Raman spectroscopy165. Studies by Raman spectroscopy revealed that in a parallel G-quadruplex the 
sugar base conformation are C2’-endo/anti dG as in B DNA. In an antiparallel G-quadruplex, it was 
suggested that both C2’-endo/syn dG besides C2’-endo/anti dG are present166,167. 
Presence or absence of 2’-OH of the ribose, may alter the sugar-base conformation. In a B DNAs sugars 
adapt the conformation of C-2’-endo. Sugar pucker of the RNA monomers are also C-2’-endo 168 but in 
an A form RNA (and DNA) C-3'-endo is favored due to steric problems. The deoxyriboses bearing C-
3’-endo tilt 19° from the helix axis, in comparison to the riboses with C-2’-endo conformation169. 
CoMA employs the 2’-OH as a chemical tag which can affect the sugar conformation of 
deoxyribozymes’ nucleosides.  
In CoMA analysis, sensitive positions to the 2’-OH tag were G3, G5, G6, C14t, G16t and G20t. In case 
that a G-quadruplex is present in the 6BX22 structure, one can deduce that the sugar pucker of the 
participating guanosines prefers to be C-2’-endo. Presence of 2’-OH tag can switch the conformation to 
C-3’-endo and therefore perturb the formation of the G-quadruplex. Here, the interference of the 2’-OH 
at these positions cannot directly confirm involvement of these positions in formation of a G-quadruplex 




but it is in agreement with this hypothesis. The 2’-OH sensitivity can be associated to the dependence of 
the catalytically active fold of 6BX22 to conformations of those sugar at those positions. 
dNAIM of trimmed 6BX22 revealed interesting data about the involvement of individual functional 
groups of 6BX22 necessary guanines. Four modifications have been studied here. c7G dNAIM and 
DMSi (m7G) provided information about the Hoogsteen side of the guanines. m1G and 2AP dNAIMs  
provided information about the Watson-Crick side of the guanines. 
c7G dNAIM  and DMSi data both revealed that positions G7, G13t and G15t of the catalytic core of the 
enzyme do not require the N7 position of the purine ring and can accept presence of a bulky methyl 
group at this position (interference values below 2 for both c7G dNAIM and DMSi). G4, G9, G17t, 
G20t, G23t and G24t had interference values between 2-5 for at least one of the two libraries c7G and 
m7G. The interference values between 2-5 reflect that the enzymatic activity of the enzyme was reduced 
but was not abolished.  
Regarding the Watson-Crick side, for G13t, the interference values of both 2AP and m1G were slightly 
above threshold (between 2-5). Our dNAIM libraries did not include any modification regarding 
position 2 of the guanine ring and its primary amino group. The fact that CoMA showed G13t is not 
mutable to any other nucleotide and at the same time 2AP, c7G and m7G were tolerated allows deducing 
that G13t is involved in catalysis by a non-canonical base pairing using the nitrogen at position 1 or 
amino group at position 2.  
Regarding the Watson-Crick side of the G7, presence of a methyl group at position 1 of the guanine ring 
(m1G) was not tolerated but the keto group at position 6 of the guanine ring could be removed (2AP) 
with no perturbation for catalysis. According to CoMA for G7 only A mutation was tolerated. Mutation 
tolerance from G to A excluded requirement of the Watson-Crick side functional groups. N7 
modification tolerance at G7 excluded requirements of the Hoogsteen side of this position. The only 
detrimental modification was m1G. Taken together one can conclude that position 7 must be a purine to 
maintain positioning and distances of the other nucleotides. It can be hypothesized that this position 
only plays a steric role for formation of the active structure. It is conceivable that G7 is buried inside the 
6BX22 structure and therefore presence of a bulky methyl group at position 1 of the guanine ring is not 
tolerated. A similar role as G7 is predictable for G15t. G15t accepts all the tested modifications and 
mutation to A but not to C and U.  
The only positions with disruptive modifications for both c7G and m7G libraries were G3, G5, G6, G16 t 
and G21t. At these positions any type of modification at N7 is detrimental and the enzymatic activity of 
the enzyme is strongly dependent on the Hoogsteen side. From these five positions G21t requires both 
Hoogsteen and Watson-Crick sides. G5 accepts m1G modification in Watson-Crick side.  G3, G6 and 
G16t have been shown to be sensitive to 2’-OH, therefore we don’t have any data about their Watson-
Crick sides. Altogether the only guanines for which requirement of both sides are not disproved are G3, 




G6, G16t and G21t. These four positions are not sufficient to form a standard G-quadruplex in 6BX22 
catalytic core. The three dimensional structure of the 6BX22 is therefore not a simple known DNA 
motif but rather a complicated structures including non-canonical base pairings. In the next paragraphs 
interesting individual cases are discusses separately to pinpoint constraints about 6BX22 three-
dimensional structure. 
c7G modified G does not provide the nitrogen atom at position 7 of the modified guanine for formation 
of hypothetical hydrogen bond or metal ion coordination. In the same track but with slight differences, 
DMS mediated methylation perturbs the hydrogen bonds or metal ion coordination of N7 by both steric 
hindrance and electronic changes. c7G dNAIM and DMSi of 6BX22 showed similar interference or 
tolerance for all positions except at four positions. G17t and G23t tolerated the absence of N7 but did not 
tolerate N7 methylation. In the other hand, despite the tolerance to N7methylation at G4 and G20t, the 
interference values of these positions for c7G modifications were significant.  
 
Fig  2.3-19 Comparison of CoMA and dNAIM data for necessary guanines of 6BX22 catalytic core. Numberings based 
on original and trimmed 6BX22 core are marked with navy and orange. CoMA was performed on original 6BX22 while 
dNAIM was performed on trimmed 6BX22.  
For G20t, the 2’-OH was shown to be detrimental in rG library therefore the c7G interference value does 
not necessarily reflect the modification effect. In the case of G17t and G23t it is conceivable that N7 is 
not directly involved in formation of a hydrogen bond or metal ion coordination, but methylation at this 
site disturbs the structure by steric hindrance.  
dNAIM showed that methylation of G5 at position 1 of the nucleobase (m1G) is tolerated which 
excludes the possibility of formation of canonical Watson-Crick base pairing with G5. Despite m1G 
tolerance, removal of the keto group from the position 6 of the guanine nucleobases (2AP) was shown to 
be detrimental at this position. Taking CoMA data into account, G5C and G5A were detrimental while 




G5U was tolerated. Uridine has a keto group at position 4 of its pyrimidine ring. Together, data about 
G5 suggested involvement of G5 keto group in formation of the catalytic core.  
Furthermore, considering the Hoogsteen side of the G5, c7G dNAIM and DMSi suggested involvement 
of N7 position of G5 in catalysis. The two methods showed that position 7 of the G5 needs to be 
occupied by a nitrogen atom, and the methylation of this nitrogen is not tolerated. Considering that the 
enzyme tolerates G5U mutation and uracil lacks the imidazole ring, raises the question that in the case 
of G5U mutation what functional group compensates the absence of N7 of G5. Further investigations are 
required to answer this question.  
Performing CoMA with a new set of libraries in which the position 5 of the 6BX22 catalytic core is 
mutated to uridine might be helpful to find the nucleobase(s) which compensates the lack of N7 at this 
position. For solid phase synthesis of the new libraries, mixtures of rN/dN should be used for synthesis 
of all of the positions of the catalytic core except for the position 5 in which deoxyribonucleotide 
uridine phopshoramidite is suggested to be used. Nucleotide analogue interference suppression 
(NAIS)170 has conceptual similarities to the suggested method, with the difference that in NAIS a 
detrimental modification is retrieved upon additional modification compensating the role of the first 
modification. In contrast, here the mutation G5U is active and comparing the CoMA pattern of wild 
type G5 6BX22 and mutant G5U will provide information about nucleobases compensating the absence 
of the keto group.   
Disregard of the hypothesis of presence of a G-quadruplex, the secondary structure of the enzyme was 
reported to have a stem loop structure, predicted by m-fold. The stem was predicted to be formed by 
G15t-T18t and G24t-C27t (G27-T30 and G36-C39 of original 6BX22 sequence). CoMA confirmed 
6BX22 catalysis is independent of C26t and C27t (C38-C39 in original sequence). Additionally, G15t 
(G27 originally) tolerated modifications at its Watson-Crick side (m1G and 2AP libraries). These data 
disproved possibility of formation of such stem loop structure in 6BX22 catalytic core.  
Although, dNAIM rejected presence of a G-quadruplex in the catalytic core of the enzyme, additional 
biochemical and biophysical studies have been performed to further investigate presence or absence of 
the G-quadruplex. Most of the data either disproved or did not support presence of a G-quadruplex in 
this enzyme.  
G-quadruplexes are mainly dependent on monovalent metal ions124. Our data suggested no significant 
dependence of 6BX22 on monovalent metal ions, but on Mn2+. It is known that G-quadruplexes are 
destabilized upon presence of Mn2+ metal ions presumably due to the coordination to nucleophilic atoms 
(N-7 and O-6) of guanine bases156. Bivalent metal ions such as Ca2+, Sr2+ and Pb2+ are shown to stabilize 
G-quadruplexes171,172. It was shown that 6BX22 is not active in presence of Ca2+ 26 but the activity of the 
enzyme in presence of Pb2+ and Sr2+ was not tested. Tb3+ was shown to occupy the central cavity of the 
G-quadruplexes124. Here we studied the catalytic activity of the 6BX22 deoxyribozyme in presence of 




Tb3+. Our data showed reversible inhibition by Tb3+ and suggested that Tb3+ and Mn2+ compete for the 
same binding site which is catalytically important. Considering the same binding site for Mn2+ and Tb3+ 
excluded the possibility of binding of the inhibitory Tb3+ to the cavity of the hypothetical G-quartet 
because it is known that Mn2+ is not capable of occupying the metal ion site of a G-quartet. Mainly, our 
kinetic analysis did not support or disprove presence of a G-quadruplex in 6BX22.  
Kinetic investigations of the enzyme in presence of a G-quadruplex stabilizer, TMPyP4 did not show 
any enhancement of the 6BX22 enzymatic activity. Also, the dependence of the enzyme to Mn2+ metal 
ion was maintained. TMPyP4 is a fluorescent dye which is shown to change its emission spectra upon 
binding to G-quadruplexes. Upon presence of DNA the fluorescence emission spectra of TMPyP4 
changed to reach the two expected peaks but the effect was not exclusively for the 6BX22 and its 
hypothetical G-quadruplex. Two unrelated DNAs (regarding 6BX22 sequence), in which presence of a 
G-quadruplex was not predictable, were shown to have the same effect as 6BX22. It can be concluded 
that the TMPyP4 has changed its emission spectra only upon non-specific intercalation to DNAs. 
TMPyP4 is traditionally considered as an stabilizer of G-quadruplexes but more recently its binding to 
other DNA motifs such as three-helix junctions173, poly dG:dC and poly dT:dA DNA duplexes as well 
as polypyrenotides is also reported174. 
The positive band at CD spectra of 6BX22 DNA (at 270 nm) with a slight blue-shift upon hybridization 
to substrates (to 265 nm) rejected the possibility of presence an anti-parallel G-quadruplex. The positive 
band of 6BX22 was in between the positive band of parallel G-quadruplex (260 nm) and B-form DNA 
(275 nm). The negative band of 6BX22 at 245 nm was also reported to be a signature for both B-DNA 
and parallel G-quadruplex CD spectra. Altogether, CD data did not directly point toward any of those 
structures.  
DMS and DNase I foot printing assays have been used to monitor global and local folding of 6BX22 in 
pre-hybridization and post hybridization states (pre- and post-catalytic). The 6BX22 global fold became 
more compact in post hybridization states and also upon presence of metal ions. The two factors, 
hybridization and metal ions, altered the structure in parallel pathways and independent from each other, 
but had shown synergistic effects. The non-hybridized DNA in water was the least protected and the 
DNA hybridized to the branched product in presence of buffer was the most protected. G20t was an 
exception to this general observation (in DMS probing). All these data confirm that 6BX22 has a 
dynamic structure with three distinct conformations. The 6BX22 global fold becomes more compact 
upon hybridization and presence of metal ions to achieve the “open form” of the enzyme-substrate 
complex.  Formation of the 2’,5’ branched product causes changes in the structure and leads to “closed 
form” of the enzyme-product complex. 
In DMS probing, the post hybridization protection at G3-G6 and post catalytic protrusion of G20t was 
shown to be the signature of the “native” conformation. The word native is quoted since 




deoxyribozymes are only synthetic DNAs. The two signs were confirmed by DMS probing of the 
6BX22 enzyme using active substrates and in presence of standard reaction condition in the course of 
reaction. While the G3-G6 became stably protected upon presence of metal ions, the G20t became more 
accessible in the course of reaction which can be associated to the formation of product. 
Our kinetic data suggested that Tb3+ and Mn2+ compete for the same binding site in the catalytic core of 
the enzyme. More investigations with DMS showed that Tb3+ is not sufficient to form the active 
conformations of the enzyme in the absence of Mn2+. In cases that both Mn2+ and inhibitory 
concentrations of Tb3+ were present, the G20t protrusion was unaffected while G3-G6 protections were 
diminished. These observations could indicate that Tb3+ interferes with formation of the compact active 
site which is the source of Tb3+ inhibition for 6BX22. The DMS data did not provide additional support 
for the hypothesis of the same binding site for Mn2+ and Tb3+, it also did not disprove it. It is 
conceivable, that G3-G6 participate in formation of a metal ion binding site for which both Mn2+ and 
Tb3+ compete.  
However both DNase and DMS data were in agreement of structural changes of the enzyme upon 
hybridization to its substrate or product, but there are differences in the cleavage patterns of the two 
assays which should be noticed. In DMS probing G13t accessibility to methylation remains unaffected 
upon presence of metal ions or substrate/products while accessibility of the DNA backbone of the same 
position was reduced in the course of reaction. G20t backbone remained protected in both post 
hybridization states while the methylation based cleavage at the same position was enhanced in post 
catalytic state. The DNA backbone at position G23 was more prone to cleavage at post catalytic state 
while methylation of N7 position of the same guanosine was decreased. The conformational changes of 
the DNA backbone likely affect the syn-anti conformation of the nucleobase175 and thereby accessibility 
or inaccessibility of the N7 position.  
CD data suggested a dramatic change in the chirality and global folding of the DNA (pre-hybridization 
state) upon hybridization to RNA substrates (pre-catalytic state), but no further change by hybridization 
to the branched product (post-catalytic state). Conversely, DMS and DNase I probing assays showed 
significant changes upon hybridization and also over the course of reaction between the two post-
hybridization states. The difference in the two sets of data might arise from the fact that the two 
methods monitor different aspects of the three dimensional fold.  
Our kinetic data showed reversible inhibition of Mn2+ dependent 6BX22 reaction upon presence of 
micromolar concentrations of Tb3+. Spectroscopic properties of Tb3+ are enhanced upon binding to 
DNA, RNA or organic metal ion chelators like EDTA. Sensitized luminescence of Tb3+ has been used 
to study metal ion binding sites of ribozymes113. Here we investigated metal ion binding sites of 6BX22 
in hybridized form to its substrates by Tb3+ luminescence. In the case of 6BX22, we were not interested 
in the hypothetical metal ion binding sites in the linker region (mutable region), therefore Tb3+ 




luminescence studies were performed employing trimmed 6BX22. Tb3+ luminescence data of trimmed 
6BX22 stalled in pre-catalytic state, “6BX22 hyb”, and the two controls for non-specific metal ion 
binding sites of double stranded binding arms, confirmed that although the luminescence data are not 
simply additive, but the luminescence intensity of the 6BX22 hyb containing both binding arms and the 
catalytic core are much higher than each of individual binding arms, reflecting more Tb3+ binding sites 
in the 6BX22 hyb complex. This set of experiments have been performed in the absence of Mn2+ to pin 
point all the possible metal ion binding sites of the 6BX22.  
Foot printing assays have shown that Mn2+ is necessary to form the active structure of the enzyme. 
Therefore, in a new Tb3+ sensitized luminescence experiment, Tb3+ titration was performed in presence 
of 20 mM Mn2+ to compare the active enzyme and its inactive mutant, G6C. The inactive mutant 
showed lower [Tb3+]1/2  and lower maximum intensity compared to the active enzyme. In this titration 
experiments the observed luminescence is associated to the replacement of Mn2+ by Tb3+ because the 
samples have been folded in presence of Mn2+.  
Hypothesizing that G6 involves in formation of the binding site for the catalytically important Mn2+, and 
considering that Tb3+ and Mn2+ compete for the same binding site which is catalytically important, it 
could be deduced that disruption of the Mn2+ binding site (G6C) disrupts the Tb3+  binding site. Our data 
supported this hypothesis, G6C provided less metal ion binding sites for Tb3+ and had reduced 
maximum luminescence intensity. Notably, the [Tb3+]1/2  of the mutant was lower than the active 
trimmed enzyme. It can be hypothesized that G6C mutation disrupts the catalytically relevant metal ion 
binding sites and the conformational effect of such mutation increases the affinity of other metal ion 
binding sites to Tb3+.  
In summary, 6BX22 enzyme was trimmed to almost 70% of its original length using CoMA data. More 
than 50% of the nucleobases of the trimmed 6BX22 were guanosines. Presence of a G-quadruplex was 
investigated by several methods. Kinetic studies in presence of different metal ions and TMPyP4 neither 
proved or disproved the hypothesis. Presence of a G-quadruplex was supported by CD data but was 
declined strongly by dNAIM data. DMS and DNase probing assays suggested dynamic conformational 
changes of the enzyme catalytic core upon hybridization to the RNA substrates, presence of metal ions 
and in the course of reaction.  
Transition from “open” state to the “closed” state was shown to be accomplished by protrusion of the 
DNA backbone at G23 and the guanine nucleobases at G20. At the same time the guanine nucleobases 
of G23 becomes buried inside the structure. The DNA backbone and guanine nucleobases of G3-G6 
remain protected upon presence of the metal ion in both open and closed states. It is likely that this 
region is involved in formation of the catalytic center of the enzyme. dNAIM and CoMA data revealed 
importance of the keto group of G5 and DMS probing and Tb3+ luminescence data revealed importance 
of G6 for formation of metal ion binding site for catalytically active Mn2+.  








3 Application of ligating deoxyribozymes 
Functional characterization of deoxyribozymes led to the discovery of conditions which enhance 
catalysis of formation of 2’,5’- branched RNA (Section 2.2) with three helix junction forming 
deoxyribozymes e.g. 10DM24 and 9F7 deoxyribozyme family. The reaction rates were shown to be 
accelerated up to 10000-fold and 2’,5’-branched RNA formation became efficient at low concentrations 
of bivalent metal ions e.g. 7 mM Mg2+. These findings encouraged us to expand application of 2’,5’-
branched RNA forming deoxyribozymes.  
Despite the fact that branched RNAs can be potentially used as a tool in cellular and molecular biology 
and nanotechnology, few reports are available on their application since the synthesis of covalently 
2’,5’-branched RNAs was not trivial by chemical methods176. Non-covalent superstructure branched 
RNAs in which the covalent 2’,5’ phosphodiester bond is missing and the branched structures were 
achieved by inter molecular hybridization of several RNAs have been proposed for RNA interference177. 
Recent advances for deoxyribozyme mediated formation of covalent 2’,5’-branched RNA potentially 
will attract several applications.  
Here we applied branch forming deoxyribozyme 10DM24 for site specific labeling of RNA molecules, 
using modified-GTPs as the donor substrates. Applying the same enzyme, 10DM24 on an mRNA as the 
scaffold (acceptor substrate) we installed adaptor RNAs (donor substrate, 19 and 33mer) and studied 
ribosomal translation in response to the presence of branched RNA in vitro. In another application, 
6BX22 deoxyribozyme was used. 6BX22 substrate sequence requirement is compatible with formation 
of branched RNAs from biologically related mRNA sequences. We performed preparative scale ligation 
reactions (nmol) and produced study materials for investigation of interaction of U2 and U6 snRNAs 
and spliceosomal proteins Cwc2 and RNase H with 2’, 5’- branched RNA and related RNAs. 
3.1 RNA site specific labeling 
Studying structures and dynamics of functional RNAs by biophysical techniques e.g. fluorescence 
spectroscopy or electron paramagnetic resonance (EPR) requires site-specific installation of 
spectroscopic labels. Current methods are dependent on functionalization or modification of RNA 
molecules by solid phase synthesis178. The functionalized RNAs undergo further reactions for 
installation of the reporter groups. Solid phase synthesis is reliably applicable for RNA molecules of up 
to 40-50 nucleotides in length. To investigate larger RNA molecules, ligation of labeled RNA fragments 
is required which can be performed with T4 RNA ligase, T4 DNA ligase or deoxyribozymes. 9DB1 and 
7DE5 deoxyribozymes have been proven to ligate RNA fragments of G-riboswitch to synthesize its full 
length31. Recently, SAM III riboswitch full length RNA has been prepared by a minimized version of 
9DB1 in preparative scale79. Direct post synthetic labeling of large RNA molecules using 10DM24 
deoxyribozyme is introduced here.  




10DM24 deoxyribozyme-substrate complex contains three extensive base-paired stems that form a 
three-helix junction (3HJ) in which the 2’-OH of the branch site becomes in close proximity to the 
triphosphate of the donor RNA. On the basis of presence of these stems, Höbartner and Silverman, 
engineered 10DM24 deoxyribozyme-substrate complex for installation of a single GTP molecule (as 
donor substrate) on an RNA scaffold (as acceptor substrate)179. Their result suggested that the 
phosphodiester bond between the most 5’ and the second most 5’ nucleotides of the donor RNA is 
unnecessary for the catalytic activity of the enzyme. Therefore, the donor RNA was dissected to a single 
GTP and R∆.  R∆ or helper RNA sequence was identical to standard triphosphorylated donor RNA of 
the enzyme except that it contained a single nucleotide deletion at its 5’ end and had a 5’-OH.  GTP was 
supplied as a free donor substrate. RNA helper was aimed to maintain the RNA-DNA helix of the right 
binding arm of the DNA and form a binding site for the donor GTP (Fig 3-1.1). The kobs of GTP 
attachment was reported to be 0.034 min-1 in presence of 1 mM GTP and 40 mM Mg2+ at pH 9.0. 
Enhanced conditions i.e. 10 mM GTP and 150 mM Mg2+ improved the reaction rate to 0.26 min-1.  
 
Fig  3.1-1 10DM24 catalyzed GTP attachment to RNA scaffold. The cytosine in the 3’ end of the 10DM24 B loop is 
responsible for the recognition of the GTP. Mutation of this C to T changes the specificity of the deoxyribozyme to ligate 
a single ATP to the branch site.  
In addition, 10DM24 was engineered to successfully attach single nucleotide ATP to the branch site of 
the acceptor RNA. ATP attaching 10DM24 sequence had a C to T mutation at the 3’ end of the loop B 
of the enzyme being capable of formation of standard Watson-Crick base pairing with A. Attachment of 
single nucleotide CTP and UTP were not successful179.  
Studies by Lea Büttner, a PhD student in our group, showed successful 10DM24 reactions with 2’-
modified GTPs using millimolar concentrations of (modified-) GTPs at pH 9.0. Employing Tb3+ 
mediated acceleration of the enzyme 10DM24, we improved the reaction rates as well as the GTP 
requirements, when performing the reaction at more neutral pH i.e. 7.5. Reduced pH, reaction times and 
GTP requirements increases the applicability of the enzyme post-synthetic labeling of RNA molecules 
in preparative scales. 




3.1.1 Tb3+ assisted single GTP attachment to RNA scaffold 
In the first step, the effect of addition of Tb3+ to the GTP ligation reaction was tested. We were 
interested to know if the Tb3+ mediated acceleration of 10DM24 for RNA-RNA ligation (section 2.2.7) 
is also valid for single GTP attachment. A 16 nucleotide long RNA (R16) was chosen as standard 
scaffold for Tb3+ mediated acceleration of GTP attachment. In analogy to other Tb3+ mediated 
accelerations reported in this thesis, we performed the reactions at pH 7.5 to avoid formation of terbium 
hydroxide at high pH.  
Performing single turnover kinetic reactions in presence of 10 mM GTP and 80 mM Mg2+ resulted in 
reaction with the kobs 0.02 min-1 (GTP: DNA; 10000:1). Presence of 100 µM Tb3+ had slight acceleration 
effect and improved the kobs only to 0.03 min-1. Surprisingly and beneficially, reducing the GTP 
concentration increased reaction rates. Down to a certain GTP concentration, a faster reaction could be 
achieved if lower concentration of GTP was present. The maximum reaction rate was in presence of 10 
µM GTP with the kobs 1.6 min-1 (GTP: DNA; 10:1). Note that the GTP: DNA ratio is reduced 1000 fold 
and simultaneously kobs increased by ca. 75 fold. At lower GTP concentrations (< 10 µM) the reaction 
rates were reduced compared to the optimum conditions but still were faster than the same reaction 
condition in the absence of Tb3+ (Fig 3.1-2-A).   
3.1.2 Reaction scale up for Tb3+ assisted acceleration  
Preparative synthesis of labeled RNAs requires optimization of scaled up conditions. Based on kinetic 
data (2 pmol scaffold) 80 mM Mg2+, 100 µM Tb3+ and 200 µM GTP in 10 µl was chosen as standard 
condition for GTP attachment. Increasing the scale (up to 500 pmol scaffold RNA) required some 
variation to the standard condition. For scale up optimization, the goal was to keep the amount of GTP 
used for each labeling reaction as standard kinetic condition i.e. 2 nmol (Table 3.1-1). Up to 250 fold 
increase in the scaffold RNA, reducing the DNA and RNA helper ratio to the scaffold RNA and at the 
same time keeping the amount of used GTP constant (2 nmol) expectedly reduced the reaction rates (Fig 
3.1-2 B). Reaction conditions A-D resulted to good yields but the reaction rates were sub-optimal i.e. 
70-90% yield in 4-10 hours. Additionally, for future practical applications, long incubation times could 
result in RNA degradation.  
An impressive improvement was achieved in condition E. The amounts for scaffold RNA, DNA, helper 
RNA and GTP were kept as condition B (500 pmol scaffold RNA), but the reaction volume was 
increased to 100 µl. Therefore, the DNA, RNA and GTP concentrations were reduced by 10 fold while 
Mg2+ and Tb3+ concentration were kept as standard i.e. 80 mM and 100 µM respectively.  The reaction 
rate was enhanced ca. 400 fold in comparison to condition B (95% product in 5 min).  
 




Table  3.1-1 Scale-up conditions for 10DM24 catalyzed GTP attachment to model RNA. (The gel images and kinetic 















 Tb3+/DNA Tb3+/GTP kobs 
(min-1) 
kinetic scale 2 10 0.2:1:2 200 2 80 100  100 0.5 0.9 
A 200 10 20:30:50 200 2 80 100  3.3 0.5 0.007 
B 500 10 50:60:80 200 2 80 100  1.6 0.5 0.004 
C 500 10 50:60:80 200 2 80 200  3.3 1 0.016 
D 500 10 50:60:80 400 4 80 200  3.3 0.5 0.018 
E 500 100 5:6:8 20 2 80 100  16 5 1.6 
 
Surprisingly, the reaction rate was higher when GTP concentration was reduced by 10-fold i.e. from 200 
to 20 µM. We hypothesized that the ratio of metal ions, Mg2+ and Tb3+ to oligonucleotides is the crucial 
factor. In standard condition for kinetic studies Tb3+ concentration was 100-fold in excess to DNA. The 
Tb3+/DNA ratios in condition A-D with reduced rates were below 4. In condition E with high reaction 
rate the Tb3+/DNA was 16. Our dataset is not sufficient to make final conclusive statement that the ratio 
of which of the metal ions to which of the oligonucleotides (scaffold, DNA or helper RNA) is 
important, but taking Tb3+ as the representative of metal ions and DNA as the representative of 
oligonucleotides we concluded that as a rule of thumb, Tb3+/DNA ratio must be above 10. 
 
Fig  3.1-2 A) 10DM24 GTP requirement in the presence and absence of optimal Tb3+. Reactions were performed in 
kinetic scale for 2 pmol scaffold RNA: 10 pmol DNA: 20 pmol helper RNA in 10 µl. The right panel is the zoomed view 
of the left panel for the kobs of the reactions in the absence of Tb3+.B) Scale-up reactions for GTP attachment to 500 pmol 
scaffold RNA. The conditions are explained in detail in table 3.1-1 .  Time points for kinetic reaction A-D: 1, 10, 30 min, 
1, 2, 4, 9, 24 h. For reaction E: 0, 5, 10, 30 min, 1, 2, 4, 8 h. The best condition (E):  scaffold: 10DM24: helper RNA 5:6:8 
µM, GTP 20 µM, MgCl2 80 mM, TbCl3 100 µM, reaction volume 100 µl.  




The same dataset suggests that the determining factor to achieve fast reactions is not the ratio of metal 
ions to GTP. The Tb3+/GTP ratio was in the same range (0.5-1) in fast standard kinetic reaction and 
reaction conditions A-D which were slower. In the other comparing standard condition and condition E 
which both have fast reactions, the Tb3+/GTP ratio is different (0.5 and 5 folds).  
3.1.3 The effect of mutations adjacent to the branch site on GTP attachment 
For General application of 10DM24 for RNA labeling we aimed to investigate the effect of neighbor 
positions adjacent to the branch site on GTP attachment rate and yield. We comprehensively studied 
kinetics of single and double mutations of the scaffold RNA (R16) in four different conditions. The 
enzyme binding arm was co-mutated to be complementary with the mutant substrates. We studied all 16 
possible combination of NAN (N: any nucleotide, A: branch site A) at four conditions; condition I: 
RNA helper, pH 9.0, 3 mM GTP, 100 mM Mg2+, condition II: RNA helper, pH 7.5, 200 µM GTP, 80 
mM Mg2+, Condition III: RNA helper, pH 7.5, 200 µM GTP, 80 mM Mg2+ with 100 µM Tb3+, Condition 
IV: DNA helper, pH 7.5, 200 µM GTP, 80 mM Mg2+ with 100 µM Tb3+.  The [scaffold]: [DNA]: 
[helper] was 2:10:20 µM for all conditions (Fig 3.1-3). The reaction rates, extrapolated yields and actual 
yields for each mutation and condition are shown in the table 3.1-2.  
 
Fig  3.1-3 Kinetic studies for scaffold mutants at the branch site. The 10DM24 binding arms were co-mutated according 
to the RNA substrate to maintain base pairings (shown schematically on top). Time points (I and II): 15 sec, 2, 5, 10, 30, 
60, 120, 180, 300 min. Times points (III and IV): 15 sec, 1, 2, 5, 10, 20, 30, 60, 120 min. The kinetic data marked with 
blue were performed by Lea Büttner. 




Comparing condition II and III reveals the Tb3+ mediated acceleration effect for each mutant. As 
expected very slow reactions were observed at condition II. Addition of Tb3+ accelerates the reaction by 
a factor of 80-1600-fold. The lowest and highest acceleration factors were for sequence context AAC 
and AAA respectively. In special cases as UAU, CAU and AAU, there was no product formed in the 
absence of Tb3+ at the given time and acceleration upon presence of Tb3+ only had a minor effect for 
formation of the product at the given time. As the product is formed in all the mutation combinations 
(although for the three special cases with reduced yield), no mutation around the branch site was 
detrimental for catalysis.  
The first report for 10DM24 mediated GTP attachment have employed an RNA sequence as helper 
oligonucleotide to hybridize to the right binding arm of the DNA. Including a DNA helper in our mutant 
studies (condition IV) confirmed no difference between the RNA and DNA helper for the efficiency of 
the reaction. 
Table  3.1-2 Rate and yield of mutant RNAs for GTP attachment. The model RNA and single point mutants relative to it 
are marked peach. In each table the rows and columns indicate the identity of the 5’ and 3’ adjacent positions 
respectively. In each cell of the tables the second line indicates the kobs, min-1 and the maximum extrapolated yield. The 
third row indicates the actual observed yield at the indicated time point. The data marked in blue were obtained by Lea 
Büttner. The kobs values marked with * are from linear fit. The reactions with the rate higher than 0.5 min-1 are marked 
with **.  
 




According to the mutation data, condition I led to high product yield within 5h incubation at pH 9.0 in 
the presence of 100 mM Mg2+ and 3 mM GTP for all sequence contexts except AAU and UAU (Fig 3.1-
5 B). Long incubation time at high pH did not result in any degradation of the RNA model (R16, 16nt). 
However, to apply the method for biologically relevant longer RNAs condition I can cause degradation 
of RNA substrate. In the other hand, for further applications, using 3 mM modified-GTP for RNA 
labeling might not be affordable. In contrast, condition III with only 200 µM GTP and at pH 7.5 reached 
more than 50% product in 10 min for 10 out of all 16 possible sequence contexts. At the same 
incubation time (10 min) condition I led to more than 50% reaction product only for 5 sequence 
contexts (Fig 3.1-4 A and C). 
    
Fig  3.1-4 Ligated fractions for all 16 sequence contexts around the adenosine branch site of R16 at conditions I (3 mM 
GTP, 100 mM Mg2+ at pH 9.0) and III (200 µM GTP, 80 mM Mg2+, 100 µM Tb3+ at pH 7.5). Data are shown for 10 min 
and 5 h of condition I and for 10 min at condition III. At both conditions purin embeded adenosines are better ligated. 
Importantly, comparing 10 min data points, ligations in presence of Tb3+ and at lower GTP concentration are more 
efficient.  
For further development of the method, condition III was chosen. Based on the mutation data it is 
predictable that in any given RNA sequence adenosines with purine neighbors at 5’ or 3’ or both sides 
are most accessible for GTP attachment and adenosines with 3’ uridine neighbor should be avoided 
except if 5’ neighbor is a guanosine.  
In addition to the standard 16 nucleotide long RNA model, condition III was employed to attach GTP 
for 22 adenosines at different RNA models ranging from 22-112 nucleotide long. Fig 3.1-5 summarizes 
the reaction rates and yield at 15 min and 3 h for model RNAs which were shorter than 55 nucleotide 
long.  





Fig  3.1-5 GTP attachment to model RNAs applying condition III (200 µM GTP, 80 mM Mg2+, 100 µM Tb3+ at pH 7.5). 
The target branch site and the sequence context are marked on top of each gel, time points for 24 h reactions were 15 
sec  2, 5, 15, 30 min, 1, 2, 3, 24 h, time points for 5 h reactions were 15 sec, 2, 5, 15, 30 min, 1 ,2 ,3 ,5 h.  
One of the RNA models in Fig 3.1-5 was a short fragment of U6-snRNA including positions 30-83 
(GenBank: X12565.1). U6-snRNA fragment was included since site specific labeling of snRNAs with 
fluorophors or paramagnetic labels would facilitate in vitro studies of ribonucleoproteins (RNP) 
complexes.  RNPs play essential roles in eukaryotic cellular processes related to gene expression i.e.  
splicing of mRNAs or maturation of tRNAs, nuclear transport and translation88.  GTP attachment to 
short U6-snRNA revealed positions with high yield for GTP attachment. Attachment of GTP to full 
length U6-snRNA (112 nucleotide long) requires further method developments for separation of the 
GTP labeled long RNA since the molecular weight of a single GTP is not sufficient to differentiate 
between labeled and non-labeled RNAs as such lengths (discussed in section 3.1.8).  
3.1.4 Labeling of RNA with modified NTP in kinetic scale 
Previous studies in our research group for attachment of modified GTPs revealed that the enzyme 
10DM24 accepts GTP modifications when the modification is placed at the 2’ position. Here we proved 
that Tb3+ mediated acceleration of GTP attachment is valid for 2’-modified GTPs. EDA linked Biotin, 
TAMRA and Cy3 GTPs were successfully attached to the model RNA. The reaction for GTP-EDA-
TAMRA was slower (kobs: 0.003- 0.004 min-1) but reached more than 65% yield in 24h. Mant-GTP 
attachment to R016 was successful as well (kobs: 0.07 min-1). Mant modification of GTP was via an ester 
bond and survived in the course of reaction. At later time points, an extra band was observed below the 
Mant-GTP ligated product which was deduced to be the hydrolyzed form of the GTP missing the Mant 
modification. The products ligated to the modified GTPs showed larger gel retardation in denaturing 




PAGE in comparison to non-modified GTP suggesting presence of the modification at the attached GTP 
(Fig 3.1-6 A).  
ATP attachment to RNA model (R16) in presence of standard condition (Condition III) showed similar 
reaction rate to reported value for ATP attachment in the presence of 1 mM ATP, 40 mM MgCl2 at pH 
9.0. Despite successful ATP attachment to R016, attachment of ATP-EDA-Cy5 at condition III was 
very poor (2% in 4 h, Fig 3.1-6 B).  
 
Fig  3.1-6 Attachment of (modified-) NTPs to model RNA (R16) using condition III of Fig 3.1-3 i.e. 200 µM (modified-) 
NTP, 80 mM Mg2+ and 100 µM Tb3+. A) Attachment of GTP and modified GTPs to RNA model. B) Attachment of ATP 
and ATP-EDA-Cy5 to RNA model.   
3.1.5 Labeling of RNA with modified GTPs in preparative scale  
To confirm resistance of the EDA and ester bond during the labeling reaction and gel purifications, 
preparative reactions were performed using a 26 nucleotide long RNA model  containing identical 
sequence to the 3’ of the SAM III riboswitch from its position 28 to 53 (Tr18). Exploiting GTP 
attaching enzyme for position A44 of SAM III (D121), attachment of modified- GTPs Tr18 was 
investigated.  
As it was observed in kinetic scale, attachment of (modified)-GTP resulted in further shift in the 
denaturing gel. The larger gel retardation confirmed persistence of the modification in the reaction 




condition and during gel electrophoresis. Fig 3.1-7 A shows the preparative scale attachment of 
modified GTPs to Tr18. The product bands which are marked with red stars were cut and extracted. The 
isolated yield of the labeled Tr18 is indicated below each reaction. In Fig 3.1-7 B, 100 pmol scale 
reactions were performed and loaded directly besides 100 pmol of the purified products from gels in Fig 
3.1-7 A. The result confirmed that the modifications persist the reaction condition and gel 
electrophoresis and also they were stable during purification steps.  
 For further confirmations gel purified Mant and TAMRA labeled Tr18 were subjected for fluorescence 
measurements. The fluorescent data (Fig 3.1-8 A) confirmed that the EDA linked TAMRA and ester 
linked Mant modification survived the reaction conditions and are present with the extracted RNA 
sample. These results do not necessarily confirm that the EDA linkage is not hydrolyzed during gel 
extraction steps. 
The same samples, in addition to biotin-EDA-GTP labeled Tr18 (gel purified) were analyzed by anion 
exchange HPLC (Fig 3.1-8 B). Non-modified Tr18 had retention time at 16.8 min. Gel purified GTP 
and Mant-GTP modified Tr18 retention times were 17.3 and 19.6 min respectively. For Mant-GTP 
modified Tr18 an additional peak at 17.3 min was observed. This peak was deduced to be the 
hydrolyzed form of the attached GTP as was also observed in denaturing PAGE. Although, EDA linked 
modifications, TAMRA and Biotin retention times were 17.3 min, similar to non-modified GTP, gel 
shifts confirmed presence of a modified GTP in the case of Biotin-EDA-GTP and TAMRA-EDA-GTP. 




Fig  3.1-7 Preparative attachment of modified GTP. A) reactions were performed for 5 µM RNA in presence of 80 mM 
MgCl2, 100 µM TbCl3, pH 7.5, 30 min at 37°C with 20 µM modified GTP in 100 µl. Samples were ethanol precipitated 
and loaded on 15% gel, 0.4 mm thick, 1 nmol per lane. Gel electrophoresis was performed at 35W for 1h30. B) purified 
(modified-) GTP labeled RNAs of A are loaded besides the reaction mixtures of (modified-) GTP attachment to Tr18. 
100 pmol samople was loaded on each lane. The gel was stained by tuloidine blue.  
It can be hypothesized that either the EDA linkage does not survive the high temperature during HPLC 
chromatography or that such conditions for HPLC are not suitable to resolve the presence of TAMRA 
and Biotin modification. The first hypothesis can be excluded as TAMRA-modified RNA showed an 




absorbance at 545 nm (signature for TAMRA) at the same retention time as the peak at 260 nm (17.3 
min, Fig 3.1-8 B). As a control experiment the reaction mixtures for attachment of TAMRA-EDA-GTP, 
Biotin-EDA-GTP and non- modified GTP (100 pmol scale) directly, skipping the gel purification step, 
injected on HPLC.  The same retention times were observed for all three cases. In summary, it can be 
concluded that the EDA linked modifications were accepted to be attached at large scale to RNA and 
the EDA linkage was tolerated under Tb3+ mediated acceleration condition, gel electrophoresis, gel 
purification and HPLC but HPLC is not suitable to resolve the presence of TAMRA and biotin on Tr18. 
Additional confirmation by Mass spectroscopy is required to confirm this hypothesis. 
 
 
Fig  3.1-8 Confirmation of persistence of the EDA linked labels through 10DM24 reaction. A) Fluorescence spectra of 1 
µM modified Tr18 with TAMRA or Mant after gel purification of the labeled band. The measurements were done in 
presence of 150 mM NaCl, 2 mM KCl and 50 mM HEPES pH 7.5 in 120 µl volume.  Excitation and emission filters were 
set at 355 and 445 nm for TAMRA (slit 5 nm). Excitation and emission filters were set at 545 and 575 nm for Mant (Slit 
5 nm).  B) HPLC chromatogram of labeled Tr18 after gel purification. HPLC gradient 30-60% B in A in 12CV at 80°C.  
A: 25 mM Tris-HCl, pH 8.0, 6 M urea.  B: 25 mM Tris-HCl, pH 8.0, 0.5 M NaClO4, 6 M urea. Black line shows UV260 nm 
trace. The red line in the bottom chromatogram shows detection at 545 nm. The numbers besides the peaks, indicate 
retention time in min. 
3.1.6 GTP attachment to SAM III 
GTP attachment to RNA molecules was aimed to be applied for site specific labelling natural functional 
RNAs with modified-GTPs. SAM III riboswitch was chosen here as a model RNA for GTP labelling. 
The SMK box (SAM III) riboswitch regulates translation of S-adenosyl- methionine (SAM) synthetase 
genes in bacteria180. Upon binding to SAM, structural changes in the riboswitch lead to sequestration of 
the Shine-Dalgarno sequence (SD) and inhibit the translation initiation (Fig 3.1-9 A)181. The structure of 
aptamer domain of SAM III has been solved by X-ray crystallography 182 and NMR181. We reasoned 




that installation of a FRET pair via the 10DM24 mediated attached GTP would allow study of SAM III 
structural changes upon binding to its ligand.   
In this study a SAM III aptamer domain containing the SD sequence (SMK51)181 was used as model 
RNA. Three point mutations were introduced to the sequence to destabilize the secondary structure of 
the SAM III riboswitch stem for better hybridization to 10DM24 binding arms. The SAM III riboswitch 
was prepared by 9DB1 3’-5’ linear ligation of two RNA strands. A minimized version of 9DB1139 was 
reported earlier for efficient synthesis of SAM III in our group79. The isolation yield after 9DB1 ligation 
was between 20-40% (Fig 3.1-9 A and B). 
 
 
Fig  3.1-9 SAM III preparation and GTP attachment. A) SAM III sequence and its fold in presence and absence of 
SAM181. The sequence used in this study was based on the SMK51 reported by Wilson et al.181 The gray regions represent 
additional RNA sequences of SMK59 which are not present in our model. Three mutations were implemented to 
destabilized the stem loop and reduce the competing secondary structure of SAM III with deoxyribozyme binding arms. 
Mutation points are marked with orange letters. Full length SAM III was prepared by ligation of two shorter fragments 
(27 and 25 nt long). The corresponding sequences are shown with navy and magenta respectively. B) 9DB1 mediated 
preparative (2 nmol scale) ligation of SAM III fragments.79  Minimized version of 9DB1139 was used. C) The result of 
analytical scale GTP attachment to 5 adenosine candidates in SAM III sequence. Accessible positions for GTP 
attachment are marked green. Practically inaccessible adenosines are marked red. D) analytical GTP attachment to 
SAM III fragment; 5’ fragment, 27nt, R35, bearing A20, navy and 3’ fragment, 25 nt, Tr18, bearing corresponding 
sequence at SAM III for A44, magenta. Time points are 0, 1, 2, 5, 15, 30, 60, 120, 180 min for A20 and 0, 2, 5, 10, 20, 30, 
60, 120 min for A44.  E) GTP attachment to the full length 52nt SAM III. Condition III was applied for single and 
double GTP attachments at A44 and A20.  Time points are 0, 2, 5, 15, 30 min, 1, 2, 3, 5 h. GTP concentration for single 
GTP attachment is 200 µM and for double GTP attachment is 400 µM. GTP attachment to position A20 was not 
successful at the full length SAM III unless the deoxyribozyme for position A44 is present.  Reaction numbers related to 
table 3.1-3 are marked in E with Roman numbers.  
Initially, GTP attachment to SAM III fragments was investigated for 5 positions; A13, A20, A21 on the 
5’ fragment and A38 and A44 on the 3’ fragment. The reactions were performed in the presence of 80 
mM MgCl2, 100 µM TbCl3 and 200 µM GTP, pH 7.5 (condition III). Although, candidate positions for 
GTP attachment were selected based on the mutation studies (table 3.1-2), but successful GTP 
attachments were observed only for positions A20 and A44 (Fig 3.1-9 C and D). In the next step, 




accessibility of positions A20 and A44 were addressed in the full length SAM III. Full length SAM III 
forms higher orders of secondary structure in comparison to its fragments.  
GTP attachment to position A44 was successful (Fig 3.1-7 E, and table 3.1-3 reaction iv) and reached 
high yield but it was slower in comparison to the corresponding position at the SAM III 3’ fragment 
(kobs 0.05 min-1 vs 0.12 min-1). GTP attachment at position 20 (Fig 3.1-7 E ) was not successful under 
the same condition. GTP attachment to highly structured RNAs includes two processes. First process is 
to resolve the RNA secondary structures by deoxyribozyme binding arms. Secondly the GTP attachment 
is catalyzed. As it is shown in section 3.1.3, in presence of Tb3+, 10DM24 catalysis is pretty fast in the 
context of GAA (sequence context for A20) and AAA (sequence context for A44). Therefore, it can be 
deduced that the slow reaction for position A44 and failure at position A20 is upon presence of 
secondary structures.  
In this study, several strategies have been used to overcome the secondary structure of the SAM III 
riboswitch including I) simultaneous addition of both DNA enzymes II) performing the reaction at 
lower ionic strength or III) in presence of disruptor DNAs.  
I) Simultaneous labeling 
Simultaneous presence of two deoxyribozymes can improve ligation yield for highly structured RNAs. 
Each enzyme’s binding arms disturb the secondary structure of the RNA and facilitate the hybridization 
of the binding arms of the other deoxyribozyme. Presence of two GTP-attaching 10DM24 
deoxyribozyme results in installation of the same GTP label at the two positions which are defined by 
deoxyribozymes’ arms. Therefore, this strategy is useful in special cases that the attachment of the same 
label or same functional group to the RNA is aimed. As an example attachment of two spin-labeled 
GTPs allows distance measurements in presence and absence of the ligand by pulsed electron–electron 
double resonance (PELDOR)126.  
We attempted attachment of non-modified GTPs at two positions of the full length SAM III, A20 and 
A44 with GTP attaching DNA enzymes. Simultaneous presence of both enzymes lead to production of 
the double labeled SAM III (Fig 3.1-9 E and table 3.1-3 reaction i) but long incubation time was 
required. Unfortunately, long incubation time resulted in partial degradation of the SAM III RNA. At 
higher time points, the percentage of the labeled RNA increases in the sample but total full length RNA 
amount is decreased due to the site specific degradation. The “achievable yield” was calculated by the 
percentage of the labeled RNA at time (t) over the total RNA present at time (0). The optimum 
incubation time for double labeling of SAM III with GTP attaching enzymes at condition III was 2h 
which led to 45% maximum “achievable yield”. Note that the time point for the maximum “achievable 
yield” is not necessarily the last time point. 
II) GTP attachment in presence of reduced ionic strength 




Reduced ionic strength destabilizes RNA secondary structures and facilitates the binding of the DNA 
enzyme arms to the RNA substrate. On the other hand, formation of the catalytic core of the enzyme and 
hybridization of DNA binding arms with the RNA substrate, both require adequate ionic strength. 
Therefore for the best result a balanced ionic strength should be present. 
Firstly, the catalytic activity of the enzyme 10DM24 for GTP attachment was investigated at low Mg2+ 
concentrations. At this step, the 16 nucleotide long model RNA (R16) was used as substrate in order to 
exclude the effect of RNA substrate secondary structures. GTP attachment to RNA model in standard 
condition (III) was a fast reaction as expected; kobs: 0.9 min-1 (table 3.1-2). Concentration of MgCl2 
could be reduced down to 20 mM without severe effects on the reaction rate and yield (kobs: 0.2 min-1 in 
presence of 20 mM Mn2+, Fig 3.1-10 A)  
Replacement of the MgCl2 with 20 mM MnCl2 resulted in a slow kinetics (kobs : 0.001 min-1). Addition 
of 10 µM TbCl3 improved the reaction rate by 10-fold (kobs: 0.01 min-1). The TbCl3 concentration of 10 
µM was selected because for 9F7 deoxyribozyme, the optimum Tb3+ concentration was 10 µM in 
combination of any Mn2+ concentration.  The reaction in presence of 5 mM Mn2+ and 10 µM Tb3+ was 
even slower (kobs :0.001 min-1, Fig 3.1-10 B).  
III) GTP attachment in presence of disruptor DNAs 
Disruptor DNAs were designed to disturb the secondary structure of SAM III riboswitch. D136 was 
designed for labeling at position 20 and was complementary to the positions 32-53 of the SAM III. 
D137 was designed for labeling at position A44 and was complementary to positions 1-22 of the SAM 
III riboswitch.  Addition of 25-fold excess of the disruptor to the standard kinetic reaction (table 3.1-3 
reactions vii and viii) resulted in high rate and yield. At the same time, partial degradation of SAM III 
was improved.  
 
 




Fig  3.1-10 GTP attachment to R16 at reduced ionic strengths. A and B) investigation of the catalytic activity of the 
10DM24 in presence of Mn2+ or low Mg2+  and 150 mM NaCl, 2 mM KCl and 50 mM HEPES pH 7.5 , 200 µM GTP. 
Time points were 0, 4, 8, 12, 20, 40 min, 1, 2, 3 h. Where marked with star (*) kobs is defined by a linear fit.  C and D) 
investigation of GTP attachment to full length SAM III in presence of 20 mM MgCl2 and 100 µM TbCl3. In D 
monovalent salts are absent.  GTP concentration for single GTP attachment is 200 µM and for double GTP attachment 
is 400 µM. The three gels in each panel are representing GTP attachment to position A44, A20 or both. Time points 
were 0, 5, 10, 20 min, 1, 4, 6, 24 h at 37°C. Reaction numbers according to table 3.1-3 are marked below gels in C and D.  
 
 
Fig  3.1-11 Reactions for optimization of the RNA:DNA ratios for scale up. Time points for 10 hour kinetics were 0, 5, 
10, 30 min, 1, 2, 4, 6, 10 h. Time points for 24 hour kinetics were 0, 5, 10, 30, min 1, 2, 4, 8, 24 h. Reactions were 
performed in presence of 80 mM MgCl2, 100 µM TbCl3 and 200 µM GTP at 37°C. SAM III structure and positions at 
which the GTP is attached are depicted on top of the gels. The disruptors are shown blue. The reaction numbers 
consistent with the table 3.1-3 are mentioned below each gel.  
For preparative scale reactions, equimolar ratios are preferred. Kinetic reactions with less excess of 
DNA enzyme and disruptor and RNA helper have been performed and their maximum “achievable 
yields” were calculated (table 3.1-3 reactions vii-xi).  At reaction xi, which was the most similar 
condition to the preparative applications, incubations more than 1 h reduced “achievable yield”. 
Therefore the reaction time more than 1 h should be avoided for practical applications 
Table  3.1-3  Labeling reactions for full length SAM III in different conditions. All reactions with * were performed in 
the presence of 150 mM Na+, 2 mM K+, 80 mM Mg2+ 100 µM Tb3+ . The reactions with § and # were performed in 
presence of  20 mM Mg2+ and 100 µM Tb3+ and in the absence or presence of monovalent metal ions and respectively . 
Gel images for reactions (Rx i-xi) are marked within the chapter figures. DNA and DNA’ are 10DM24 deoxyribozymes 




oligonucleotides (µM) GTP (µM)  metal ions position max. achievable yield kobs (min-1) 
i 





0.45 (2 h) - 
ii # 0.31 (1 h) - 
iii § 0.34 (1 h) - 
iv 





0.52 (2 h) 0.05 
v # 0.53 (1 h) 0.03 
vi § 0.47 (1 h) 0.05 
vii 
SAM III: DNA: helper: disruptor 
0.2:1:2:5 
200 * A44 0.93 (2 h) 0.2 
viii SAM III: DNA: helper: disruptor 200 * A20 0.38 (4 h) 0.08 






SAM III: DNA: helper: disruptor 
0.2:1:2:4 
200 * A44 0.93 (24 h) 0.2 
x 
SAM III: DNA: helper: disruptor 
0.2:0.2:2:0.4 
200 * A44 0.61 (30 min) 0.05 
xi 
SAM III: DNA: helper: disruptor 
0.2:0.2:0.2:0.4 
200 * A44 0.48 ( 1h) 0.07 
 
Taken together, the conditions for GTP attachment to full length SAM III was optimized. Optimized 
conditions for GTP and modified-GTP attachment in preparative scale for model RNAs and knowing 
accessible positions of full length SAM III for GTP attachment encouraged us for one step further for 
double labeling of full length SAM III with (modified-) NTPs in preparative scale.  
3.1.7 Site specific cleavage of SAM  III 
For preparative labeling of long RNA molecules, methods need to be developed for removal of the non-
labeled- RNAs. The standard separation procedure which is based on gel retardation of GTP-attached 
RNAs is not useful for long RNAs. We introduced a method for purification and analysis of the 
efficiency of GTP attachment to large RNA molecules (section 3.1.8). The method employs the ability 
of RNA cleaving deoxyribozymes for site specific cleavage of substrates with free 2’-OH at the 
cleavage site. In this section, cleavage of SAM III riboswitch and its fragments are investigated using 
E5112 and 10-23 deoxyribozymes.  
E5112 was originally selected in presence of 7.5 mM MgCl2 and 7.5 mM MnCl2, 50 mM HEPES pH 
7.0 100 mM KCl and 400 mM NaCl and was reported to cleave N↓A linkages with the efficiency of 
more than 10% in 10 min21. To optimize reaction condition for the clean-up and analysis steps, non-
labeled full length SAM III was subjected to the cleavage by E5112 enzyme at A20 (D124) and A44 
(D125) and by 10-23 deoxyribozyme for position A36 (D126).  A variety of metal ion concentrations at 
pH 7.0 or 7.5 were applied. 10-23 cleavage at the junction G36-U37 was efficient on the full length 
SAM III i.e. more than 80% 30 min (Fig 3.1-12 A). E5112 cleavage was not successful on the full 
length SAM III at any of the junctions A20-A21 and A44-A45. (Fig 3.1-12 B). The cleavage reaction 
was additionally performed on the SAM III 3’ fragment (Tr18) which lacks the strong secondary 
structure of the full length. The best activity was observed at pH 9.0 in presence of 100 mM MgCl2. The 
reaction reached more than 60% in 10 h (Fig 3.1-12 C).  





Fig  3.1-12 Cleavage of the dinucleotide junctions AA with E5112 and the dinucleotide junction GU with 10-23 enzyme. 
Starting materials (SM, either full length SAM III or SAM III 3’ fragment; Tr18) are depicted on each gel. Times for 24 
h kinetics: 0, 5, 10, 30 min, 1, 2, 4, 8, 24 h, times for 7 h kinetics: 0, 5, 30, 80, 240 min. Time points for 10 h kinetics 0, 5, 
10, 30 min, 1, 2, 4, 6, 10 h. The reactions were performed in presence 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl 
and indicated concentrations of MnCl2 or MgCl2 (and TbCl3).   
Studying site specific cleavage of RNAs by 10-23 and E5112 was essential to develop the protocol for 
double labeling of SAM III and the removal of the non-labeled RNAs and analysis of the labeling 
efficiency. The protocol is described in the next section.  
3.1.8 Discussion and outlook 
The work presented in this section, is an example of transferring the basic knowledge to the application 
of deoxyribozymes. Tb3+ mediated rate enhancement of 3HJ forming deoxyribozymes was employed to 
attach GTP molecules to RNA models at specific positions. The reaction rates and the required GTP 
concentrations were impressively improved. Additionally, the working pH was reduced from 9.0 to 7.5. 
At kinetic scale (0.2 µM scaffold RNA, 10 µl), the optimum concentration for GTP was 10 µM when 
Tb3+ was present. The reaction in presence of only 5-fold excess of GTP (1 µM) was shown to be 
reasonably fast i.e. kobs 0.27 min-1.  For preparative scale GTP attachments, the ratio of GTP to RNA 
was kept 4-5 fold keeping high reaction rate, i.e. kobs 1.6 min-1 (5 µM RNA and 20 µM GTP in presence 
of 100 µM Tb3+ and 80 mM Mg2+ in 100 µl). 
Comprehensive studies have been performed to investigate the effect of adjacent nucleotide to the 
branch site in presence of 4 different combinations of pH, metal ions and helper oligonucleotides.  
Condition III (80 mM Mg2+, 100 µM Tb3+ and 200 µM GTP with RNA helper at pH 7.5) was selected 
for further kinetic studies on any new RNA model. The mutation data also suggested that purine 
embedded adenosines are best positions for GTP attachment and presence of U nucleotide should be 
avoided at the 3’ neighborhood of the branch site except the 5’ adjacent nucleotide is a G.  
In this study, attachment of EDA-linked modified-GTPs with Cy3, TAMRA and biotin and ester linked 
Mant-GTP to RNA was shown to be successful in preparative scale. It was shown that the linkages 
survive labeling reactions (presence of Tb3+) and also purification steps.  




We employed our findings towards labeling of biologically related RNA molecules, SAM III and U6 
snRNA. The accessible positions were identified by performing kinetic scale GTP attachment to 
radiolabeled fragments or full lengths RNAs. The most challenging problem for labeling of large RNA 
molecules was presence of secondary structures for large RNAs. Strong secondary structures compete 
with the hybridization of enzyme binding arms to the target sequence. We used DNA disruptors or 
simultaneous addition of two DNA enzymes to disturb the RNA secondary structures of SAM III. Also 
we increased the lengths of the DNA 3’ binding arms wherever possible.  
Based on our investigations, we proposed “one pot” and “sequential” protocols for double labeling of 
large biological RNAs. For one pot double labeling, “label-I” and “label-II” were designed to be 
attached to RNA via ATP and GTP respectively. Four components are then incubated with RNA 
substrate simultaneously: 1) ATP-attaching 10DM24 for position-I, 2) modified ATP with label-I, 3) 
GTP-attaching 10DM24 for position-II, 4) modified GTP with label-II. Cross-reactivity of the GTP-
attaching and ATP-attaching deoxyribozymes must be extensively studied for each NAN context to 
guarantee attachment of proper label at the desired position. Preliminary data on model RNA (GAC) 
have been obtained by Lea Büttner showing low rate for mis-incorporation of GTP by ATP-attaching 
10DM24 (less than 5% in 5h) but higher rate for ATP mis-incorporation by GTP-attaching 
deoxyribozyme.  
For sequential labeling, firstly, modified ATP with label-I is attached at position-I by ATP-attaching 
deoxyribozyme. Non-incorporated modified-ATPs are removed by ethanol precipitation. At this step, 
removal of the ATP attaching enzyme is not required (explained below). In the second step, label-II is 
attached via GTP using GTP-attaching deoxyribozyme which is designed for position-II. 
At this step, the ATP attaching enzyme for position-I and modified-GTP with label-II are both present. 
The rate of mis-incorporation of GTP-label-II at position-I depends on the efficiency of ATP-label-I 
attachment at position-I during the first step (PI) and the efficiency of mis- incorporation of GTP-label-
II at position-I during the second step (PII). Only (1-PI) fraction of the samples is available for mis-
incorporation with the probability of (PII);  
𝑃𝑚𝑖𝑠−𝑖𝑛𝑐𝑜𝑟𝑝𝑜𝑟𝑎𝑡𝑖𝑜𝑛 = (𝑃𝐼𝐼)(1 − 𝑃𝐼)  
Ideally, PI is required to be > 0.8. The yield of 80% was shown to be achievable yield for most of the 
NAN contexts when the reaction was performed at condition III. The mis-incorporation rate of GTP by 
ATP-attaching enzyme for an RNA model, studied by Lea Büttner, was only 5% in 5 h. Therefore, 
theoretically, under such conditions maximum 1% of the samples will be wrongly labeled with GTP-
label II at position I.  
Enzymatic reactions never yield 100% efficiency. For RNA fragments smaller than ~50 nucleotides, 
denaturing PAGE can be applied to separate labeled and non-labeled RNAs. Labeling larger RNA 




molecules with small moieties such as modified GTPs is more challenging. Denaturing PAGE is not 
applicable for separation in these cases.  We proposed a clean-up strategy to remove the non-labeled 
RNAs from the sample. After attachment of the desired labels, ligating enzyme 10DM24 are removed 
via denaturing PAGE and the mixture of labeled and non-labeled RNA are subjected for a cleavage 
reaction with RNA cleaving enzymes.  
The cleaving DNA enzymes are called clean-up enzyme for this purpose and are designed to cleave at 
the same position in which the GTP attachment has been performed. The cleaving deoxyribozymes 
require the 2‘-OH  present at the cleavage site to start the nucleophilic attack to the phosphodiester 
backbone of the RNA.183 The RNA molecules which were ligated via 2‘,5‘ phosphodiester bond to the 
GTP-label lack the 2‘-OH at the branch site and therefore at the cleavage site. Thus, the branched RNA 
molecules will stay intact after the clean-up step, while the non-labeled RNAs will be cleaved. The 
cleaved fragments of non-labeled RNA are separable from the full length RNA with the attached GTP-
label (Fig 3.1-13 A)  
 
Fig  3.1-13 Clean-up and analysis strategies for long RNA labeling. A) Clean-up stratgegy for the removal of non-labeled 
RNA molecules. B) Analysis strategy for long RNA fragments. SM: starting material, cl. Prod.: cleaved product. 
The efficiency of the clean-up deoxyribozymes and percentage of the modified RNA over non-modified 
RNA after the clean-up step need to be analyzed. Exploiting RNA cleaving deoxyribozymes for 
cleavage at distant positions from the branch site will produce smaller fragments in which presence of 
modified-NTPs are distinguishable. The total efficiency of ligation and clean-up steps could be analyzed 
by the ratio of the labeled over non-labeled short fragments.  (Fig 3.1-13 B) 
We have performed several experiments to find best conditions for GTP attachment to SAM III A20 and 
A44 in kinetic scale (0.2 µM substrate). The data are summarized in the table 3.1-3. Comparing reaction 
i (simultaneous double labeling of SAM III) and reactions vii and viii (attachment of a single label to 
SAM III in presence of disruptors) less degradation was observed for reactions vii and viii. This 
observation could be due to the fact that the disruptor DNAs were designed to sequester the 3’ and 5’ 
end of the SAM III and form blunt ends.  





Fig  3.1-14 Schematic plan for labeling, clean up and analysis of SAM III. The branch site adenosines, length and 
positions of disruptor DNAs, the cleavage sites for clean-up and analysis were individually tested in previous sections. 
For details see the text.  
Therefore, despite the advantages of the explained “sequential” double labeling strategy which does not 
required gel purification between the two labeling steps, in the special case of SAM III riboswitch an 
additional gel purification step was required for removal of the disruptors. Removal of disruptors was 
necessary since disruptor for labeling at position A44 sequester the binding sites for the 10DM24 for the 
labeling at position A20 and vice versa.  
For the clean-up and analysis steps, selection of the suitable cleavage enzymes are crucial to achieve 
high efficiency. For SAM III, based on sequence contexts A20-A21 and A44-A45, we chose the enzyme 
E5112 for clean-up step. For analytical step we decided to cleave the SAM III RNA at the junction G36-
U37 with 10-23. 
In analysis step, after analytical cleavage at distant position in respect to the labeling site, cleaved 
products bear a 5’-OH. For visualization reasons, all the fragments are radiolabeled with 32P using PNK 
which is specific for 5’-OH. Fig 3.1-14 summarizes the protocol and conditions that are designed 
specifically for double labeling, clean-up and analysis of SAM III. Preliminary data showed successful 
GTP and ATP attachments at the desired positions.  
The designed protocol for double labeling of U6-snRNA is shown in Fig 3.1-15. GTP attachment to 
short U6-snRNA fragment was shown to be successful at positions A51 and A76 with 64% and 50% 
yield in 3h (Fig 3.1-5). For full length U6-snRNA, 8-17 deoxyribozymes were designed for clean-up 
step for positions A51 (Cl-I) and A76 (Cl-II). For analysis, three RNA cleaving DNA enzymes were 
designed i.e. one 10-23 deoxyribozyme for position A35 (An-i) and two 8-17 deoxyribozymes for 
positions A62 (An-ii) and A97 (An-iii).  





Fig  3.1-15 Schematic plan for labeling, clean up and analysis of U6-snRNA. Regions of U6 snRNA which are base paired 
in the 10DM24 GTP attaching enzymes or cleavage enzymes for clean-up or analytical steps are colored green, magenta 
and blue respectively. The adenosine branch sites and cleavage sites for cleaving enzymes are marked red and black 
respectively. The red circles resemble the attached GTP to the RNA. 
The selection for the type of cleavage deoxyribozyme was only based on the sequence context at the 
cleavage site. The length of the binding arms of the DNA enzymes were designed to facilitated 
simultaneous GTP attachment at the labeling step, removal of non-labeled RNAs at the clean-up step 
and cleavage at the analysis step.  
Analytical cleavages by An-1, An-2 and An-3 will result in four RNA fragments; 1) 5’ fragment of U6 
which is not GTP- labeled, is triphosphorylated and is 36 nucleotide long (pppf36), 2) a fragment 
corresponding to positions 35-62 which is supposed to be GTP-labeled at position A51, has 5’-OH and 
is 27 nucleotide long (f27+G), 3) a fragment for positions 63-97 which is considered to be labeled at 
position A76, has 5’-OH and is 35 nucleotide long (f35+G) and finally 4) the 3’ end of the U6 which is 
not GTP- labeled, has  5’-OH and is 23 nucleotide long (f23). 
Structural and functional studies with labeled RNAs are only valid if the label does not affect the 
structure and function of the target molecule. Although, the (modified-) GTPs introduced here are rather 
small labels their effect on the global folding of the RNA need to be investigated.  Modification of RNA 
molecules with a fluorescent nucleoside e.g. 2-Aminopurine (2AP) at near positions to the branch point 
adenosine can be useful in this respect. Comparative fluorescence analysis of the non-labeled and 
labeled RNAs with modified-GTP, while 2AP is the fluorescent reporter of the local changes will allow 
detection of the structural effects of the GTP label.  
To perform such studies on SAM III RNA, there are plenty of adenosines in vicinity of the promising 
labeling positions at which 2AP can be incorporated with little disturbances. RNA need to be 




synthesized on solid phase with SAM III sequence and bearing 2AP at position A21 or either of the 
positions A43 or A45, to monitor local changes at position A20 or A44 respectively. Addition of the 
ligand (SAM) causes structural changes on the RNA and affects the 2AP environment and therefor its 
emission. It is expected that the GTP labeled SAM III and non-labeled SAM III result in similar titration 
curves e.g. similar binding constant to SAM. 
In summary, Tb3+ mediated acceleration of deoxyribozymes has been applied for post-transcriptional 
DNA-catalyzed labeling of RNA molecules by attachment of (modified-) GTPs.  The applicability of 
10DM24 deoxyribozyme for GTP attachment was improved in three aspects: 1) enhancement of 
reaction rate, 2) performing the reaction at pH nearer to neutral conditions, and 3) reduction of the GTP 
requirement of the enzyme. Further method developments are needed for labeling of long (>50 nt) 





3.2 Formation of splicing intermediates 
To expand the utility of deoxyribozymes and in particular of 2‘,5‘-branch forming deoxyribozymes, in 
collaboration with the group of Dr. Vladimir Pena, research group macromolecular crystallography at 
Max Planck Institute for Biophysical Chemistry (MPI-BPC), Göttingen, Germany and the group of 
Professor Reinhard Lührmann, department of cellular biochemistry at MPI-BPC, we built up the basis 
for in vitro studies using 2’,5’-branched RNAs. Studies on formation of RNA-RNA and RNA-protein 
spliceosomal complexes are described in this section.  
The splicing of messenger RNA precursors (pre-mRNA) to mature mRNAs is a highly dynamic and 
flexible process. Small nuclear ribonucleoprotein particles (snRNPs) U1, U2, U4/U6, and U5 with 
additional proteins participate in formation of the spliceosome complex. Formation of transient inter- or 
intra-molecular base pairs between components of snRNPs and pre-mRNA results in several 
intermediate in the assembly pathway of spliceosome. The multiple transient RNA-RNA hybridizations 
and RNP remodelings guarantee correct recognition of 5’ and 3’ splice sites (SSs) and the branch point 
(BP), formation of catalytically active spliceosome184 and further disassembly of the complex185.  
In the chemical point of view, splicing consists of two sequential phospho-transesterification reactions. 
In the first step the 2’-OH of the branch point (BP), located within the intron, attacks the 5’ SS. In the 
next step, the free 3’ OH at the 5’ SS attacks the 3’ SS and lariat RNA is removed. The core of the lariat 
RNA contains both 2’,5’ and 3’-5’ phosphodiester bonds and is structurally similar to the product of the 
2’,5’ branched-RNA forming deoxyribozymes.  
Several helicases facilitate required RNA rearrangements for spliceosome activation186. For example, 
during spliceosome activation, Brr2 (a U5 snRNP protein), unwinds U4/U6 snRNAs. Subsequently U6 
snRNA forms catalytically important U6 internal stem-loop (ISL) and base pairs with 5′-splice site and 
U2 to form catalytically important ACAGAG motif and Ia and Ib base paired regions88. Crystallography 
data showed that the activity of Brr2 is modulated by the U5 snRNP protein, Prp8187. Additionally, the 
RNase H-like domain of Prp8 was shown to be present at the catalytic core of the spliceosome188.  
For yeast spliceosome, a complex of eight proteins (nineteen complex, NTC) including Prp19, was 
reported to be involved in stabilizing hybridizations of U5 and U6 snRNAs with pre mRNA189. In 2009, 
O’Keefe and coworkers have reported involvement of the Cwc2 protein, a NTC-related protein, in the 
binding of U6 snRNA to Prp19 190. In 2012, Lührmann and coworkers suggested that Cwc2 promotes 
active conformation of the spliceosome catalytic center. The hypothesis was supported by in vitro 
splicing, cross linking and foot printing data. It was shown that Cwc2 interacts with the U6-ISL and a 
region upstream of the ACAGAG motif191.  
The hypothesis got strength when the crystal structure of Cwc2 reported by Pena and coworkers192. 
Cwc2 structure composed of an RRM domain (RNA recognition motif) and a ZnF (Zinc Finger, CCCH 




type), connector element and variable insertions. A toroidal domain (Torus domain) was shown to act as 
a scaffold for the ZnF and RRM domains. Finally, it was proposed that Cwc2 is a multipartite RNA 
binding protein. MS analysis of UV cross linked Cwc2 with U4 and U6, revealed six sites in Cwc2 
which are in close contact to U6 including ZnF and RRM domains and connector element.  
In collaboration with the department of cellular biochemistry and the research group of macromolecular 
crystallography at Max Planck Institute for Biophysical Chemistry, we aimed to investigate the complex 
formation between branched RNA and U2 and U6 snRNAs in presence of Cwc2 and RNase H domain 
of Prp8. Finding stable complexes with the branched-mRNA, snRNAs and/ or spliceosomal proteins 
would facilitate in vitro studies to track conformational changes during complex formation using labeled 
RNAs and would be a starting point for crystallization trials. 
We harnessed the ability of the deoxyribozyme 6BX22 for formation of branched-RNA with sequences 
similar to the yeast actin core mRNA. We synthesized several branched RNAs with different sizes of 
the RNA strands 5’ and 3’ of the branch site. In addition to the branched RNA, two linear single 
stranded RNAs with sequence similarities to parts of U2 and pre-mRNA were included in our studies. 
The plasmid template for in vitro transcription of U6-snRNA was provided by the group of Professor 
Reinhard Lührmann, department of cellular biochemistry. The proteins for binding assays were 
provided by the group of Dr. Vladimir Pena, research group of macromolecular crystallography.  
3.2.1 Preparative scale synthesis of 2’,5’-branched-RNA  
Preparative scale Mn2+ dependent 2’, 5’ branch formation have been performed using trimmed or 
original 6BX22. Generality of reparative scale formation of 2’,5’-branched RNAs was investigated by 
formation of several combinations of branched products with different lengths of donor RNA and the 5’ 
and 3’ of the branch site in acceptor RNA (Fig 3.2-1 A).   
The length of the acceptor RNA strand 5’ of the branch point was 13-17 nucleotide long, the length of 
the RNA strand 3’ of the branch point was between 2-17 and the length of the donor RNAs were 
between 11-28 nucleotide long. Synthesis of br2-br9 was a part of a collaborative project with 
department of Cellular Biochemistry at Max Planck Institute for Biophysical Chemistry. The effects of 
branched RNAs with different lengths on the nucleolytic activity of human 220K- and Prp8- RNaseH-
like domains were studied by Alexey Rozov (PhD thesis, April 2011).  
3.2.2 Binding assays with 2’,5’-branched RNAs 
Formation of RNA-RNA and RNA-protein complexes (consisting of 6BX22 branched RNA products) 
was studied by gel mobility shift assays and is described in this section. We aimed to investigate 
formation of three complexes consisting of branched or linear RNAs with U2 and U6 (Fig  3.2-1 C, D 
and E) in presence or absence of spliceosomal proteins. Fig  3.2-1 B shows the structural arrangement 




around the branch site adenosine of the yeast actin pre-mRNA with U2 and U6 snRNAs within the 
catalytic center of the spliceosome.  
 
Fig  3.2-1 Branched RNAs and splicing intermediate complexes A) sequence and schematic depiction of 6BX22 branched 
products prepared in preparative scale. br2-br9 were part of the collaborative project with the department of Professor 
Reinhard Lührmann. br2 was additionally used for binding assays with spliceosomal proteins and snRNAs. B) The 
original sequences of yeast actin mRNA and parts of U2 and U6 snRNAs. C) The sequences of br3 in complex with part 
of U2 and U6-snRNAs. D and E) complexes with linear single stranded RNAs and U2 and U6-snRNAs. R11 consists of 
sequences similar to 5’SS and U2 snRNA. R10 resembles the 5’ SS.  
All the experiments were performed after annealing of RNA molecules in the presence of 150 mM 
NaCl, 2 mM KCl and stated concentration of MgCl2 at pH 7.5. Two different experimental setups were 
used in the annealing step. In the first setup, serial dilutions of the stated RNA molecules (2 µM- 1 nM 
trace labeled RNA) were prepared and annealed at the indicated concentrations. The trace labeled RNAs 




are marked with a star (*) in the text and figures. At this set up, non-radiolabeled components were in 
slight excess to the labeled RNA (1.25:1). 
 
 
Fig  3.2-2 Binding assays in the absence of proteins. A) optimization for binding assays, the effect of high and low Mg2+ 
concentration and voltage. The trimmed 6BX22 deoxyribozyme that has extensive binding arms for the branched 
product was used as a control experiment. Concentrations of the complexes are marked with green (nM) and blue (µM) 
colors. B) Formation of trimolecular complex by annealing in presence of all three RNAs. C) Formation of tri-molecular 
complex by addition of U6 RNA (or water) to the pre-annealed *br3 and U2 complex. D) Formation of bimolecular 
complexes with U6 snRNA.   
At the first step, we optimized the conditions for the binding assays. Fig 3.2-2 A represents the effect of 
Mg2+ concentration and the electrophoresis voltage for a set of samples. Combination of br3 and 
trimmed 6BX22 was used as a positive control for binding assays. 6BX22 which was used for 
preparation of br3 provides two extensive arms for the branched RNA. It was observed that br3 and U2 
form a complex when the complex concentration was above 60 nM. At concentrations above 0.5 µM 
br3 and U2, a second band was visible which could be interpreted as a different conformation of br3 
and U2 complex or higher order complexes. In a separate experiment, the three components of *br3, U2 
and U6 snRNA were annealed together (Fig 3.2-2 B).  
Similar result was observed when U6 was not present (Fig 3.2-2 A) indicating that the additional shift is 
not because of presence of U6. To confirm this observation, U6 or H2O were added to pre annealed 
*br3 and U2 in presence of 2 mM Mg2+; final ratios of U6: U2: br3 were 1:1:1 (Fig 3.2-2 C). Data were 
consistent with previous observations in Fig 3.2-2 B. Additionally, binding of small RNAs resembling 




U2 snRNA (R08), 5’SS (R10) or a combination of 5’ SS and U2 snRNA (R11) to U6 snRNA was 
investigated. (Fig 3.2-2 D).  
In the second setup, RNAs were annealed in relatively high concentration and diluted afterwards to 
reach the stated concentration. Cwc2 or RNase H domain of Prp8 proteins were added to pre-annealed 
br3 and U2 RNA-RNA complexes in presence or absence of part of U6-snRNA (30-83, U6-sh). To get 
better insights either of D121 and U2 RNA were radiolabeled in each experiment. *U2-br3 or *br3-U2 
were annealed at 1 µM (1:1 ratio) and diluted 100-fold. Samples were mixed with increasing 
concentrations of U6 and Cwc2/RNase H domain in presence of Mg2+ and glycerol. Final concentrations 
of the RNA complexes were 2 nM.  
 
Fig  3.2-3  Titration of Cwc2 and RNase H domain and U6-sh snRNA to pre-annealed complexes of br3 and U2. A and 
B) show results for addition of U6 and/or RNase H to the mixture when the br3 or U2 are radiolabeled respectively. C 
and D show results for addition of U6 and/or Cwc2 to the mixture when the br3 and U2 are radiolabeled respectively. 
U6 concentrations were 0, 2, 10, 20, 100, 200 nM and 1 µM. Cwc2 or RNase H concentrations were 0, 20, 100, 200 nM 
and 1, 2, 10 µM.  
The result showed addition of U6 snRNA resulted in no extra shift on the native gel even when it was 
provided 50-fold in excess to *U2-br3 or *br3-U2. RNase H domain did not cause significant binding 
to *U2-br3 or *br3-U2 complexes in presence or absence of U6-sh (Fig 3.2-4 A and B). Binding assays 
in presence of Cwc2 did not result in additional shift of the RNA-RNA complexes with the protein, but 




one of the bands in *br3-U6 complex disappeared upon presence of increasing concentrations of Cwc2. 
This effect was independent of presence or absence of U6 snRNA (Fig 3.2-4 C) and was not observed 
with br3-*U2 complex. It could be hypothesized that the Cwc2 RNA binds to one the components (e.g. 
non-radiolabeled U2) of one of the conformations of *br3-U2 complex, and cause dissociation of *br3.  
Radiolabeled U2 was annealed with U6-sh at 4 µM and diluted to final concentration of 2 nM. The 
samples were incubated at 5 mM Mg2+ at 4°C. Increasing concentrations of Cwc2 and br3 RNA were 
titrated to the samples (Fig 3.2-5 A). Almost 50% of U2 molecules formed a complex with U6-sh in the 
absence of protein or br3. Addition of Cwc2 protein, br3 or both did not stabilize or destabilize this 
complex and caused no further shift or dissociation.  
 
Fig  3.2-4 Comparative complex formation of Cwc2 and RNase H domain and U6-sh snRNA with pre-annealed 
complexes of br3 and U2. A) Complex formation at 5mM Mg2+. br3 concentrations were 0, 2, 10, 20, 100, 200 nM and 1 
µM. Cwc2 or RNase H concentrations were 0, 20, 100, 200 nM and 1, 2, 10 µM. B) RNA complexes used in gel images in 
C. C) comparison of complexes formed with combinations of U2, U6-sh and br3 with Cwc2 and RNase H. The RNA 
complexes were annealed at 2 µM and diluted to the final concentration of 40 µM. In the lanes that protein is present 
the final concentration of proteins are 2 µM.  
For a better comparison of different combinations of RNA-RNA and RNA–proteins, all six 
permutations of two of the three RNAs (br3, U2 and U6) with the radiolabel present at either of the br3 
or U2, were annealed at 2 µM and diluted to final 0.04 µM and further incubated with either Cwc2 
(final 2 µM), RNase H domain (final 2 µM) or protein dilution buffer in the presence of 10 mM Mg2+ 
and 300 µM Zn2+ (Fig 3.2-5 B and C). Consistent with previous data, in the absence of proteins, more 
than 50% of *U2 is involved in complex formation with U6, when U2 and U6 are annealed together (i). 
*U2 and br3 (ii) form two complexes which stay intact when U6-sh RNA is present in addition to *U2 
and br3 (iii). Addition of Cwc2 to the complex i had no effect. Cwc2 addition to complex ii decreased 
the ratio of the upper band in the native gel. This observation was less pronounced in the presence of 
RNase H domain. The same pattern was observed when the label is on the *br3 instead of *U2 (Fig 3.2-
5 lanes 11-20).  




The results in Fig 3.2-5 B were consistent with previous data achieved in this project, in spite of slight 
differences in the experimental setups (compare with Fig 3.2-4 B). The samples in Fig 3.2-5 B were 
incubated in the presence of 10 mM Mg2+ and 300 µM Zn2+ while Zn2+ was absent and Mg2+ 
concentration was lower at all previous gels shown in this sub chapter. In summary, formation of a 
trimolecular format RNA complex in presence or absence of spliceosomal protein could not be achieved 
using the techniques and the conditions which we tested. Further investigations are required using other 
techniques e.g. binding assays with gel filtration.  
3.2.3 Binding assays with linear RNAs 
In comparison to the natural RNA arrangements in the catalytic core of the spliceosome, the 
trimolecular complex consisting of br3, U2 and U6 was more realistic. Nevertheless, besides all 
attempts for formation of trimolecular complex, we performed gel mobility shift assays to investigated 
complex formation between linear single stranded RNAs and U6 snRNA (Fig 3.2-2 D).  
Here, formation of complex between R11 (resembling 5’SS and U2) and U6-sh was further investigated 
in the presence of 2 and 5 mM Mg2+. The complex formation was enhanced in presence of higher Mg2+ 
concentration. Addition of Cwc2 did not cause further shifts in the native gels (Fig 3.2-6 A). In addition, 
complex formation between U6-sh snRNA (final 0.04 µM) and Cwc2 or RNase H domain (final 2 µM) 
was investigated in presence of 10 mM Mg2+. Presence of proteins only resulted in smear but not a clear 
band (Fig 3.2-6 B). Altogether, formation of the bimolecular complex between R11 and U6-sh was 
shown to be successful but addition of spliceosomal proteins did not result in any extra shift on the 
native gels. 
 
Fig  3.2-5 EMSA in the absence of branched RNA. A) Formation of bimolecular complexes with and without Cwc2. B) 








3.2.4 Discussion and outlook 
Preparative synthesis of 2’,5’-branched RNA have been achieved using 6BX22 deoxyribozymes. The 
2’,5’-branched RNAs are naturally found in lariat RNAs and are formed with spliceosome and group II 
intorns in eukaryotes and prokaryotes 89. Additionally, 2’,5’ phosphodiester linkage is present in cyclic 
GMP-AMP (cGAM) which is a secondary messenger of the immune system193. An immediate 
application of the preparative synthesis of 2’,5’-branched RNAs was to utilize them as a component for 
in vitro studies on spliceosomal rearrangement. Preliminary experiments that are performed and 
represented in this section have initiated the basis of in vitro studies with simplified lariat RNAs i.e. 
2’,5’-branched RNAs. 
Formation of trimolecular and bimolecular RNA-RNA complexes was investigated in presence of 
spliceosomal proteins. The conditions used in this study did not result in formation of any trimolecular 
complex consisting of branched RNA (br3), and parts of U2 and U6 snRNA. Complex formation was 
observed U2 and br3 (forming 2 complexes) but full length U6 or U6-sh were not able to bind to the 
previously annealed br3 and U2 complex. Simultaneous annealing of the three components also did not 
improve the result. Addition of Cwc2 and RNase H domain of the Prp8 did not result in further gel 
retardation but in contrast presence of Cwc2 decreased the ratio of one of the complexes of U2 and br3. 
Hypothetically Cwc2 promotes dissociation of the two RNAs. The collected data at different conditions 
were consistent to each other. It was also observed that R11, consisting of sequences of 5’ SS and a part 
of U2 snRNA is able to form a complex with U6-sh.  
Electrophoresis mobility shift assay (EMSA) is a standard method for determination of the binding 
partners of nucleic acids and proteins. The disadvantage of the technique is that parts of multipartite 
complexes can be easily dissociated during gel electrophoresis and result in a false negative result194.  
Conversely, false positive result could be observed for binding effects that are only in non-biological 
context195. The obtained data with EMSA need to be confirmed by additional biochemical 
investigations. Binding assays using gel filtration will support additional information about the RNA-
RNA or RNA-protein complexes involved in splicing. 
Our studies showed preliminary results on building the platform for binding assays using 2’,5’-branched 
RNAs. With the applied experimental setup, formation of the desired complexes was not observed and 





3.3 Ribosomal interference by branched RNAs 
To expand the molecular and cellular basis of application of RNA ligating deoxyribozymes, we aimed 
to investigate the ribosomal response against presence of a branched mRNA template. We have 
hypothesized that a branched mRNA can stall the ribosome during peptide synthesis. For the initial step, 
2’,5’-branched RNAs were synthesized separately and afterwards were used for in vitro translation 
studies.   
3.3.1 Bacterial protein translation 
Protein synthesis consists of three steps: initiation, elongation and termination. Initiation is a crucial step 
in which the translation reading frame is established. Three initiation factors (IF1-IF3), fMet-tRNAfMet, 
30S ribosomal subunit and the mRNA, are responsible for accurate initiation and binding of initiator 
tRNA to the start codon in the peptidyl site (P site) of the small (30S) ribosomal subunit196. Transient 
30S pre initiation complex (30S PIC) is formed by assembly of initiation factors on 30S subunit and 
recruitment of fMet-tRNAfMet via IF2197. Exploiting the base complementarity between Shine-Dalgarno 
sequence of mRNA and the anti-Shine-Dalgarno sequence of the 3’-end of the 16S rRNA, mRNA is 
properly positioned in the 30S PIC.  
Assembly pathway of 30S PIC is recently investigated by Rodnina and coworkers using rapid kinetic 
approach198. Based on association constants and cellular concentrations of each component, it was 
concluded that IF3 and IF2 are the first components that bind to the 30S subunit. The assembly events 
are followed by binding of IF1 and fMet-tRNAfMet 198. Binding of the three initiation factors and initiator 
tRNA to the 30S subunit is independent from the binding of mRNA, suggesting parallel pathways of 
30S PIC assembly. The recognition of the mRNA start codon by fMet-tRNAfMet triggers conformational 
changes that convert the 30S PIC to a functionally competent 30S initiation complex (30S IC). 50S 
ribosomal subunit joins 30S IC. IF1, IF2, IF3 are released and 70S IC is formed198. 
Elongation of the peptide chain consists of several steps. In the first step, a new aminoacylated tRNA is 
brought to the A site of the ribosome in a ternary complex. Ternary complex consists of GTP- activated 
elongation factor Tu (EF-Tu) and aminoacylated tRNA (aatRNA); EF-Tu_GTP_aatRNA. EF-Tu 
intrinsically is a slow GTPase. Upon codon-anticodon recognition, a conformational change induces the 
GTPase activity of the EF-Tu and GTP is hydrolyzed. The GDP bound EF-Tu has less affinity to the 
complex and is released. Release of the EF-Tu and consequently, proper positioning of aminoacylated 
tRNA allows peptide bond formation. The ribosomal complex is then in the pre-translocation state199. 
Pre- translocation complex contains peptidyl tRNA in the A site and deacylated tRNA in the P site. 
Elongation factor G (EF-G) is also a GTPase. EF-G initiates numerous physical rearrangements of the, 
rRNAs, tRNAs and ribosomal proteins that accommodate forward translocation of ribosome against 
mRNA by one codon. In the post-translocation complex, the deacylated tRNA is released from E site 




and peptidyl tRNA is positioned at the P site. The last step in the elongation cycle is the release of the 
deacylated tRNA from E site201.  
Translation termination is dependent on the release factors. Release factors (RF1 or RF2) recognize 
presence of a stop codon in mRNA sequence and induce hydrolysis of the ester bond between the 
peptide chain and the tRNA in the P site. Peptide chain is released consequently. RF3-GTP induces 
replacement of RF1 and RF2 and ribosome is left with mRNA and the deacylated tRNA in the P site. 
Ribosomal release factor (RRF), EF-G and IF3 dissociate 50S subunit and the deacylated tRNA to 
prepare the 30S subunit bound to mRNA for the next round of translation.202 
Ribosome is a large molecular machine which is evolved to tackle secondary structure of variant mRNA 
templates. It is known that ribosome is capable to resolve structures such as stem loops and 
pseudoknots. Such structures are regulatory elements for the rate of translation and are linked to co-
translational folding and modifications of proteins201. Additionally, ribosome is able to bypass specific 
regions of mRNA such as slippery codons, pseudoknots or stem loops without translation. Ribosome 
hopping (translational bypass) in combination with programmed frame shift occurs mostly in viral 
mRNAs203,204.  
In collaboration with the department of Professor Marina Rodnina, department of Physical Biochemistry 
at Max Planck Institute for Biophysical Chemistry, we aimed to challenge the ribosome with a novel 
substrate i.e. a 2’,5’ branched mRNA. We hypothesized that ribosome should be stalled in front of the 
branch point but nevertheless, the possibility of translational bypass for 2’,5’ branched mRNAs was also 
investigated. We performed in vitro assays to study formation of pre-initiation complex, pre-
translocation complex and proceeding elongation with branched- and linear mRNAs. “Adaptor” RNAs 
were ligated to a “scaffold” RNA to produce the branched mRNA. The scaffold RNA was originally a 
standard linear mRNA template for efficient in vitro translation and was provided by Riccardo 
Belardinelli, department of Physical Biochemistry. 
3.3.2  Sequence setup 
We anticipated that the location of the branch site is important for the ribosomal response to the 2’,5’ 
branched mRNA. We hypothesized that presence of the branch site in the 5’ untranslated region (5’ 
UTR) or near the initiation codon would abort formation of initiation complex. Presence of the branch 
site in the coding region could potentially lead to three different observations. The first possibility was 
the ribosome stall at the branch site. The second possibility was translation elongation at down-stream 
region of the mRNA (possibly with a frame shift). In the third scenario ribosome would exchange its 
template and the adaptor RNA (The RNA which is ligated via 2’,5’ phosphodiester bond to the mRNA) 
would be translated.  




The sequence for scaffold and adaptor RNA were designed to fulfill two requirements. In one hand, 
each of the two RNAs should contain codons of a specific amino acid in all possible frames. In the other 
hand, the corresponding amino acids should be mutually exclusive between the two RNAs (scaffold and 
adaptor, Fig 3.3-1).  A short and mutant version of HemK205 mRNA206 was chosen as the model RNA. 
Performing in vitro translation experiment with combinations of [3H] Phe, [3H] Gly, [14C] Leu and [14C] 
Pro, would allow detection of translated peptide from either of the scaffold and/or adaptor RNAs in any 
frame.  
Incorporation of both [14C] Leu and [3H] Phe with the ratio of 2:1 would be a confirmation for 
translation of the original template without any frame shift. Incorporation of [14C] Leu and [3H] Gly in 
the translated peptide with the ratio of 1:1 would be a sign of frame shifted translation from scaffold 
RNA (frame 2*). Incorporation of [14C] Leu, as sole radiolabeled amino acid in the peptide, would be a 
sign for scaffold RNA translation within frame 3*. The star sign indicates that the frame shift only is 
considered after the branch point.  
Translation from adaptor RNA would be also detectable with the designed sequences. The adaptor RNA 
contained one codon for [3H] Gly and one codon for [14C] Pro in frame 1, only one codon for [14C] Pro 
in frame 2, and 2 codons for [14C] Pro in frame 3. Therefore, by performing in vitro translation in the 
presence of [3H] Gly and [14C] Pro, presence of the signal for [14C] Pro would be a confirmation for 
translation of at least one of the frames. By the ratio of [3H] Gly to [14C] Pro incorporation and also the 
number of incorporated [14C] Pro per RNA molecule we would be able to identify the selected frame(s). 
The length of the adaptor strand could have some impact on the result of the experiment. To investigate 
if the shorter adaptor has less interference with the translation, we performed the experiments with two 
different adaptors which were different in length.  
 
Fig  3.3-1 Hypothetical peptide sequences translated from any of the three frames of scaffold (Hem K) and adaptor 
RNAs. The peptide sequence based on original frame of the scaffold mRNA is underlined. In the scaffold strand, the 
hypothesized shifted frames are considered only after the branch site. The radiolabeled amino acids with 14C are 
marked green and blue. The amino acids radiolabeled with 3H are marked red and purple. The amino acids and 
nucleotide sequence which are only available in the longer adaptor are marked Italic. The mutation points to the HemK 
sequence are marked orange. The branch site at which the adaptors are ligated is marked green. 
Originally two positions in the scaffold mRNA were addressed to be ligated to the adaptor RNAs; A82 
and A92. We harnessed the benefit of Tb3+ dependent acceleration of 10DM24 enzyme for ligation 
reactions. Kinetic scale ligation at position A82 in the presence of 80 mM Mg2+ and 100 µM Tb3+ at pH 




7.5 yielded more than 70% conversion in 15 minutes. Partial degradation of the mRNA was observed at 
longer time points. Excluding Tb3+, 40 mM Mg2+ at pH 9.0 resulted in less degradation but also reduced 
ligation yield (Fig 3.3-2 A). Adaptor ligation at position A92 was not successful even in presence of 50-
fold excess of disruptor DNA to the 3’end of the HemK (Fig  3.3-2 B). Preparative scale reactions have 
been performed to attach adaptor RNAs at position A82 in presence of 80 mM Mg2+, 100 µM Tb3+ at 
pH 7.5 (Fig  3.3-2 C). The branched products were separated from starting materials by denaturing 
PAGE. The isolated yields for branched products were 28-30% (Fig  3.3-2 D).  
  
Fig  3.3-2 Ligation of adaptor RNAs to the HemK mRNA (scaffold). A) Kinetic scale branch formation was successful 
for position A82 of HemK. B) Schematic depiction of predicted secondary structure of Hemk mRNA in presence and 
absence of disrupter DNA to facilitate branch formation at position A92. C) Applying 10DM24 deoxyribozyme for site 
specific attachment of adaptor RNA molecules to scaffold RNA. D) Preparative branch formation at position. 
3.3.3 Formation of 70S initiation complex (70S IC) 
Formation of initiation complex with linear and branched mRNA was investigated. Ribosomal subunits 
(0.1 µM, 5 pmol) and slight excess of initiation factors IF1, IF2 and IF3 and [3H] fMet-tRNAfMet were 
incubated with branched and non-branched HemK (0-0.5 µM) and filtered through nitrocellulose. The 
amount of [3H] fMet-tRNAfMet bound to the nitrocellulose filters was associated as the efficiency of 70S 
IC formation. Linear HemK mRNA formed 4.5 pmol 70S IC and provided participation of 91% of 
ribosomal subunits for formation of initiation complex. Branched HemK mRNAs with short and long 
adaptors formed 4.0 pmol (89%) and 4.3 pmol (87%) 70S IC respectively. This data showed no 
significant difference upon presence of adaptor RNAs in formation of 70S IC (Fig  3.3-3 A).  
3.3.4 Formation of pre-translocation complex 
After successful formation of 70S IC, bacterial translation is proceeded to form pre translocation 
complex. We investigated the efficiency of EF-Tu mediated delivery of a radiolabeled aminoacylated 
tRNA to the 70S IC and attributed presence of the delivered amino acid with the formation of the pre-
translocation complex. To the initiation complexes which were formed in presence of [3H] fMet-
tRNAfMet, ternary complex containing EF-Tu-GTP-[14C] Glu-tRNAGlu was added. Samples were filtered 




through nitrocellulose.  The ratio of bound [3H] fMet-tRNAfMet to [14C] Glu-tRNAGlu reflected there is no 
significant difference upon presence of adaptor RNAs. In this experiment, ribosomal subunits were the 
limiting factors (7.5 pmol) and RNA templates were 1.3-fold in excess to the ribosomal subunits. 
Incorporation of both [3H] fMet-tRNAfMet and [14C] Glu-tRNAGlu were between 6.2-6.8 pmol for all 
three RNA templates. The ratio of [3H] fMet-tRNAfMet to [14C] Glu-tRNAGlu for non-branched HemK 
and branched mRNA with short and long adaptors were 1.09, 0.97 and 0.95 respectively. (Fig  3.3-3 B). 
The data suggested similar level of formation of pre-translocation complexes in all three samples.  
 
Fig  3.3-3 Formation of 70S IC and pre-translocation complex with branched and non-branched mRNAs. A) Efficiency 
of 70S IC formation with branched and non-branched mRNAs. No significant difference is observed. B) Efficiency of 
formation of pre translocation complex with branched and non-branched RNAs. There was no significant difference in 
the ratio of [14C] Glu (the second amino acid in the translated peptide from HemK mRNA) to [3H] fMet (initiation 
amino acid) for the three tested RNAs. 
3.3.5  In vitro translation  
In vitro translation of HemK mRNA, using 7.5 pmol of ribosomal subunits as limiting factor was 
performed with radiolabeled [3H] Gly and [14C] Pro or [3H] Phe and [14C] Leu. The data confirmed 
normal translation of HemK, resulting in incorporation of 2.7 pmol [3H] Gly and 7.2 pmol of [14C] Leu. 
The result is consistent with two incorporation events for [14C] Leu per [3H] Gly (HemK, original 
frame). No glycine or proline was incorporated into the peptide translated from HemK mRNA as it was 
expected. Branched mRNAs with short or long adaptor RNAs did not result in any counts more than 
negative control (Fig  3.3-4). It was concluded that no translation occurred taking either of adaptor 
strands or downstream of the branch point of the scaffold strand as template (in any frame).  





Fig  3.3-4 In vitro translation of branched and non-branched RNAs. Non-branched HemK was positive control for 
translation of standard frame (incorporation of 1 Phe and 2 Leu per synthesized peptide). It could also be considered as 
the negative control for Gly and Pro incorporation. In vitro translation in presence of no mRNA was also included as 
the negative control. The background incorporation of each amino acid was considered separately and was deduced 
from the values in experimental samples.  
3.3.6 Discussion and outlook 
Ribosome is a large protein-RNA molecular machine which is capable to tackle strong secondary 
structures of mRNAs e.g. pseudoknots and stem loops. Here we investigated the response of the 
ribosome to the branched mRNA template. Our in vitro studies showed presence of the branched RNA 
at the 2nd position of the 4th codon of an mRNA does not perturb formation of 70S IC or EF-Tu 
mediated delivery of the aminoacylated tRNA to the second codon. In bacterial translation, after 
delivery of amino acids and GTP hydrolysis of the EF-Tu_GTP complex, aminoacylated tRNA is 
accommodated in the A site and peptide bond is formed rapidly to form the pre-translocation complex. 
Our method confirmed successful delivery of the second amino acid to the ribosomal complex but did 
not provide any data on GTP hydrolysis of EF-Tu and dipeptide formation. Additional experiments such 
as assays for GTPase activity of EF-Tu can support further hints to confirm formation of dipeptide.  
Despite successful 70S IC formation and delivery of the second aminoacylated tRNA, in vitro 
translation of branched mRNAs was aborted suggesting ribosome stall behind the branch point. The 
branch site, A82, was very close to the start codon and only three amino acids could be incorporated 
before reaching the branch site i.e. to synthesize the tripeptide fMet- Glu- Tyr. Data confirmed fMet 
binding to the ribosomal subunits and successful Glu delivery to the A site but unfortunately no 
radiolabeled Tyr was available in our hand to confirm peptide formation and ribosomal translocation. 
Installation of branched RNA adaptors at downstream positions of the scaffold mRNA would be helpful 
to address the question if the branched RNA can halt the ribosome in its elongation phase. Attempts to 
ligate adaptor RNAs to A92 was not successful in our hand. However in the HemK mRNA sequence, 
there are additional candidate positions e.g. A97 and A98. Position A98 is especially beneficial since it 
is located at the 3rd position of its corresponding codon. A82 was located at the 2nd position of its codon. 




Comparing the two data sets would allow investigating the importance of position of the codon on 
ribosomal response.   
The length of the adaptor RNA could affect final results; it is possible that the shorter adaptor has less 
interference with the translation. Although, we observer no difference between the two adaptor RNAs in 
respect to translation, it would be interesting to investigate the effect of a single GTP attachment at 
branch sites as adaptor. Single nucleotide GTP attachment to RNA molecules are described in the 
section 3.1. 
Additionally, in the case of ribosomal hopping or exchange of the template strands, a short adaptor RNA 
might not be sufficient to fulfill the length which is required. We preformed our experiments with two 
adaptor lengths, 19 mer and 33 mer.  No re-selection of any frames of the branched RNAs or even the 
scaffold RNA 3’ of the branch site was observed, but nevertheless this could be a false negative result. 
Although one adaptor strand was longer, the extended sequence was containing only Ala, Gln and Ser in 
frame 1, 2 and 3 respectively (Fig 3.3-1). As we did not used labeled Ala, Gln and Ser in our 
experiments we have no data, in case the ribosome selects to translate from adaptor strand after 6-7 
codons. Our result only confirmed that the adaptor strand until 19 nucleotide long is not taken as the 
template. In general, studies with a longer scaffold mRNA and adaptors and including radiolabeled 
amino acids, both before and after branch site, will answer the question if any frame of the scaffold or 
adaptor RNA is reselected by ribosomal machinery to continue peptide synthesis.  
Besides answering fundamental questions about the ribosomal response to the branch site, the most 
promising result of our in vitro translation studies was that we were successful to abort translation of an 
mRNA by installation of adaptor RNAs as road blocks for ribosome. With further developments, the 
ribosomal interference effect of the 2’,5’ branching is anticipated to be applicable in the field of 
molecular biology as a novel RNA silencing approach.  
In summary the work presented in this section shows possibility of utilizing 2’,5’-branched RNAs to 
answer questions of molecular biology or to engineer biological systems. The application was 
exemplified for studying and controlling in vitro peptide synthesis. For the next steps and application of 
deoxyribozymes in biological systems combination of two findings would be very beneficial: 1) the 
peptide synthesis was aborted with a template bearing 2’, 5’-linkage, and 2) the bivalent metal ion 
requirements of the deoxyribozyme 9F7 was reduced in presence of Tb3+. New hopes are expected for 
the control of protein synthesis with in situ synthesis of branched RNAs catalyzed by 9F7.  




4 General discussion 
Self-splicing group I introns and RNase P ribozyme were the first reported natural RNA catalysts. Since 
then several other natural ribozymes have been found most of which catalyze trans-phosphorylation 
reactions207. Discovery of the natural ribozymes encouraged scientists to select new and efficient 
artificial functional nucleic acids e.g. aptamers and  synthetic ribozymes9. When the RNA catalysis was 
revealed in 1980s, questions raised for possibilities of DNA catalysis. Successful in vitro selection of 
deoxyribozymes in 1994 was an end to the discussions on the catalytic capabilities of DNA molecules. 
Understanding the principles of the catalytic mechanisms of deoxyribozymes is still an open 
fundamental question.  
Currently, all discovered natural functional nucleic acids are solely RNA. Natural double stranded DNA 
is still only associated with the responsible molecule for genetic storage among generations. All the 
known deoxyribozymes are synthetic and discovered by in vitro selection. Among all deoxyribozymes, 
a group of DNA hydrolyzing deoxyribozymes reported by Beaker and his group are remarkable35. 
Breaker and his group showed that natural similar DNA sequences to these DNA hydrolyzing 
deoxyribozymes are also capable of catalyzing DNA hydrolysis. However, the intrinsic hydrolysis 
abilities of such natural sequences were weak and DNA sequences were only tested in vitro and in 
single stranded form in presence of 2 mM Zn2+.  
Although Breaker and his group were cautious on their report, I would like to underline that possibility 
of presence of natural DNA catalysts is not completely impossible. DNA in nature is not always double 
stranded. Formation of Holliday junction during homologous recombination is an example of natural 
non-Watson-Crick DNA structure. DNA also possesses transient single stranded forms during 
replication and transcription. Super coiling of the circular DNAs alters their standard double helical 
forms. Additionally, the genome of several viruses such as bacteriophage M13 consists of only single 
stranded DNA molecules.  
For any hypothetical natural DNA catalysts, I would assume that assistance of accessory proteins might 
be required for proper folding as it is observed for some natural ribozymes e.g. group II introns89. In 
vitro self-splicing activity of most variants of group II introns (except variant IIE and IIF)  is dependent 
on non-physiological conditions  and high salt concentrations208. The self-splicing and retrotransposition 
activity of the group II intron in vivo is assisted with proteins including host- and intron-encoded 
proteins such as endonucleases and a reverse transciptase209. 
In addition to fundamental interests to understand the mechanism of DNA catalysis, functional 
characterization of deoxyribozymes will boost the applicability of these catalysts. The presented study 





mediated acceleration of RNA ligating deoxyribozymes was found. The discussion is presented in two 
parts for characterization and application of deoxyribozymes. 
4.1 Functional characterization of deoxyribozymes 
(Deoxy)ribozymes depend strongly on metal ions for catalysis and folding. In the case of ribozymes, 
crystal and solution NMR structures and vast biochemical investigations allowed scientist to elucidate 
their potential mechanisms and metal ion binding sites. For example, mechanisms are proposed for 
nucleolytic ribozymes such as hammerhead or HDV ribozyme. The mechanisms involve activation of 
the 2’-OH at the cleavage site for the nucleophilic attack to the scissile phosphate group of the RNA 
backbone7. In contrast, the techniques and data for DNA catalysts are very restricted.  No crystal 
structure of any active form of any deoxyribozyme is present94 and methods on functional 
characterization of functional DNAs were limited at the beginning of this project. 
4.1.1 Combinatorial mutation interference analysis revealed necessary nucleotides for 
catalysis 
At the time of starting this PhD project, understandings about the three dimensional folding of 
deoxyribozymes was little and only few reports were available on the metal ion binding sites of DNA-
catalysts135.  In the case of ligating deoxyribozymes, the available scientific knowledge was only 
characterization of their substrate requirements. To investigate nucleotides involved in formation of the 
catalytic center of deoxyribozymes, conventional mutagenesis methods were possible. However, 
synthesis and characterization of single point mutants are laborious (3 mutations per position and for 
example 40 positions in catalytic core of the deoxyribozymes) and development of new methods was 
necessary.  
The work presented in this thesis started with the development of a combinatorial approach for 
simultaneous investigation of all three possible mutations of all nucleotides of a catalytic DNA at a 
given condition. Combinatorial mutation interference analysis (CoMA)139 revealed necessary 
nucleotides of several deoxyribozymes (6BX22, 9F7 and 9F13 are reported in this thesis).  
CoMA allowed minimization of the deoxyribozymes by two third of their original length without 
affecting the catalytic efficiency of the deoxyribozymes.  In the case of 6BX22, the deoxyribozyme was 
reported for catalysis of formation of lariat RNAs from biologically related RNA sequences. Lariat 
formation ability of 6BX22 was kept intact after minimization. 
CoMA was proven to be a reliable and sensitive method to compare the nucleobase requirement of 
functional DNAs and in particular deoxyribozymes. The second step of CoMA at which the catalytic 
reaction of the deoxyribozyme is taking place is a critical step. Performing the catalytic reaction of the 
deoxyribozyme at different conditions such as different time points at this step and comparison of the 





catalytic reaction of the deoxyribozymes in presence of different metal ions reflected the potential 
candidates for formation of the metal ion binding sites (studied on 9F7).  Further biochemical and 
biophysical studies such as spectroscopic investigations of active and inactive mutants of 9F7 i.e. 
sensitized luminescence of Tb3+, DMS and DNase probing assays and phosphorothioate rescue 
experiments supported CoMA data on 9F7.  
4.1.2 Nucleotide analogue interference mapping of DNA provided data on functional 
group demands of catalytic DNAs 
In addition to CoMA, Nucleotide analogue interference mapping of DNA (dNAIM)140 was applied to 
characterize the minimized version of 6BX22. dNAIM is a complementary method to CoMA and 
elucidates the functional groups demands of the necessary nucleotides of a deoxyribozyme. dNAIM also 
benefits from the combinatorial approach which was introduced by CoMA. More recently combinatorial 
nucleoside-deletion-scanning mutagenesis (NDS) is also reported by our group210. NDS employs one 
library of deletion mutants and allows fast detection of the nucleotides which are not involved in 
formation of the catalytic core of the deoxyribozyme.  
In the case of 6BX22, the minimized version of the deoxyribozyme contained a G-rich sequence, 
suggesting presence of a G-quadruplex in its structure. dNAIM provided data to disprove possibility of 
presence of a G-quadruplex in 6BX22 structure. Other biophysical and biochemical data from CD 
spectroscopy, porphyrine TMPyP4 binding assays and kinetic analyses in presence of different metal 
ions were in agreement with the dNAIM data and rejection of the hypothesis of presence of a G-
quadruplex in 6BX22 catalytic core.  
4.1.3 Lanthanides have been useful for fundamental studies on deoxyribozymes 
We utilized lanthanide ions and in particular Tb3+ as a probe for functional analysis of deoxyribozymes. 
Lanthanide ions have the ability to replace Mg2+ ions in their specific binding sites and have been used 
to study Mg2+ binding sites with footprinting assays and with spectroscopic methods. Sensitized 
luminescence of Tb3+ was reported to study metal ion (in particular Mg2+) interaction with ribozymes126 
and G-quadruplex DNAs124,123. Lanthanides have rich spectroscopic properties when they are site bound 
to the DNA or RNA nucleobases115. Importantly, inner sphere coordination of lanthanide ions is 
required for detectable luminescence. To study metal ion interactions with the 2’,5’-branched RNA 
forming deoxyribozymes, binding of Tb3+ to the deoxyribozymes must have been proven.  
Impressively and beneficially, micromolar concentrations of lanthanides (especially studied with Tb3+) 
accelerated  most of the 2’,5’-branched RNA forming deoxyribozymes in this study i.e. 9F7, 9F13, 7S11 
and 10DM24 when millimolar concentrations of bivalent metal ions were present. In contrast, 6BX22 
deoxyribozyme was inhibited in presence of Tb3+ at concentrations above 50 µM. Tb3+ mediated 





An optimal concentration of Tb3+ was required for maximum acceleration of the deoxyribozymes. For 
Mg2+ dependent reactions of 9F7, the Tb3+ optimal concentration was 100 µM. Higher Tb3+ 
concentrations caused fast reaction of only a fraction of the available RNA substrate, resulting in 
reduced amplitude with retained high rate constant. Addition of 100 µM Tb3+ to Mg2+ dependent 
reactions of 9F7 accelerated the reaction rate up to 10000 fold (kobs 7x10-6 vs 0.08 for 7 mM Mg2+ vs 7 
mM Mg2+ + 100 µM Tb3+). Impressively, the reaction rate in presence of 7 mM Mg2+ and 100µM Tb3+ 
was higher than the reaction rate in presence of 400 mM Mg2+ and in the absence of Tb3+. The optimal 
concentration of 9F7 was almost the same for other lanthanide ions i.e. La3+, Ce3+, Eu3+, Gd3+ and Yb3+ 
but reduced to 10 µM for Mn2+ dependent reactions of 9F7.  
Presence of optimal concentration of lanthanides reduced the bivalent metal ion requirements of the 
deoxyribozyme 9F7. The apparent binding constant for Mg2+ and Mn2+ were reduced ca. 4-fold. 
Reduction of the required Mg2+ concentration to near cytosolic concentrations will open opportunities 
for in vivo application of such deoxyribozymes especially as a tool in cellular and molecular biology. 
Based on these biochemical studies, presence of two types of binding sites was proposed for 9F7. One  
group of metal ion binding sites was proposed to be important for catalysis.  The other group was 
assumed to only play a role for proper folding and being peripheral. The  catalytically important metal 
ion binding sites of 9F7 must be occupied with bivalent metal ions for catalysis. The peripheral binding 
sites cause acceleration of the deoxyribozyme when they are occupied with Ln3+. This hypothesis was 
mainly based on two observations. Firstly, 9F7 deoxyribozyme was confirmed to be absolutely 
dependent on presence of bivalent metal ions. In the absence of M2+ and presence of a wide 
concentration range of Tb3+, no product formation was observed up to 48 h. Secondly, the biphasic 
titration curve of 9F7 activity  with increasing concentrations of lanthanides, suggested both synergistic 
(below optimal concentration) and antagonistic (above optimal concentration) effects of Ln3+ and M2+ 
on 9F7 activity.  
4.2 Tb3+ mediated acceleration of RNA-ligating deoxyribozymes enhanced 
deoxyribozymes’ application 
At the time of the start of this project, it was expected that functional and chemical characterization of 
deoxyribozymes would lead to improved applicability of such enzymes. Gratefully, the presented work 
in this thesis is an example of such direct impact of fundamental studies on the application of a system. 
Tb3+ mediated acceleration of branched RNA formation shifted reaction rates into a region that makes 
DNA enzymes practical for applications in RNA engineering and molecular biology.  
An immediate in vitro application of Tb3+ mediated acceleration was in the direction of site specific 
labeling of RNA. Biochemical and biophysical studies on natural RNAs such as riboswitches require 





methods are based on solid phase synthesis of functionalized or labeled RNA. RNA molecules smaller 
than 50 nt are reliably synthesized by solid phase synthesis. For longer RNAs, smaller labeled RNA 
fragments are ligated with T4 RNA ligase. Thereby, the current protocol is time and material consuming 
and there are rooms for improvements. Development of a fast and efficient method for site specific 
labeling of RNA using deoxyribozymes is reported in section 3.1 of this thesis. Deoxyribozyme 
mediated post synthetic labeling of RNAs is independent from the length of the RNA molecules and 
therefore is advantageous over the current protocols.  
4.2.1 Site-specific labeling of RNA with modified GTPs was impressively efficient in 
presence of Tb3+ 
Site-specific attachment of a single GTP to a model RNA was successfully reported using 10DM24179.  
Studies in our lab (currently unpublished), showed that 2’-modifications of GTP are allowed for the 
GTP attachment reaction. The reaction demanded high pH and high concentration of GTP (kobs 0.1 min-1 
in presence of 3 mM GTP, 100 mM Mg2+ at pH 9.0). Addition of 100 µM Tb3+ to the reaction in 
presence of 80 mM Mg2+ reduced the GTP requirement to an optimal concentration of only 10 µM. The 
pH of the reaction was also reduced to more neutral pH. The reaction rate of GTP attachment in 
presence of 10 µM GTP, 80 mM Mg2+ plus 100 µM Tb3+ at pH 7.5 was above 1.0 min-1 which means 
that the reaction was completed within the first minute. In the absence of Tb3+, at such low 
concentration of GTP, formation of the product was undetectable.  
Careful analysis for the preparative GTP attachment to a model RNA revealed that only 4-5 fold excess 
of GTP to RNA substrate is sufficient to reach a kobs above 0.1 min-1 when the reaction is performed at 
80 mM Mg2+ +100 µM Tb3+ at pH 7.5 and the Tb3+: DNA ratio is above 10. To study the generality of 
the method, comprehensive studies were performed to investigate the effect of point mutations adjacent 
to the adenosine at the GTP attachment site. The mutation studies revealed that purine embedded 
adenosines are the best sites for GTP attachment. The data was cross validated on several other model 
RNAs. Furthermore, it was shown that 2’-modified GTPs with EDA- or ester- linked fluorescent dyes 
were efficiently attached to the model RNA and more importantly, the EDA and ester linkages resisted 
the reaction condition.  
Preparative labeling of large natural RNA molecules demands further method developments to tackle 
two main challenges. First of all, the secondary structures of large natural RNAs compete with the 
hybridization of the DNA binding arms to the RNA substrate. Performing the reactions in presence of 
disruptor DNAs might be helpful in this respect. The second main challenge is the removal of the 
unreacted RNAs. For the RNA molecules smaller than 50 nt separation of GTP attached RNAs from 
intact RNAs is possible by denaturing gel electrophoresis. For longer RNA molecules, a clean-up 
strategy was proposed in this thesis for removal of the unreacted RNA molecules. The proposed strategy 
is based on the DNA-catalyzed site specific cleavage of the unreacted RNA molecules for which the 2’-





successful GTP attachment at the branch site adenosine excludes possibility of the cleavage for the 
reacted RNA molecules. Efficiency of this strategy must be further investigated practically.  
4.2.2 Preparative synthesis of 2’,5’-branched RNA was shown to be useful in molecular 
biology  
Besides attempts for applying deoxyribozymes for RNA labeling, synthesized 2’,5’-branched RNA have 
been used to study bacterial peptide translation in vitro. Presence of an adaptor RNA to an mRNA 
(scaffold RNA) aborted peptide synthesis as it was expected. Although further carful inspections are 
required to exclude the possibility of ribosomal hoping, current data suggests that installation of a 
branched RNA can halt ribosomal translocation and abort protein synthesis. Finally, formation of 
branched RNAs with RNA fragments with naturally related sequences allowed in vitro binding assays 
with RNA and protein components of yeast spliceosome such as U2 and U6 snRNAs and Cwc2 and 
RNase H domain of Prp8.   
In summary, the reported work in this thesis provided fundamental insights in the world of DNA-
catalysts with development of combinatorial mutation interference analysis (CoMA) and by employing 
lanthanide ions as cofactors. Lanthanides and in particular Tb3+ mediated acceleration of 2’,5’-branched 
RNA forming deoxyribozymes allowed mechanistic characterization of deoxyribozymes in respect to 
their metal ion binding sites. Impressive rate acceleration upon presence of Tb3+ was employed for site-
specific labeling of RNA molecules with beneficial reduced requirements on the valuable modified 
GTPs. Further development of the methods is aimed for preparative labeling of large natural functional 






5 Material and methods 
5.1 RNA and DNA preparation 
Non-modified DNAs have been purchased from Sigma Aldrich. RNAs and modified DNAs for CoMA 
and dNAIM were synthesized by solid phase synthesis. RNAs with 5’ triphosphate were transcribed 
using T7 RNA polymerase. RNA and DNAs were purified by denaturing PAGE and the synthesis 
quality was controlled by anion exchange HPLC. Plasmid template for U6 snRNA transcription was 
provided by department of Professor Reinhard Lührmann. The transcribed mRNA for ribosomal 
interference studies was provided by the department of Professor Marina Rodnina. 
5.2 Solid phase synthesis 
5.2.1 Chemicals and building blocks for solid phase synthesis 
Custom Primer SupportTM dG40s              GE Healthcare 
Custom Primer SupportTM dC AC 40             GE Healthcare 
Custom Primer SupportTM T 40s              GE Healthcare 
Custom Primer SupportTM Ribo A 80             GE Healthcare 
Custom Primer SupportTM Ribo G 80             GE Healthcare 
Custom Primer SupportTM Ribo C Ac 80            GE Healthcare 
Custom Primer SupportTM Ribo U 80             GE Healthcare 
Custom Primer SupportTM 3’-phosphate 100s           GE Healthcare 
5’-DMT-2’-TOM-ribo Guanosine (n-acetyl OP)          ChemGenes 
5’-DMT-2’-TOM-ribo Cytidine (n-acetyl OP)            ChemGenes 
5’-DMT-2’-TOM-ribo Uridine OP              ChemGenes 
5’-DMT-2’-TOM-ribo Adenosine (n-acetyl OP)          ChemGenes  
5’-DMT-2’-TOM-ribo N2-isobutyl-7-deazaguanosine (c7G)       ChemGenes 
DMT-dThymidine β-Cyanoethylphosphoramidite          SAFC 
DMT-dGuanosine (dimethylformamidin) β-Cyanoethylphosphoramidite     SAFC 
DMT-dAdenosine (Benzoyl) β-Cyanoethylphosphoramidite        SAFC 
DMT-dCytidine (Benzoyl) β-Cyanoethylphosphoramidite         SAFC 
DMT-dCytidine (Acetyl) β-Cyanoethylphosphoramidite         SAFC 
Acetonitrile for DNA synthesis (< 10 ppm H2O)           Sigma-Aldrich 
Acetonitrile (HPLC grade)                Sigma-Aldrich  
Dichloroacetic acid, 99%+                Acros organics 
1,2-Dichloroethan                   Roth 
Acetic anhydride 99%+                 Acros organics 
2,4,6 collidine                    Acros organics 
Oxidation (50 mM Iodine in Pyridine 90%/ Water 10%)          Amersham Bioscience 
Capping B1 (40% (v/v) Acetic anhydride in Acetonitrile)        Amersham Bioscience 
Methylamin solutiosn                 Aldrich 
Amonia solution 25%                  Merck  
Tetrabutylamonium fluoride trihydrate 99%            Acros organics 




Tetrahydrofuran (water < 50ppm)               Acros organics  
Iodine                     Acros organics  
5-Benzylthio-1H-tetrazole (BTT)              Carbosynth 
4-Dimethylamino-pyridin (DMAP)             Fluka 
5.2.2 Instruments 
LKB. Gene Assembler Plus                Pharmacia 
392 DNA/RNA synthesizer               Applied Biosystems 
5.2.3 Solutions for solid phase synthesis of oligonucleotides 
Oxidation, Cap A and Cap B solutions were purchased or alternatively prepared as is described here. 
Detritylation and activation solutions were only prepared manually.  
Cap A     0.5 M 4-dimethylamino-pyridin (DMAP) in acetonitrile 
Cap B     acetic anhydride/2,4,6-collidine/acetonitrile 20/30/50 
Oxidation     10 mM I2 in acetonitrile/2,4,6-collidin/H2O 10/1/5 
Detritylation    3% dichloroacetic acid (DCA) in 1,2-dichloroethane 
Activation     0.25 M benzylthiotetrazole (BTT) in acetonitrile 
5.2.4 Solid phase synthesis and deprotection 
Standard DNA and RNA 3’-ß-cyanoethyl diisopropylamino phosphoramidites were 5’-O-4,4’-
dimethoxytrityl (DMT) protected. Phosphoramidites have been purchased from ChemGenes, 
Wilmington, USA, or SAFC, Saint Louis, US, or have been synthesized by Dr. Falk Wachowius at 
Research Group Nucleic acid Chemistry, Max Planck Institute for Biophysical Chemistry, Göttingen. 
Phosphoramidite solutions (100 mM) were prepared by dissolving the phosphoramidites in absolute 
acetonitrile (≤ 10 ppm H2O). Phosphoramidite solutions used for the CoMA and dNAIM were mixtures 
of parent 100 mM dN phosphoramidite with 100 mM (modified-) rN phosphoramidite with the ratio of 
90:10. For each coupling step 75 µl of the solution was used. Activator solution, BTT was prepared with 
low water content acetonitrile to the final concentration of 250 mM. Each coupling step required 250 µl 
of the BTT solution. Both phosphoramidite and BTT solutions were dried overnight using activated 
molecular sieves. Molecular sieves (4 Å) were previously washed with water, dried at 110°C for at least 
48 h followed by heating under high vacuum for at least 24h.  
RNA or DNA oligonucleotides were synthesized on polystyrene primer supports on Pharmacia Gene 
Assembler Plus with 0.7 µmol synthesis scales. Loading density for DNA and RNA solid supports were 
40 and 80 µmol/g respectively. For 0.7 µmol scale synthesis ca. 20 and ca. 10 mg supports were used 
respectively for DNA and RNA synthesis.  Most of the syntheses were in “trityl-off” mode, cleaving the 
terminal DMT group off at the final step, except otherwise was required. 
Synthesis started with detrtiylation of the solid support using 3% Dichloroacetic acid (DCA) in 1,2-
Dichloroethane for 2 min. After detritylation step dicloroethane wash and acetonitrile wash were 




performed generously. The coupling time for DNA and RNA phosphoramidites were 2 and 4 min 
respectively in presence of activation solution (0.25 M BTT in acetonitrile). Capping solutions A and B 
were mixed 1:1 and incubated for 1 min before and after oxidation step. Iodine mediated oxidation was 
accomplished in presence of oxidation solution for 1 min. The solid phase was rinsed with low water 
content acetonitrile in between coupling, capping and oxidation steps.  
DNA oligonucleotides were deprotected by 16 h incubation at 55°C with 1 ml mixture of NH4OH: 
ethanol 3:1. RNA oligonucleotides were deprotected by 4-6 h incubation at room temperature or 
alternatively at 37°C with 1 ml mixture of methylamine in H2O (41%): methylamine in ethanol (33%) 
1:1. For DNA and RNA oligonucleotides with acetyl protection group on cytidines samples were 
incubated with AMA (1:1 mixture of NH4OH: methylamine in H2O (41%)) for 2 h at 65°C.  
Samples were filtered and the dried under vacuum. DNA samples were dissolved in water and collected. 
RNA samples were further incubated with 600 µl of 1 M TBAF in THF at 40°C for 5 hours for removal 
of the 2’-OH protection group (TOM). Deprotection was finished by addition of same volume of Tris-
HCl 1 M, pH 8.0. THF was evaporated and samples were desalted using size exclusion chromatography 
(H2O as solvent, flow rate 2 ml/min). Sample were collected, dried and dissolved in water.  
5.3 RNA in vitro transcription 
For in vitro transcription 100 pmol single stranded DNA template containing T7 RNA promoter 
complement, 100 pmol T7 RNA promoter were annealed in 50 µl and in presence of transcription 
annealing buffer (15 mM NaCl, 4 mM Tris-HCl pH 8.0, 0.1 mM EDTA) by 2 min heating at 95°C and 
at least 15 min incubation at room temperature. Buffer and NTPs were added to reach final 
concentration of 40 mM Tris-HCl pH 8.0, 30 mM MgCl2, 10 mM DTT, 2 mM spermidine, 4 mM of 
each NTP in the final volume of 100 µl. 2 µl of non-commercial T7 RNA polymerase were added to 
start the transcription. Samples incubated at 37°C for 5 h. EDTA (100 mM) was added to the samples to 
stop the reaction. For experiments with phosphorothioate donor, 5’-γ (or 𝛼)-thio-triphosphorylated 
acceptor RNA were transcribed in vitro using the same protocol and suing guanosine- 5’-(γ –thio)-
triphosphate or guanosine- 5’-(𝛼 –thio)-triphosphate from Jena bioscience.  
DNA templates for short RNA transcript (< 60 nucleotides) were purchased from Sigma Aldrich. DNA 
templates for long RNA transcripts i.e. U6 snRNA (121 nucleotides long) were prepared by PCR 
amplification of a plasmid containing yeast U6 snRNA. Plasmid containing U6 RNA of Saccharomyces 
cerevisiae with a T7 promoter (pT7 U6 S.cer.) was provided by Olexandr Dybkov, department of 
Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry. PCR reaction with primers 
D027 (T7 promoter) and D138 (reverse primer including BamHI restriction site) and the DNA template 
pT7 U6 yielded the transcription template for U6 snRNA. An extra G in the 5’ end and 8 additional 
nucleotides on the 3’ end were introduced to the sequence to improve transcription efficiency.    




5.4 Gel purification and ethanol precipitation 
Denaturing 10-20% polyacrylamide gel containing 7 M urea were prepared by standard protocol212 
using urea (from Merck), Tris, Boric acid and Rotiphorese gel 40 (from Carl Roth). Crude synthesized 
oligonucleotides and in vitro transcribed RNAs were purified by denaturing polyacrylamide gel 
electrophoresis containing 7 M urea and 1x TBE (89 mM Tris-HCl pH 8.0, 89 mM Boricacid, 2 mM 
EDTA pH 8.0). The desired bands were cut and extracted. Sliced pieces of the gel was incubated with 
TEN buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0 and 300 mM NaCl) for 1.5 hour at 37°C or 
overnight at room temperature. The extraction was performed two times for higher efficiency. The 
oligonucleotides in the supernatant were precipitated with ethanol. Three volumes of ethanol was added 
to the samples, samples incubated at -20°C for 2h and centrifuged at 13200 rpm for 30 min at 4°C. 
Supernatants of the samples were removed and the pellets were washed once or twice with 70% ethanol, 
continued by at least 10 min further centrifugation at 4°C and removal of the supernatant. The 
concentration of the samples were measured using Nanophotometer from IMPLEN. Pellets were dried 
and dissolved in 40-100 µl water. The purity of the samples was controlled by HPLC.  
5.5 PCI extraction 
To 100 µl of aqueous solution containing mixture of oligonucleotides and proteins, 100 µl of phenol-
chloroform-isoamyl alcohol 25:24:1 (Roth) was added. Sample was mixed thoroughly for 1 min and 
centrifuged for 1 min to separate the two phases. Aqueous phase (top) was removed to a new tube. 
Phenol phase was washed with 50 µl H2O. To the 150 µl of the aqueous phase 100 µl chloroform-
isoamyl alcohol (Roth) was added. Samples were mixed thoroughly and centrifuged to separate the two 
phases. The aqueous phase was removed to a new tube. The chloroform-isoamyl alcohol phase was 
washed with additional 50 µl of H2O. Extracted oligonucleotides in aqueous phase (200 µl) were 
precipitated by addition of 20 µl 3 M NaCl and 600 µl of absolute cold ethanol. Ethanol precipitation 
was perused as described above.  
5.6 HPLC analysis 
Äkta purifier (GE healthcare) was used for HPLC analyses of this report. Anion-exchange 
chromatography on a Dionex DNAPac PA200 Analytical column was performed by increasing gradient 
of eluent B (25 mM Tris-HCl pH 8, 0.5 M NaClO4, 6 M urea,) in eluent A (25 mM Tris-HCl pH 8.0, 6 
M urea). All the HPLC analyses have been performed at 80°C. For analysis of the quality of the 
synthesized and purified RNA and DNA oligonucleotides 25 µl sample (containing ca 100 pmol nucleic 
acid) were injected by auto-sampler and eluted with a gradient of 0-60% eluent B in eluent A in 45 min 
at 80°C. HPLC analysis of the fate of triphosphate donor RNA in presence of Tb3+ started with 25% 
eluent B in A for 1 column volume (CV), percentage of B increased to 50% in 8 CV. Column was 
washed for 1 CV with 100% eluent B and additional 2 CV with 100% eluent A. For HPLC analysis of 




preparative ligation reactions, HPLC started with 35% eluent B which increased to the target percentage 
of 100 in 12 CV. Additional wash with 2 CV of 100% eluent A was the last step.  
5.7 Enzymatic phosphorylation of 5’ends 
T4 polynucleotide kinase (PNK) enzyme was used to phosphorylate 5’ ends with free hydroxyl groups. 
5’-OH oligonucleotides (0.5-2 nmol) were incubated in presence of 1x PNK buffer (50 mM Tris-HCl, 
pH 7.6, 10 mM MgCl2, 5 mM DTT, 0.1 mM spermidine, 0.1 mM EDTA) and 1 mM ATP in 30-40 µl at 
37°C for 3h. Samples were ethanol precipitated afterwards to remove non-incorporated ATPs. For 
radiolabeling reactions, 50 pmol 5’-OH oligonucleotides were incubated in presence of 1x PNK buffer 
and γ-32P-ATP (5 µCi) in 10 µl at 37°C for 1 h. Radiolabelled samples were loaded on a 0.4 mm thick 
20% denaturing PAGE for 45 min and extracted as described above. Alternatively, the reaction mixtures 
were passed through a MicroSpin G-25 column to remove the unincorporated γ-32P-ATP following the 
company’s suggested protocol. The procedure continued by phenol-chloroform-isoamyl alcohol (PCI) 
extraction and completed by ethanol precipitation.  
For 5’-radio labeling of RNA transcript, first a dephosphorylation step was performed using calf 
intestinal alkaline phosphatase (CIAP) or antarctic alkaline phosphatase. The free 5’-OH then was 
subjected for phosphorylation reaction by PNK. Dephosphorylation by CIAP was performed for 0.2-1 
nmol of transcript in presence of 1x CIAP buffer (50 mM Tris-HCl pH 8.5, 0.1 mM EDTA) and 5 units 
of CIAP enzyme from Fermentas in 30 µl at 37°C for 3h. Dephosphorylation by antarctic alkaline 
phosphatase was performed for 50-200 pmol of transcript in presence of 1x antarctic buffer (50 mM 
Bis-Tris-HCl-Propane-HCl, 1 mM MgCl2, 0.1 mM ZnCl2, pH 6) using 5 units of antarctic phosphatase 
enzyme from New England Biolabs. (NEB) in 30 µl at 37°C for 30 min. For both CIAP and antarctic 
alkaline phosphatase, the transcript was extracted by PCI and ethanol precipitation prior to PNK 
reaction. 
5.8 Enzymatic radiolabeling of 3’ ends 
Labeling of the 3’ ends of DNAs have been performed using Klenow 3’  5’ exo- from Jena 
Bioscience. A short DNA strand (splint, ca 20 nucleotide long) was hybridized to the 3’ end of the DNA 
and served as a template for Klenow dependent strand extension. DNA (50 pmol) and splint (300-500 
pmol) were annealed in 12 µl by heating to 95°C for 2 min and further incubation at room temperature 
for 15 min. Klenow buffer (final 1x concentration: 10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 7.5 mM 
DTT), α-32P dATP (5 µCi) and 1 unit Klenow fragment were added. Samples were incubated at 37°C 
for 3 hours. After formation of a phosphodiester bond between 3’ end of DNA and the α- phosphate of 
the dATP by Klenow, the 3’ α -32P-labeled reaction products were isolated by purification on a 12% 
denaturing PAGE to separate splint and non-incorporated α-32P  dATP from radiolabeled 
oligonucleotides.  




5.9 Standard annealing procedure 
Annealing of oligonucleotides was performed before catalytic assays, spectroscopic investigations and 
DNase or DMS probing assays. Nucleic acid components were incubated for 2 min at 95°C in presence 
of annealing buffer (5 mM HEPES pH 7.5, 15 mM NaCl, 0.1 mM EDTA). Samples were annealed at 
room temperature for at least 15 min.  
5.10 T4 RNA ligation 
To ligate acceptor RNAs to CoMA, dNAIM and DMSi libraries, 5’ phosphorylated DNA molecules (1 
nmol) were annealed with acceptor RNA (2 nmol).  T4 RNA ligation buffer (50 mM Tris pH 7.5, 10 
mM DTT, 5 mM MgCl2), ATP (0.5 mM) and T4 RNA ligase from Fermentas (10 units) were added and 
volume was adjusted to 30 μl. Samples incubated at room temperature for overnight. The ligation 
products were purified after 10% denaturing PAGE by extraction and ethanol precipitation. 
5.11 Combinatorial mutation interference analysis (CoMA) 
CoMA consists of 4 steps: 1) solid phase synthesis of the mutant libraries, 2) separation of the active 
mutants, 3) alkaline hydrolysis and 4) PAGE analysis139. Experimental details of CoMA analysis of the 
deoxyribozymes used in this report were as follows. 
Step1: Four mutant libraries (rA, rC, rG, rU) were synthesized on solid supports using the standard solid 
phase synthesis protocol with slight modifications. The deoxyribozymes’ binding arms were synthesized 
with solutions of dN phosphoramidites. The 3’ binding arms were synthesized in “trityl-on” mode. 
Syntheses were continued using dN:rN phosphoramidite mixtures 90:10 for the catalytic core of the 
deoxyribozymes. The syntheses of the catalytic cores were in “trityl-on” mode as well. The final steps 
were syntheses of the 5’ binding arms with standard dN phosphoramidites in “trityl-off” mode. 
Step2: DNA libraries were phosphorylated at 5’ end.  The 5’ phosphorylated libraries have been ligated 
to the acceptor RNA using T4 RNA ligase. The conjugated donor RNA and DNA libraries were 
radiolabeled at 3’ end using Klenow fragment and 6-10 times excess of DNA splint. Ideally the splint 
DNA should not be extended and therefore radiolabeled i.e. the DNA library binding arm should not 
serve as a template for α-32P-dATP attachment to the splint. To avoid any radiolabeling of the splint a 
5’-phosphorylated splint was used instead of 5’-OH containing splint. 5’-phosphorylated splint was 
synthesized on solid phase having a DMT-protected phosphate group as initiator building block for 
DNA synthesis.  
The time and conditions are crucial for the ligation reaction of CoMA separation step. Deoxyribozyme 
ligation for CoMA of 6BX22, 9F13 and 9F7 were in presence of 50 mM HEPES pH 7.5, 150 mM NaCl, 
2 mM KCl and millimolar concentrations of a bivalent metal ion as active metal ion and in cases 




micromolar concentrations of TbCl3. The catalytic step of the enzyme was performed with 50 pmol of 
donor RNA-DNA library and equimolar amount of the acceptor RNA (in the case of 9F7) or excess of 
the acceptor RNA (60 pmol in the case of 6BX22 and 9F13). The reaction volumes were 50-70 µl.  The 
reaction times were between 20 min and 10 h. The reaction times were selected based on the kinetics of 
the enzyme at different condition (table 5.11-1).  






Step3: The active and inactive fractions were separately subjected to alkaline hydrolysis. 2 μl sample 
was incubated with 2 μl 20 mM NaOH and incubated at 95°C for 10 min. Heating was performed using 
an Eppendorf Mastercycler. The temperature for lid and samples were set at 95°C. The heating from the 
lid avoids evaporation and increasing NaOH concentration.  
Step4: The hydrolyzed samples were loaded on 20% denaturing PAGE for ca. 4h at 35W. After 
electrophoresis the gel was dried on a 3MM chromatography paper (Whatman) in gel dryer (Bio-RAD) 
at 80°C for 30 min and exposed to a storage phosphor screen (GE healthcare) overnight. Scanner 
STORM 820 GE Healthcare was used to scan the phosphorimager screens. Storage phosphor screen 
were erased afterwards using Image eraser (Amersham Bioscience). ImageQuant 5.2 was used to 
quantify the band intensities. The borders of each band were defined manually by drawing a box around 
each band. For each band, background was deducted by the intensity of another box with the same size. 
Band intensities were normalized to eliminate loading differences. One of the positions which accepted 
all mutations under the tested conditions was selected for normalization (Pos.norm). Normalization factor 
was defined as a factor which makes the intensity of Pos.norm of all lanes equal to each other. 
Normalization factor for each lane was calculated as the ratio of the Pos.norm intensity of that lane to the 
pos.norm of a reference lane. Usually active rG library was selected as the reference lane. All the bands of 
each lane were divided by the normalization factors of the respective lane. After normalization, 
interference values were calculated as the ratio of the unselected library over active library at the same 
band position. The interference values below 2 were considered as non-significant.  
 
 
deoxyribozyme Condition  volume (µl) time 
9F7 20 mM Mn2+ 60 20 min 
9F7 2 mM Mn2+ 70 10 h 
9F7 2 mM Mn2++ 10 µM Tb3+  70 1 h 
9F7 80 mM Mg2+ 60 8 h 
9F7 80 mM Mg2++100 µM Tb2+  60 2 h 
6BX22 20 mM Mn2+ 60 0.5-5 h 
9F13 20 mM Mn2+ 60 3 h 




5.12 dNAIM  
dNAIM140 and DMSi39 have been performed on trimmed 6BX22. For dNAIM four DNA libraries of 
(modified) guanosines have been synthesized. The libraries were as follows: dG/rG, dG/r- c7G, dG/r- 2 
aminopurine and dG/r- m1G. For each library a mixture of 90:10 dG/rGmod phosphoramidite has been 
made and used wherever G is present in the sequence. With each dG/rGmod mixture a pentamer has been 
synthesized to control rGmod incorporation. To have statistically one rGmod distributed in the catalytic 
core of the trimmed 6BX22 5% incorporation of rGmod was desired.  
The phosphorylated DNA libraries were ligated the donor RNA (Tr03) as explained in CoMA. Donor 
RNA- DNA libraries (60 pmol) were radio-labeled with α-32P dATP at their 3’ end. To perform the 2’,5’ 
branch formation reaction and separation of active fractions, the labeled donor RNA-DNA libraries 
incubated with 120 pmol acceptor RNA (R01) in presence of 6BX22 buffer i.e. 50 mM HEPES pH 7.5, 
50 mM NaCl, 2 mM KCl  and 20 mM MnCl2 at 37°C for 3 hours. Active fractions, inactive fractions 
and unseparated libraries were hydrolyzed and analyzed as in CoMA. 
To prepare the m7G library for DMSi, 2 nmol trimmed 6BX22 was annealed with 2.5 nmol of 
inactivated donor RNA (R005) and inactivated acceptor RNA (R02) in 50 µl. To the annealed sample, 1 
µl of 5% DMS was added. Samples were mixed and spin down and incubated for 1 h at room 
temperature. Methylation reaction was stopped by addition of 40 µl of DMS stop solution. DNA was 
precipitated, phosphorylated at 5’ end and further ligated to the acceptor RNA (Tr03) using T4 RNA 
ligase. Separation of active fraction was performed like other dNAIM libraries. Modification sites were 
visualized by piperidine cleavage and further PAGE analysis as it was done for other dNAIM libraries. 
Piperidine cleavage was performed by addition of 50 µl 10% Piperidine and further incubation at 90°C 
for 30 min continued by evaporation of Piperidine in speedvac. 
5.13 Kinetic and preparative reactions of deoxyribozymes 
The suppliers of buffers and metal ions used for kinetic experiments were as follows. 
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES)      Roth 
2-(Cyclohexylamino)-ethansulfonic acid (CHES)         Roth 
Sodium chloride                  Merck 
Potassium chloride                 Merck 
Magnesium chloride hexahydrate              Merck 
Manganese (II) chloride 99+%              Aldrich 
Lanthanum (III) chloride heptahydrate  99.999%         Aldrich 
Cerium (III) chloride heptahydrate 99.9%           Aldrich 
Europium (III) chloride hexahydrate 99.99%           Acros organics 
Gadolinium (III) chloride hexahydrate 99.999%          Aldrich 
Terbium (III) chloride hexahydrate 99.9%            Acros organics 
Ytterbium (III) chloride hexahydrate 99.9%          Aldrich 





6BX22 standard kinetics experiments have been performed in three-molecular format using 5 pmol 
acceptor (R001, 1 pmol 5’-32P-radiolabelled RNA and 4 pmol non-radiolabeled RNA), 15 pmol trimmed 
6BX22 (D010) and 30 pmol donor RNA (Tr03). Nucleic acid components of the reactions were 
annealed with standard procedure. 5x HEPES mix buffer (250 mM HEPES pH 7.5, 750 mM NaCl, 10 
mM KCl) added to the samples to reach final concentration of 50 mM HEPES pH 7.5, 150 mM NaCl 
and 2 mM KCl. The reaction started by addition of 1 µl of 10x MnCl2 or the mixture of indicated metal 
ions. Standard reaction volume for kinetic assays was 10 µl. aliquots (0.7 µl) of reactions were 
quenched by addition of 2 µl of stop solution (80% formamide, 1x TBE, 50 mM EDTA, 0.0025% each 
of bromophenol blue and xylene cyanol). Samples were kept on dry ice before loading on 15% 
denaturing PAGE for 45 min at 35 W. The gel dried and exposed to Phophorimager screen. The band 
intensities were quantified by ImageQuant. After background correction the ratio of the product band to 
the substrate RNA was calculated and plotted against time. The kinetic curves were fit to the 
exponential fit formula 𝑌 = 𝑌𝑚𝑎𝑥�1 − 𝑒−𝑘𝑜𝑏𝑠∙𝑡� or to the linear fit whenever suitable.  𝑌 = 𝑘𝑜𝑏𝑠. 𝑡 
For 6BX22 chase experiment, the reaction started with standard concentrations of substrates and metal 
ion in 30 µl. single and double chase experiments started with 10 mM Mn2+. Tb3+ (up to 100 µM) and 
additional Mn2+ (up to 20 mM) were added after 20 min and 60 min of start of the reaction. For control 
experiments (10 and 20 mM Mn2+, no chase) only water was added at the indicated time points.  
Standard kinetic experiments for 9F7 or 9F13 were carried out in three-molecular format and in 10 µl 
volume. 1 pmol 5’-radiolabeled acceptor RNA mixed with 4 pmol non-radiolabeled acceptor RNA, 15 
pmol 9F7 DNA and 30 pmol donor RNA and annealed in 6 µl. standard acceptor and donor RNAs for 
9F7 and 9F13 were R012 and Tr12 respectively. Standard original length 9F7 was D046. Reactions 
were performed in presence of 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and 20 mM MnCl2 or 
indicated concentration of other metal ions at 37°C. In cases that Tb3+ is present in the reaction, 10x 
Tb3+ and 10x M2+ solutions were premixed prior to addition to the reaction. The reaction times varied 
between 20 min to 24 hours.  Samples were separated and analyzed as explained for 6BX22 kinetics.  
Kinetic investigations with 10DM24 were performed by annealing of 2 pmol acceptor RNA (1 pmol 5’-
radiolabeled and 1 pmol non-radiolabeled RNA), 10 pmol 10DM24 deoxyribozyme and 20 pmol of 
either donor RNA or helper RNA (in the case of GTP attachment) in 4-6 µl volume. In cases of GTP 
attachment, GTP served as the donor substrates. GTP (2 nmol) was added after the annealing step and 
before addition of reaction buffer and metal ions.  Then 5x HEPES mix buffer was added to the sample 
to reach final concentrations of 50 mM HEPES, 150 mM NaCl and 2 mM KCl respectively. Reactions 
were started by addition of 80 mM MgCl2, except otherwise is mentioned. For experiments with Tb3+ 
mediated acceleration 10x MgCl2 and 10x TbCl3 were premixed prior to addition to the reaction. 
Standard condition for acceleration effect was in presence of 80 mM MgCl2 and 100 µM Tb3+.  




For preparative (modified-)GTP attachment to SAM III 3’ fragment, substrate (Tr18), GTP attaching 
10DM24 (D121) and helper RNA (R14) were annealed in 50 µl. (modified)-GTP, buffer and metal ions 
were added sequentially. The reaction volume was adjusted to 100 µl to reach the final concentrations of 
5:6:8 µM of substrate: DNA: helper RNA, 20 µM GTP, 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM 
KCl, 80 mM MgCl2 and 100 µM TbCl3. The 10x concentrated MgCl2 and TbCl3 were pre-mixed prior 
to addition to the reaction. The samples were incubated 20-30 min at 37°C. The higher amount of 
oligonucleotide loaded on a gel volume leads to the higher extraction efficiency. Therefore, after the 
reaction two samples (each containing 500 pmol RNA) were mixed, ethanol precipitated and loaded on 
one pocket of 0.8 well 0.4 mm thick gel. The bands containing helper RNA, 10DM24 DNA and labeled 
RNA were cut and the oligonucleotides were extracted. 10DM24 enzymes and helper RNAs could be 
used for a new labeling reaction. 
To produce full length SAM III, SAM III 5’ fragment (R35) and 3’ fragment (Tr18) were ligated by 
minimized version of 9DB1 deoxyribozyme. 9DB1 catalyzes the nucleophilic attack of the 3’-OH of the 
acceptor RNA to the α phosphate of the donor RNA strand to form a natural linear 3’-5’ phosphodiester 
bond. Here the acceptor RNA strand was synthesized by solid phase synthesis. Triphosphorylated donor 
was prepared by in vitro transcription. Equimolar ratios of minimized 9DB1 deoxyribozyme139, donor 
and acceptor RNA (2 nmol of each) were incubated in presence of 150 mM NaCl, 2 mM KCl, 40 mM 
MgCl2, 50 mM CHES buffer at pH 9.0 in 150 µl at 37°C for 5h. The reaction mixtures were loaded on 
15% denaturing PAGE, 0.4 mm spacer, 1 nmol per lane. Electrophoresis was performed for 1h30 at 
35W. 
For preparative scale formation of branched products by 6BX22, reactions were started with 1 nmol of 
donor RNA and equimolar or slight excess of DNA and acceptor RNA, incubated in the presence of 20 
mM Mn2+ for 3 h at 37°C and resulted in 15%-60% recovery yield of the branched product. 
5.14 HPLC analysis of 9F7 kinetics 
For kinetic experiments of 1 µM oligonucleotide complexes, acceptor RNA, 9F7 original DNA and 
donor RNA were mixed and annealed in 60 µl. Buffer and metal ions were added to reach the indicated 
metal ion concentrations in 100 µl. The samples incubated at 37°C for the stated time. Reactions were 
stopped by addition of 100 mM EDTA. Ethanol precipitation was the next step. The pellets were 
washed one or two times by 70% ethanol to remove excess of metal ions. The precipitated pellet 
dissolved in 25 µl of water prior to injection. For kinetic experiments of 10 µM oligonucleotide 
complexes, the annealing step was done in 6 µl and the final reaction volume was 10 µl and no ethanol 
precipitation was required. Samples were injected into analytical HPLC (gradient: 1 CV: 25% eluent B, 
target concentration: 50% eluent B during 8 CV) and the area under UV260nm trace was integrated to 
calculated the ligation yield.  




5.15 Circular dichroism (CD) measurements 
CD measurements have been performed with ChiraScan Applied Photophysics CD spectrometer. The 
spectra were measured in the range of 200-320 nm with acquisition time of 2.0 seconds. Scans were 
repeated at least 3 times. Sample volumes were 400 μl. Nucleic acid component concentration was 1.5 
µM. The measurements were all buffered with 50 mM HEPES, pH 7.5 and were done in presence of 
150 mM NaCl, 2 mM KCl and 20 mM MnCl2. In case of Tb3+ titration, the raw data were normalized by 
correction for volume changes.  
5.16 Fluorescence spectroscopy of TMPyP4 
Meso-5,10,15,20-Tetrakis-(N-methyl-4-pyridyl)porphine, Tetratosylate (TMPyP4) was purchased from 
Calbiochem. TMPyP4 was dissolved in water and 500 µM aliquots were stored in -20°C. Fluorescence 
spectra of the TMPyP4 were measured in presence of 6BX22 DNAzyme, the 6BX22 catalytic core only 
and unrelated DNA under standard reaction conditions in a volume of 120 μl. DNA titration (0-20 µM 
in 5 steps in presence of 2 µM TMPYP4) has been done in excitation wavelength of 433 nm with the slit 
width of 5 nm. Emission spectra were collected between 600 and 800 nm, the emission slit width was 
set to 5 nm160. The measurements were done with Varian Cary Eclipse Fluorescence Spectrophotometer. 
PMT detector was set at 700 V. TMPyP4 titration was performed at the same excitation and emission 
wavelengths in presence of 20 µM DNAs. 
5.17 Tb3+ luminescence spectroscopy 
Luminescence studies of 9F7 were performed using 1.2 nmol trimolecular format oligonucleotide 
complexes. Samples were annealed in 50-60 µl. Buffer and metal ions were added to reach final 
concentration of 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and indicated divalent metal ion to 
the final volume of 600 µl. The final oligonucleotide complex concentrations were 2 µM. The 
complexes were incubated at room temperature for 1 h to equilibrate with the bivalent metal ion and 
fold properly prior to Tb3+ titration.  
Tb3+ titration started by stepwise addition of 1 µl aliquots of concentrated Tb3+ solutions according to 
the table 5.16-1. Tb3+ titration were performed with CARY Eclipse Fluorescence Spectrophotometer 
using Kinetics software. The excitation wavelength was at 284 nm (slit 10 nm) and the emission was set 
on 545 nm (slit 10 nm). The settings for the data collection were as follows: total decay time: 0.02 s, 
number of flashes: 1, delay time: 0.2 ms, gate time: 5.0 ms. The detector voltage was 600-800 V and 
was adjusted to signal strength. Data acquisition started 10-20 seconds after addition of each Tb3+ 
aliquots. For 9F7 Tb3+ titrations the luminescence intensities after 10 min equilibration time are plotted. 
The titration curves were fitted to the equation: I = Imax*[Tb3+]n/([Tb3+]1/2n +[Tb3+]n).  




For Tb3+ luminescence studies of 6BX22, final oligonucleotide complex concentrations were 2 µM. 
measurements were performed in presence of 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and 
in presence or absence of 20 mM MnCl2 in 120 µl at 25°C. Tb3+ titrations started by addition of 1 µl of 
appropriate concentrated Tb3+ solutions. Tb3+ solution stocks were kept in -20°C.  
Table  5.17-1 Preparation of stock solutions for Tb3+ titration. Concentrated stock solutions for each step were prepared 
by dilution of two parent stock solutions of 10 and 100 mM TbCl3. 
Titration 
 step  
desired  Tb3+ 
concentration (µM) 
concentrated stock  
for each step ( µM)   
To make the concentrated stock  
Parent stock (µM)  
   
how much (µl)  H2O (µl) 
  1 1.00 601 10000 30.05 469.95 
2 1.50 302 10000 15.1 484.9 
3 2.00 303 10000 15.15 484.85 
4 3.00 606 10000 30.3 469.7 
5 4.00 608 10000 30.4 469.6 
6 5.00 610 10000 30.5 469.5 
7 7.00 1219 10000 60.95 439.05 
8 10.00 1831 10000 91.55 408.45 
9 12.00 1228 10000 61.4 438.6 
10 15.00 1842 10000 92.1 407.9 
11 20.00 3070 100000 15.35 484.65 
12 30.00 6140 100000 30.7 469.3 
13 40.00 6160 100000 30.8 469.2 
14 50.00 6180 100000 30.9 469.1 
15 70.00 12350 100000 61.75 438.25 
16 90.00 12390 100000 61.95 438.05 
17 100.00 6260 100000 31.3 468.7 
18 130.00 18640 100000 93.2 406.8 
19 150.00 12510 100000 62.55 437.45 
20 200.00 31150 100000 155.75 344.25 
 
5.18 DNase I probing 
For DNase probing assays, 2 pmol of nucleic acid complexes were annealed and further incubated at 
room temperature for 5 min with buffer and metal ions for proper folding in 10 µl.  1 µl DNase I buffer 
(10 mM Tris-HCl pH 7.6, 2.5 mM MgCl2, 0.5 mM CaCl2) and 1 µl DNase I (RNase free, NEB) were 
added to the samples. Samples incubated at 37°C for 10 min. The DNase I digestion stopped by addition 
of 3 µl of 3 M NaCl and 100 µl of ethanol and ethanol precipitation. Palettes were dried and dissolved 
in 3-5 µl H2O plus 3-5 µl of loading dye (80% formamide, 1xTBE, 50 mM EDTA, 0.0025% each of 
bromophenol blue and xylene cyanol).  
5.19 DMS probing 
DMS was performed according to the reported procedure by Li et al39. For DMS probing 2 pmol of 
DNA/RNA complexes were annealed in 5-7 µl. samples further incubated for 5 min at room 
temperature with reaction buffer and metal ions as stated for individual samples in final volume of 10 µl 
for proper folding. 1 µl of 2% dimethyl sulfate (DMS, from Riedel-de Haen) was added to the samples. 
Samples further incubated at room temperature for 10 min. Methylation was stopped by addition of 8 µl 




of DMS stop solution (1 M ß-mercaptoethanol and 1.5 M NaCl) and further ethanol precipitation. The 
palettes were dissolved in 50 µl of 10% piperidine and incubated at 90°C for 30 min. samples were 
dried in speedvac (35°C) and washed two times by addition of 100 µl H2O and subsequent vacuum 
drying in speedvac. Samples were dissolved in 3-5 µl H2O. Equal volume of loading dye was added to 
the samples prior to loading on a sequencing gel.  
For DMS probing of active 6BX22 complex in the time course of reaction 5 samples were prepared by 
annealing of 3 pmol of radiolabeled trimmed 6BX22 in presence of 30 pmol active substrates (R001 and 
Tr03). The annealing was performed in 7 µl. For one of the samples (control) only H2O was added to 
reach final 10 µl volume. For the other four samples buffer and metal ions were added to reach standard 
6BX22 reaction condition i.e. 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM KCl and 20 mM MnCl2. At 
time points after addition of Mn2+ (0, 5, 20 and 90 min) one of the samples were taken from 37°C and 
subjected for DMS methylation at room temperature in presence of 2% DMS. Methylation reactions 
were stopped after 10 min and piperidine cleavage was followed as explained.  
5.20 EMSA 
Binding assays have been performed in 5-10 µl. Samples were incubated either at room temperature and 
electrophoresed at room temperature or incubated on ice and electrophoresed at cold room (4°C). The 
gel plates used for casting the urea-free polyacrylamide gels for binding assays were 20 cm long , with 
0.4 mm spacer, except it is mentioned otherwise (8 cm). Concentrated protein samples were provided by 
the group of Dr. Vladimir Pena, Macromolecular Crystallography, Max Planck Institute for Biophysical 
Chemistry, Göttingen, Germany. 20 µl of 50 µM protein stocks were prepared by dilution of proteins in 
protein dilution buffer. Aliquots were deep frozen in liquid nitrogen and kept at -80°C. Prior to binding 
assays, protein samples were thawed at room temperature for 10 min and kept on ice afterwards.  The 
general buffers and solutions used in EMSA were prepared as follows. 
RNA dilution buffer     50 mM HEPES pH 7.5, 150 mM NaCl and 2 mM KCl 
Protein dilution buffer     50 mM HEPES pH 7.5, 150 mM NaCl, 10% v/v glycerol and 2 mM DTT 
5x TB         27 g Tris, 14 g boricacid, up to 500 ml H2O 
8% gel solution (0.5x TB) 3 ml 40% polyacrylamide, appropriate volume of 3 M MgCl2, 1.5 ml 5x TB, up to 15 
ml H2O  
Loading buffer 50% Glycerol: 10x Mg2+; 2:1. Loading buffer was prepared for each gel according to 
final concentration of Mg2+ in that special gel. 
5.20.1 Binding assay (strategy 1) 
 In the first strategy samples were diluted, first and annealed afterwards. Here as an example the 
procedure for Fig 3.2-2 B is explained. The procedures for other gels in Fig 3.2-2 are similar with slight 
changes in the amount of the present RNAs and the order of addition of the RNAs. 20 pmol non-
radiolabeled br3, 20 pmol U2 (R08) and 20 pmol of U6 snRNA were mixed in 5 µl in presence of RNA 




dilution buffer. Samples were sequentially diluted with 2.5 µl of RNA dilution buffer. At this stage, 
only 2.5 µl is remained to each tube and samples are named 2x because the final volume for the binding 
assay will be increased to 5 µl. Table 5.20-1 shows an example of the final concentration of the dilution 
series. 
Then, 1 µl of 1 nM radiolabeled *br3 was added to each samples. Samples were annealed in 
thermocycler programmed for 2 min 95°C and stepwise temperature decrease (5°C per min) down to 
20°C. To the 3.5 µl annealed samples, 1.5 µl of loading buffer was added to reach final volume of 5 µl. 
samples were loaded on 8% native gel containing 1x Mg2+ (in this case: 2 mM Mg2+) and 0.5x TB.  


















1 20 5 4 2.5 10 2 
2 10 5 2 2.5 5 1 
3 5 5 1 2.5 2.5 0.5 
4 2.5 5 0.5 2.5 1.25 0.25 
5 1.25 5 0.25 2.5 0.625 0.125 
6 0.625 5 0.125 2.5 0.3125 0.0625 
7 0.3125 5 0.0625 2.5 0.15625 0.03125 
8 0.15625 5 0.03125 2.5 0.078125 0.015625 
 
5.20.2 Binding assay (strategy 2) 
In the second strategy, samples were annealed at higher concentration and diluted afterwards with RNA 
dilution buffer. Additional RNA component or proteins were added to the dilute samples without further 
annealing. Here the procedure for Fig 3.2-4 A is explained. 10 nmol of trace labeled *br3 and 10 nmol 
of U2 RNA were annealed in presence of RNA dilution buffer in thermocycler programmed for 2 min 
95°C and stepwise temperature decrease (5°C per min) down to 20°C. Sample was diluted 100-fold by 
RNA dilution buffer. The 0.01 µM annealed oligonucleotide complexes were used for further annealing 
to the third RNA complex or protein or both. U6-sh snRNA and RNase H protein were diluted 
sequentially to the stated concentration, in RNA dilution buffer or protein dilution buffer. Binding 
assays were performed in 10 µl. 2 µl of protein (desired concentration) or protein dilution buffer 
(control) and 1 µl diluted U6-sh or only RNA dilution buffer (control), 1 µl 10x Mg2+, 3 µl 50% 
glycerol and 1 µl RNA dilution buffer were added to 2 µl of diluted annealed *br3 and U2. Samples 
were further incubated on ice for at least 1 h.  










lane 1 2 3 4 5 6 7 9 10 11 12 13 14 15 17 18 19 20 21 22 23 25 26 
final Rnase H (µM) 0 0.02 0.1 0.2 1 2 10 - 0 0.02 0.1 0.2 1 2 10   
final U6-sh (µM) - 0 0.002 0.01 0.,02 0.1 0.2 1 0 0.002 0.01 0.02 0.1 0.2 1   
final *br3+U2 (µM) 0.002 0.002 0.002 0.002 
 




5.21 Ribosomal interference by branched RNAs 
HemK mut3 DNA template for in vitro transcription was produced by PCR from HemK plasmid, using 
primers which introduced the mutations. Preparation of the DNA template and subsequent transcription 
of HemK mut3 mRNA was performed by Riccardo Belardinelli, department of Physical Biochemistry at 
Max Planck Institute for Biophysical Chemistry, Göttingen. Adaptor RNAs were transcribed in vitro 
from single stranded DNA template using T7 promoter. Kinetic scale mRNA branch formation (1 pmol) 
followed standard kinetic conditions for 10DM24 Tb3+ mediated acceleration (2:10:20 acceptor: DNA: 
donor, pH 7.5, 80 mM MgCl2 and 100 µM TbCl3 in 10 µl at 37°C). Preparative scale (500 pmol) mRNA 
branch formation was performed by 10DM24 deoxyribozyme in 200 µl for 20 min at 37°C.  
E. Coli 70S ribosome and aminoacylated tRNAs were purified in the department of Physical 
Biochemistry. IF1, IF2, IF3, EF-Tu and EF-G were recombinant and were provided from the same 
department. To form 70S initiation complex (IC), ribosomal subunits (0.1 μM), 3-fold excess of [3H] 
fMet-tRNAfMet (specific activity 3500 dpm/pmol) and initiation factors IF1, IF2 and IF3 were incubated 
with mRNA (0-0.5 μM) and GTP (0.5 mM) in buffer TAKM7 (Tris-HCl pH 7.5, NH4Cl 70 mM , KCl 
30 mM, MgCl2 7 mM) for 20 min at 37°C. The samples were passed through a nitrocellulose filter.  
Filters were washed with 3-4 ml of TAKM7 buffer, dried and their radioactivity was quantified in a 
scintillation cocktail.  In the absence of mRNA no 70S IC can be formed. Free [3H] fMet-tRNAfMet has 
lower molecular weight than the cut off of the filter and therefore passes through the filter. The amount 
of bound [3H] fMet-tRNAfMet to filter in the absence of mRNA was measured as background. After 
background correction the amount of incorporated [3H] fMet-tRNAfMet as a function of the ratio of 
mRNA over ribosomal subunits was plotted.  
To form pre-translocation complex, 70S IC was formed with 70S ribosome (0.3 µM), 3- fold excess of 
initiation factors and [3H] fMet-tRNAfMet (0.9 µM) and slight excess of mRNA and branched mRNAs 
(0.4 µM). This specific concentration of mRNA was used to perform the experiment at concentrations 
which the system is saturated with mRNA. Data in Fig 3.3-3 showed system reaches saturation by 1:1 
ratio of 70S and mRNA. In parallel activated ternary complex was prepared by mixing EF-Tu (1.2 µM) 
and GTP (1 mM). The mixture incubated 15 min at 37°C with phosphoenol pyruvate (PEP, 3 mM) and 
pyruvate kinase (PK, 0.02 units) in presence of TAKM7 buffer to avoid presence of GDP and therefore 
non-active EF-Tu. [14C] Glu-tRNAGlu (0.6 µM, specific activity 577 dpm/pmol) was added to the 
mixture and incubated further 2 min to form the ternary complex. The 70S IC were mixed to the 
activated ternary complex 1:1 and incubated for further 1-2 min. The samples filtered through the 
nitrocellulose filters and incorporated radioactivity was measured. Ternary complex has molecular 
weight below the nitrocellulose cut off. And therefore, the bound [14C] Glu-tRNAGlu  to the 
nitrocellulose represents the bound [14C] Glu-tRNAGlu to the 70S ribosome.  An aliquot of ternary 




complex in the absence of ribosomal subunits were filtered and the bound [14C] Glu-tRNAGlu were 
considered as background. 
For in vitro translation of HemK mRNA and its branched forms, 70S IC complexes were prepared with 
70S ribosome (0.1 μM) and 3-fold excess of non-radiolabeled fMet-tRNAfMet and initiation factors, as 
described earlier. mRNA concentration was 0.15 µM.  Elongation complexes were prepared by mixing 
EF-Tu (60 µM), EF-G (2 µM), MgCl2 (2 mM), DTT (2 mM), GTP (1 mM), PEP (3 mM) and PK (0.02 
units) in presence of TAKM7 buffer and 15 min incubation at 37°C. Total tRNA (30 µM) containing  1-
2 µM radiolabeled aminoacylated tRNA were added to the mixture and incubated for further 2 min. 
Two different combination of radiolabeled aminoacylated tRNA were used.   1) [3H] Gly-tRNAGly,  
6000 dpm/pmol and [14C] Pro-tRNAPro, 566 dpm/pmol, 2) [3H] Phe-tRNAPhe , 2480 dpm/pmol and [14C]  
Leu-tRNALeu , 187 dpm/pmol . 70S IC and elongation complexes were mixed 1:1 and incubated for 
further 10 min at 37°C. Reactions were quenched with 0.5 M NaOH and, 30 min at 37°C.  20 µl of 
glacial acetic acid, 20 µl BSA 10 µg/µl ,  1200 µl 10% trichloroacetic acid (TCA, ice-cold) added to the 
samples for precipitation at -20°C at least for 30 min. samples were filter and washed with 5 ml 6% 





6.1 List of DNAs  
Enzymatic core of the deoxyribozymes are marked with bold letter. Mutations from the original 
sequences are marked with red color. For minimized versions of deoxyribozymes the nucleotides 
remaining from the mutable region (linker region) are marked with purple color. DNA overhangs which 
were only present to accommodate proper DNA length for PAGE separation are marked with gray 
color. For the 3HJ forming deoxyribozymes i.e. 7S11 and 10DM24, the region which forms the P4 stem 
with the acceptor RNA is underlined. 
DNA description sequence 
   
D001 6BX22, original binding arms CGAAGCGCTAGAACATCAGGGGGAGCGAGCACTAATACAAGCGGGTAGGAGGC
CCTAGTACATGAGACTT  
D002 6BX22, original core, for standard substrates CAACGCTAGCACATCAGGGGGAGCGAGCACTAATACAAGCGGGTAGGAGGCCC
TAGTACATGAGAC 




D004 6BX22, rA mutant library  CAACAGCACATXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTAG
TACATGAGACTT X=rA/dN 5/95 
D005 6BX22, rG mutant library CAACAGCACATXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTAG
TACATGAGACTT X=rG/dN 5/95 
D006 6BX22, rC mutant library CAACAGCACATXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTAG
TACATGAGACTT X=rC/dN 5/95 
D007 6BX22, rU mutant library CAACAGCACATXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXTAG
TACATGAGACTT X=rU/dN 5/95 
D008 6BX22, trim+1 CAACGCTAGCACATCAGGGGGAGCGGCGGGTAGGAGGCCCTAGTACATGAGAC 
D009 6BX22, trim+8 CAACGCTAGCACATCAGGGGGAGCGAGCAAGCGGGTAGGAGGCCCTAGTACAT
GAGAC 
D010 6BX22, trim CAACGCTAGCACATCAGGGGGAGCTTGCGGGTAGGAGGCCCTAGTACATGAGA
C 
D011 6BX22, original core, for YBL059W GTTATTGCCTATGCATCAGGGGGAGCGAGCACTAATACAAGCGGGTAGGAGGC
CCTAGTAAACGTGTTCTTTG 
D012 6BX22, trimmed, for YBL059W  GTTATTGCCTATGCATCAGGGGGAGCTTGCGGGTAGGAGGCCCTAGTAAACGT
GTTCTTTG 
D013 6BX22, trimmed, for  branched RNA 7,8,9 CGAAGCGCTAGAACATCAGGGGGAGCTTGCGGGTAGGAGGCCCTAGTACATGA
GACTT  
D014 6BX22, original core, G6A CAACGCTAGCACATCAGGGAGAGCGAGCACTAATACAAGCGGGTAGGAGGCCC
TAGTACATGAGAC 
D015 6BX22, trimmed, G6A CAACGCTAGCACATCAGGGAGAGCTTGCGGGTAGGAGGCCCTAGTACATGAGA
C 
D016 6BX22, trimmed, G3A CAACGCTAGCACATCAAGGGGAGCTTGCGGGTAGGAGGCCCTAGTACATGAGA
C 
D017 6BX22, trimmed, G16A  CAACGCTAGCACATCAGGGGGAGCTTGCGAGTAGGAGGCCCTAGTACATGAGA
C 
D018 6BX22, trimmed, G20A  CAACGCTAGCACATCAGGGGGAGCTTGCGGGTAAGAGGCCCTAGTACATGAGA
C 
D019 6BX22, trimmed, G16C  CAACGCTAGCACATCAGGGGGAGCTTGCGCGTAGGAGGCCCTAGTACATGAGA
C 
D020 6BX22, trimmed, G16T  CAACGCTAGCACATCAGGGGGAGCTTGCGTGTAGGAGGCCCTAGTACATGAGA
C 
D021 6BX22, trimmed, G6C  CAACGCTAGCACATCAGGGCGAGCTTGCGGGTAGGAGGCCCTAGTACATGAGA
C 
D022 6BX22, trimmed, G6T  CAACGCTAGCACATCAGGGTGAGCTTGCGGGTAGGAGGCCCTAGTACATGAGA
C 
D023 6BX22, trimmed, dNAIM pool; dG r-7deaza G CAACGCTAGCACATCAXXXXXAXCTTXCXXXTAXXAXXCCCTAGTACATGAGA
C x= r-7deasa G/dG 5:95 
D024 6BX22, trimmed, dNAIM pool; dG rG   CAACGCTAGCACATCAXXXXXAXCTTXCXXXTAXXAXXCCCTAGTACATGAGA
C x= rG/dG 5:95 
D025 6BX22, trimmed, dNAIM pool; dG r-
Aminopurine 
CAACGCTAGCACATCAXXXXXAXCTTXCXXXTAXXAXXCCCTAGTACATGAGA
C x= r-Aminopurine/dG 5:95 
D026 6BX22, trimmed, dNAIM pool; dG r-m1G  CAACGCTAGCACATCAXXXXXAXCTTXCXXXTAXXAXXCCCTAGTACATGAGA
C x= r-m1G/dG 5:95 




DNA description sequence 
   
D028 template for Tr01 TCCGCGCTAGAACATACTATAGTGAGTCGTATTACAGCGTGCGT  
D029 template for Tr02 CCAGCACATACTATAGTGAGTCGTATTACAGCGTGCGT  
D030 template for Tr03 CCGCTAGCACATACTATAGTGAGTCGTATTACAGCGTGCGT  
D031 template for Tr04, YBL059W  CTATGTAAATAAGTTATGTTAGTAAACGTGTTCTTTGAGTATGAGGCCGAAGT
TATTGCCTATGCATACTATAGTGAGTCGTATTACAGCGTGCGT 
D032 template for Tr05 CGATGTTAGTACATGAGACTTCCTATAGTGAGTCGTATTACAG 
D033 template for Tr06 GAATGAAGCAATCGATGTTAGTACATGAGACTTCCTATAGTGAGTCGTATTAC
AG 
D034 template for Tr07 ATGGGATGCTGCAAGCGCTAGAACATACTATAGTGAGTCGTATTACAG 
D035 template for yU6snRNA(30-84) GTTCATCCTTATGCAGGGGAACTGCTGATCATCTCTGTATTGTTTCAAATTGA
CCTATAGTGAGTCGTATTACAG 
D036 forward primer for U6 starting at nt 30 (including 
20nt T7 promoter) 
CTGTAATACGACTCACTATAGGTCAATTTGAAACAATACAG 
D037 reverse primer for U6 ending with 102 AAATCTCTTTGTAAAACGGTTC  
D038 template for yU2-like fragment (binding to br3) CACATACTACACTTGATCTAAGCCAAAAGGCAAAGAGATTCTATAGTGAGTCG
TATTACAG 
D039 reverse primer for U6 upto BamH1 GTCCTTTAAAACGAAATAAATCTC 
D040 6BX22 minimized core CAGGGGGAGCTTGCGGGTAGGAGGCCC 
D041 D010 5'-binding arm complement to R05 CAACGCTAGCACAT 
D042 D010 3'-binding arm complement to R03 plus 
two nt overhang 
TAGTACATGAGACGCAC 
D043 splint for 3'-labeling of  6BX22 CoMA  GTAAGTCTCATGTACTp-3' 
D044 control DNA for terbium luminescence GAATGAAGCAATCGATGTTAGTACATGAGACTTCCTATAGTGAGTCG
TATTACAG 
D045 D010 3'-binding arm complement to R03 TAGTACATGAGAC 
D046 9F7 original CAACGTCGCCATCTCAATGAGGCTTGGCAGGGATTTAGTATTTTAACACTCCC
GGGTAGTCGTATTA 
D047 9F7 short binding arm for CoMA CAACATCTCAATGAGGCTTGGCAGGGATTTAGTATTTTAACACTCCCGGGTAG
TCGTATTA  
D048 9F7 rA mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAG
TCGTATTA X=rA/dN 5/95 
D049 9F7 rG mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAG
TCGTATTA X=rG/dN 5/95 
D050 9F7 rC mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAG
TCGTATTA X=rC/dN 5/95 
D051 9F7 rU mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAG
TCGTATTA X=rU/dN 5/95 
D052 9F7 trim-3 CAACGTCGCCATCTCAATGAGGCTTGGCAGGGCCCGGGTAGTCGTATTA 
D053 9F7 trim-2 CAACGTCGCCATCTCAATGAGGCTTGGCAGGGTCCCGGGTAGTCGTATTA 
D054 9F7 trim-1 CAACGTCGCCATCTCAATGAGGCTTGGCAGGGCTCCCGGGTAGTCGTATTA 
D055 9F7 trim CAACGTCGCCATCTCAATGAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D056 9F7 trimmed with binding arm for "1G" donor  TGGTGTGGATGTTAATGAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D057 9F7 trimmed, blunt end for Tb lumin.  CCGTCGCCATCTCAATGAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D058 9F7 G4A, trimmed, blunt  CCGTCGCCATCTCAATAAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D059 9F7 G4C, trimmed blunt CCGTCGCCATCTCAATCAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D060 9F7 G4T, trimmed blunt CCGTCGCCATCTCAATTAGGCTTGGCAGGGACTCCCGGGTAGTCGTATTA 
D061 template for Tr12 CCGTCGCCATCTCTTGGTATAGTGAGTCGTATTACAG 
D062 template for Tr13 CCATCTCTTGGTATAGTGAGTCGTATTACAG 
D063 template for 9F7 "1G" donor TGGTGTGGATGTTATTCTATAGTGAGTCGTATTACAGT 
D064 complementary to donor substrate for HPLC 
analysis 
CCGTCGCCATCTCTTCC 
D065 9F13 original  CAACGTCGCCATCTCAGGATGTGGGGTTTTGCCCGAGGGTATGGCAGTGGGGA
GAGAGTCGTATTA 
D066 9F13 short binding arm for CoMA CAACATCTCAGGATGTGGGGTTTTGCCCGAGGGTATGGCAGTGGGGAGAGAGT
CGTATTA 
D067 9F13 rA mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGAGT
CGTATTA X=rA/dN 5/95 
D068 9F13 rG mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGAGT
CGTATTA X=rG/dN 5/95 
D069 9F13 rC mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGAGT
CGTATTA X=rC/dN 5/95 
D070 9F13 rU mutant library CAACATCTCXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXGAGT
CGTATTA X=rU/dN 5/95 
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D072 9F13 minus 14nt CAACATCTCAGGATGTGGGGTTTTGCCCGGGGAGAGAGTCGTATTA 
D073 9F13 replace 14nt by 1xT CAACATCTCAGGATGTGGGGTTTTGCCCTGGGGAGAGAGTCGTATTA 
D074 9F13 replace 14nt by 2xT CAACATCTCAGGATGTGGGGTTTTGCCCTTGGGGAGAGAGTCGTATTA 
D075 9F13 replace 14nt by 3xT CAACATCTCAGGATGTGGGGTTTTGCCCTTTGGGGAGAGAGTCGTATTA 
D076 9F13 minus 3xT CAACATCTCAGGATGTGGGGTGCCCGAGGGTATGGCAGTGGGGAGAGAGTCGT
ATTA 
D077 9F13 combination CAACATCTCAGGATGTGGGGTTGCCCTTTGGGGAGAGAGTCGTATTA 
D078 9F13 trimmied CAACATCTCAGGATGTGGGGTGCCCTTGGGGAGAGAGTCGTATTA 
D079 6CE8 original enzyme CAACGCGCTAGAACATGGCACTCAGAGCGCACGGCGAGTACATGAGACT 
D080 template for Tr15 CCGCGCTAGAACATTCTATAGTGAGTCGTATTACAGT 
D081 7S11 CCGTCGCCATCTCCAGTGCAGGGCGTGAGGGCTCGGTTCCCGTATTATCC 
D082 10DM24 original CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAGGGTTCCATTCCCGTATTATC
C 
D083 10DM24 for R05 G10C (R17) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAGGGTTCCATTCCGGTATTATC
C 
D084 10DM24 for R05 G10A (R18) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAGGGTTCCATTCCTGTATTATC
C 
D085 10DM24 for R05 G10A (R19) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAGGGTTCCATTCCAGTATTATC
C 
D086 10DM24 for R05 G10A (R20) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGACGGTTCCATTCCCGTATTATC
C 
D087 10DM24 for R05 G10A (R21) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGATGGTTCCATTCCCGTATTATC
C 
D088 10DM24 for R05 G10A (R22) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAAGGTTCCATTCCCGTATTATC
C 
D089 10DM24 for R05 double mutant UAU (R23) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAAGGTTCCATTCCAGTATTATC
C 
D090 10DM24 for R05 double mutant UAU (R24) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGATGGTTCCATTCCAGTATTATC
C 
D091 10DM24 for R05 double mutant UAU (R25) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGATGGTTCCATTCCTGTATTATC
C 
D092 10DM24 for R05 double mutant UAU (R26) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAAGGTTCCATTCCTGTATTATC
C 
D093 10DM24 for R05 double mutant UAU (R27) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGACGGTTCCATTCCTGTATTATC
C 
D094 10DM24 for R05 double mutant UAU (R28) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGATGGTTCCATTCCGGTATTATC
C 
D095 10DM24 for R05 double mutant UAU (R29) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGAAGGTTCCATTCCGGTATTATC
C 
D096 10DM24 for R05 double mutant UAU (R30) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGACGGTTCCATTCCGGTATTATC
C 
D097 10DM24 for R05 double mutant UAU (R31) CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGACGGTTCCATTCCAGTATTATC
C 
D098 10DM24 for A40 in yU6snRNA  CCGTCGCCATCTCCCGTAGGTGAAGGGCTTGTTGGTTCCATTCCCAAATTGAC
C 
D099 10DM24 for A51 in yU6snRNA  CCGTCGCCATCTCCCGTAGGTGAAGGGCTCATCGGTTCCATTCCCTGTATTGT
TTC 
D100 10DM24 for A56 in yU6snRNA  CCGTCGCCATCTCCCGTAGGTGAAGGGCGCTGAGGTTCCATTCCCATCTCTGT
ATTG 
D101 10DM24 for A62 in yU6snRNA  CCGTCGCCATCTCCCGTAGGTGAAGGGCGGAACGGTTCCATTCCGCTGATCAT
CTC 
D102 10DM24 for A76 in yU6snRNA  CCGTCGCCATCTCCCGTAGGTGAAGGGCCATCCGGTTCCATTCCTATGCAGGG
GAAC 
D103 10DM24 for A29 in RNA model R33  CCGTCGCCATCTCCCGTAGGTGAAGGGCCGCATGGTTCCATTCCTGAAACGTG
GC 
D104 10DM24 for A20 in RNA model R34 CCGTCGCCATCTCCCGTAGGTGAAGGGCTACGTGGTTCCATTCCTAGAAGAAG
AC 
D105 10DM24 for A33 in RNA model R34  CCGTCGCCATCTCCCGTAGGTGAAGGGCAGTTCGGTTCCATTCCTTAGCAATA
CG 
D106 10DM24 for A35 in RNA model R34  CCGTCGCCATCTCCCGTAGGTGAAGGGCTTAGTGGTTCCATTCCCTTTAGCAA
TA 
D107 10DM24 for A10 in Tr16 CCGTCGCCATCTCCCGTAGGTGAAGGGCCAAGCGGTTCCATTCCAGCTTTCC 
D108 10DM24 for A18 in Tr16 CCGTCGCCATCTCCCGTAGGTGAAGGGCCGAGAGGTTCCATTCCCCCAAAGCT 
D109 10DM24 for A24 in Tr16 CCGTCGCCATCTCCCGTAGGTGAAGGGCTAGTCGGTTCCATTCCCAGAGATCC
CA 
D110 10DM24 for A23 in Tr17 CCGTCGCCATCTCCCGTAGGTGAAGGGCAAGCCGGTTCCATTCCCCTTTAGTC 
D111 10DM24 for A32 in Tr17 CCGTCGCCATCTCCCGTAGGTGAAGGGCTGTCCGGTTCCATTCCTAAAAGCCT
CC 
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D113 10DM24 for A48 in Tr17 CCGTCGCCATCTCCCGTAGGTGAAGGGCTCGACGGTTCCATTCCCAATATTAC
GT 
D114 10DM24 for A53 in Tr17 CCGTCGCCATCTCCCGTAGGTGAAGGGCCACGGGGTTCCATTCCCGACTCAAT
ATT 
D115 10DM24 for A82 in HemK mRNA GTCGGGTCGGGTCTCCCGTAGGTGAAGGGCAGTGTGGTTCCATTCCGATATTC
CATAT 
D116 10DM24 for A92 in HemK mRNA GTCGGGTCGGGTCTCCCGTAGGTGAAGGGCTCGCGGGTTCCATTCCACCAGTG
TTGAT 
D117 10DM24 for A13 in R35 CCGTCGCCATCTCCCGTAGGTGAAGGGCCACCAGGTTCCATTCCCCTTTCGGG
AAC 
D118 10DM24 for A20 in R35 CCGTCGCCATCTCCCGTAGGTGAAGGGCGTGATGGTTCCATTCCCCACCATCC
TT 
D119 10DM24 for A21 in R35 CCGTCGCCATCTCCCGTAGGTGAAGGGCGGTGAGGTTCCATTCCTCCACCATC
C 
D120 10DM24 for A38 in SAM-III CCGTCGCCATCTCCCGTAGGTGAAGGGCGGTGAGGTTCCATTCCTCCACCATC
C 
D121 10DM24 for A44 in SAM-III CCGTCGCCATCTCCCGTAGGTGAAGGGCGGTGAGGTTCCATTCCTCCACCATC
C 
D122 10DM24 for A44 in SAM-III, for ATP  AACAACAACCGTCGCCATCTCCCGTAGGTGAAGGGCCCCCTGGTTCCATTCTT
CGGTTACAAGGCA 
D123 9DB1 for SAM-III (27|28) TCGGTTACAAGGCATGGATCATACGGTCGGAGGGGTTTGCCGTTTAGGTGATT
CCACCATCCTTTCGG 
D124 E5112 for cleavage of SAM-III at A20 CATCTGGTGAGTCAGCTGACTCGAACCACCATCCTT 
D125 E5112 for cleavage of SAM-III at A44 ATTCCCCCGTCAGCTGACTCGAATCGGTTACAAGG 
D126 10-23 for cleavage of SAM-III at G36 AACCCCCTTTCGGTTAGGCTAGCTACAACGAAAGGCATCTGGTGA 
D127 8-17  U6A51   Cl-I GCTGATCATTCCGAGCCGGACGACTGTATTGTTTCAAATTGACACACACACAC
ACA      
D128 8-17  U6A76   Cl-II ACACACACACACACGTAAAACGGTTCATCTCCGAGCCGGACGATATGCAGGGG
AAC     
D129 10-23 U6A35   An-i TATTGTTTCAAAGGCTAGCTACAACGATGACCAAATGTCCACACACACACACA
CAC 
D130 8-17  U6A62   An-ii TCATCCTTATGCAGGGGAATCCGAGCCGGACGAGCTGATCATCTCACACACAC
ACA       
D131 8-17  U6A97   An-iii AAAACGAAATAAATTCCGAGCCGGACGACTTTGTAAAACGGACACACACACAC
ACA       
D132 DNA helper for NTP attachment GAAGAGATGGCGACGG 
D133 template for Tr16 ACACGGTCGACTCAATATTACGTGTCCTTAAAAGCCTCCTTTAGTCTATAGTG
AGTCGTATTACAG 
D134 template for Tr17 TAGTCTCGAGATCCCAAGCTAGCTTTCCTATAGTGAGTCGTATTACAG 
D135 template for SAM-III (28-53) ATTCCCCCTTTCGGTTACAAGGCATCTATAGTGAGTCGTATTACAG  
D136 Disruptor 1 (to be used for labeling at position 
20, complementary to 32-53 of SAM-III  ligated 
ATTCCCCCTTTCGGTTACAAG 
D137 Disruptor 2 (to be used for labeling at position 
44, complementary to 1-22 of SAM-III ligated 
ATTCCACCATCCTTTCGGGAAC 
D138 primer for U6 GTCCTTTAAAACGAAATAAATCTC 
D139 template for generic adaptor-1 GTCGGGTCGGGTCTCTTCCTATAGTGAGTCGTATTACAGCGT 
D140 template for generic adaptor-2 TGCTGCTGCTGCTTGTCGGGTCGGGTCTCTTCCTATAGTGAGTCGTATTACAG
CGT 
D141 disruptor for 3'-end of HemK14 mRNA AAGTTGGCTAAATG 





6.2 List of synthetic RNAs 
RNA Description sequence 
R01 6BX22 acceptor substrate AAGUCUCAUGUACUAACAUCGAUUG 
R02 6BX22 acceptor substrate with no overhang GUCUCAUGUACUAA 
R03 6BX22 acceptor substrate C overhang GUCUCAUGUACUAAC 
R04 6BX22 acceptor substrate CAU overhang GUCUCAUGUACUAACAU 
R05 6BX22 inactive donor substrate GUAUGUGCUAGCGG 
R06 6BX22 substrate 5'-A mutant AUAUGUGCUAGCGG 
R07 6BX22 acceptor substrate GGAAGUCUCAUGUACUAACA 
R08 part of U2snRNA UGCUUAGAUCAAGUGUAGUAUGUGAGA 
R09 6BX22 acceptor substrate  UCUCAUGUACUAACA 
R10 RNA for complex formation with yU6snRNA GUCUGUAU 
R11 RNA for complex formation with yU6snRNA UGCUUAGAUCUAGUAGUCUGUAU 
R12 acceptor substrate for 9F7(A14) and 9F13 (U13) UAAUACGACUCACUAUA 
R13 R012 A14dA UAAUACGACUCACU(dA)UA 
R14 5'-delta Tr015, RNA helper for NTP attachment GAAGAGAUGGCGACGG 
R15 Tr012 analogue GGAAGAGAUGGCGACGG 
R16 10DM24 acceptor RNA GGAUAAUACGACUCAC 
R17 R016 analog G10C GGAUAAUACCACUCAC 
R18 R016 analog G10A GGAUAAUACAACUCAC 
R19 R016 analog G10U GGAUAAUACUACUCAC 
R20 R016 analog C12G GGAUAAUACGAGUCAC 
R21 R016analog C12A GGAUAAUACGAAUCAC 
R22 R016 analog C12U GGAUAAUACGAUUCAC 
R23 R016 analog double mutant G10UC12U GGAUAAUACUAUUCAC  
R24 R016 analog double mutant G10UC12A GGAUAAUACUAAUCAC  
R25 R016 analog double mutant G10AC12A GGAUAAUACAAAUCAC  
R26 R016 analog double mutant G10AC12U GGAUAAUACAAUUCAC  
R27 R016 analog double mutant G10A/C12G GGAUAAUACAAGUCAC  
R28 R016 analog double mutant G10C/C12A GGAUAAUACCAAUCAC  
R29 R016 analog double mutant G10C/C12U GGAUAAUACCAUUCAC  
R30 R016 analog double mutant G10C/C12G GGAUAAUACCAGUCAC  
R31 R016 analog double mutant G10U/C12G GGAUAAUACUAGUCAC  
R32 RNA model for GTP ligation-1 GGCCACGUUUCAAAUGCGUGCU 
R33 RNA model for GTP ligation-2 GUCUUCUUCUAAACGUAUUGCUAAAGAACUAA  
R34 5'part of SAM-III (1-27), for 9DB1 ligation, GAAU loop GUUCCCGAAAGGAUGGUGGAAUCACCA 
R35 6CE8, acceptor substrate AGUCUCAUGUACUAUCG 
  





6.3 List of transcribed RNAs 
Transcript Description sequence 
   
Tr01 6BX22 donor original GUAUGUGCUAGCGG 
Tr02 6BX22 donor short GUAUGUGCUGG 
Tr03 6BX22 donor (standard donor in this 
thesis) 
GUAUGUUCUAGCGCGGA 




Tr05 6BX22 acceptor for br7 GGAAGUCUCAUGUACUAACAUCG 
Tr06 6BX22 acceptor for br8 GGAAGUCUCAUGUACUAACAUCGAUUGCUUCAUUUC 
Tr07 6BX22 donor for br9 GUAUGUUCUAGCGCUUGCAGCAUCCCAU 
Tr08 yeast U6snRNA (30-84) GGUCAAUUUGAAACAAUACAGAGAUGAUCAGCAGUUCCCCUGCAUAAGGAUGAAC 
Tr09 yeast U6snRNA (1-102) GGUUCGCGAAGUAACCCUUCGUGGACAUUUGGUCAAUUUGAAACAAUACAGAGAUGAUCAGCAGUU
CCCCUGCAUAAGGAUGAACCGUUUUACAAAGAGAUUU 
Tr10 yeast U6snRNA upto BamH1 GGUUCGCGAAGUAACCCUUCGUGGACAUUUGGUCAAUUUGAAACAAUACAGAGAUGAUCAGCAGUU
CCCCUGCAUAAGGAUGAACCGUUUUACAAAGAGAUUUAUUUCGUUUUAAAGGATC  
Tr11 yeast U2-like RNA, partly 
complement with br3 
GAAUCUCUUUGCCUUUUGGCUUAGAUCAAGUGUAGUAUGUG 
Tr12 9F7,9F13,10DM24 donor original GGAAGAGAUGGCGACGG 
Tr13 9F7,9F13,10DM24 donor short GGAAGAGAUGG 
Tr14 9F7 donor "1G" GAAUAACAUCCACACCA 
Tr15 6CE8 donor substrate GAAUGUUCUAGCGCGG 
Tr16 RNA model for GTP attachment-1 GGAAAGCUAGCUUGGGAUCUCGAGACUA 
Tr17 RNA model for GTP attachment-2 GACUAAAGGAGGCUUUUAAGGACACGUAAUAUUGAGUCGACCGUGU  
Tr18 SAM-III (28-53) GAUGCCUUGUAACCGAAAGGGGGAAU 
Tr19 HemK mRNA up to BamHI site GGUUCGCGAAGUAACCCUUCGUGGACAUUUGGUCAAUUUGAAACAAUACAGAGAUGAUCAGCAGUU
CCCCUGCAUAAGGAUGAACCGUUUUACAAAGAGAUUUAUUUCGUUUUAAAGGATC  
Tr20 adapter 1- for ribosomal interference GGAAGAGACCCGACCCGAC  






6.4 List of branched products (preparative scale) 
branched 
products acceptor donor enzyme 
 br1 R12 Tr12 9F7 brP used for 9F7 DMS and DNase probing 
br2 R01 Tr03 6BX22 
brP used for 6BX22 DMS and DNase probing and CD analysis and also used for splicing 
assays 
br3 R07 Tr01 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br4 R01 Tr01 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br5 R01 Tr02 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br6 R04 Tr02 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br7 Tr05 Tr01 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br8 Tr06 Tr01 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br9 R01 Tr07 6BX22 brP used for splicing assays in collaboration with department of Cellular Biochemistry 
br10 R07 Tr03 6BX22 brP used for binding assays 
br11 Tr19 Tr20 10DM24 brP used for ribosomal interference 














3HJ Three helix junction 
6MI 6-methylisoxanthopterin 
70S IC 70S initiation complex 
A adenine 
Å angstrom 
aatRNA aminoacylated tRNA 
ABTS 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) 
APS ammonium persulfate 
ATP adenosine triphosphate 
AuNPT gold nanoparticles 
AUR Amplex UltraRed 
BP branch point 
bp base pair 
brP branched product 




CD Circular Dichroism 
CHES N-Cyclohexyl-2-aminoethanesulfonic acid 
Ci Curie; 1Ci=37 Gigabecquerel 
CIAP Calf intestinal alkaline phosphatase 
CoMA combinatorial mutation interference analysis 
CTP cytidine triphosphate 
Cy cyanine 
dATP deoxyadenosine triphosphate 
dCTP deoxycytidine triphosphate 





DNA deoxyribonucleic acid 
dNAIM DNA-nucleotide analogue interference mapping 
Dt Trimmed DNA 
DTP 2,6-diaminopurine ribonucleoside triphosphate 
DTS DNA-templated synthesis  
DTT dithiothreitol 
dTTP deoxythymidine triphosphate 
E.Coli Escherichia coli 
EDTA Ethylenediaminetetraacetic acid 
EF-G elongation factor-G 
EF-Tu elongation factor thermo unstable 
ELISA enzyme-linked immunosorbent assay 
EPR Electron Paramagnetic Resonance 
ESIPT Excited-state intramolecular proton transfer 
FAM 5-carboxyfluorescein 




glucosamine-6-phosphate activated riboswitch 
GTP guanosine triphosphate 
h hour 
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid  
HPLC High-performance liquid chromatography 




IF initiation factor 
iS inactivated substrates 
ISL internal stem loop 
IVS intervening sequence 
L-arm left binding arm 
m1G 1-methyl guanosine 
MANT-GTP 2'- / 3'- O- (N'- Methylanthraniloyl)guanosine- 5'- O- triphosphate 
MB methylene blue 
min minute 
MMLV-RT moloney mouse leukemia virus reverse transcriptase 
mRNA messenger RNA 
ms millisecond 
MS mass spectroscopy 
nm nanometer 
nt nucleotide 
NTP nucleoside triphosphate 
PAGE polyacrylamide gel electrophoresis 
PCR polymerase chain reaction 
PEG Polyethylene glycol 
PELDOR pulsed electron–electron double resonance 
PK pyruvate kinase 
PNK polynucleotide 5'-hydroxyl-kinase 
PS phosphorothioate 
R-arm right binding arm of a deoxyribozyme 
RCA rolling circle amplification 
RF release factors 
rN ribonucleotide 
RNA ribonucleic acid 
RRF ribosomal release factor 
RRM RNA recognition motif domain 
rRNA Ribosomal RNA 
S.cer. Saccharomyces cerevisiae 
SAM S-adenosyl- methionin 
SD Shine-Dalgarno 
snNRA small nuclear ribonucleic acid 




TBAF Tetrabutylamonium fluoride 
TBE Tris Borate EDTA 
TCA Tricloroacetic acid 
TEMED Tetramethylethylenediamine 
Tm melting temperature 
TMB 3,3’,5,5’-tetramethylbenzidine sulfate 
TMPyP4 meso-5,10,15,20-Tetrakis-(N-methyl-4-pyridyl)porphine 
TOM [(triisopropylsilyl)oxy]methyl 
TPP Thiamine pyrophosphate 
TPP thiamin pyrophosphate 
trim trimmed 
TTP thymidine triphosphate 
tRNA transfer RNA 
U uracil 
UTP uridine triphosphate 
UV ultra violet 
W.C. Watson-Crick base pairing 
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